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Abstract 
 
Prymnesium parvum is a harmful microalga which produces glycosylated ichthyotoxic 
metabolites called prymnesins.  This thesis describes the synthesis of chemical tools to 
explore the biosynthesis and detection of prymnesins. 
Sugar-nucleotides proposed to be involved in the glycosylation of prymnesins were 
synthesised.  UDP-α-ᴅ-galactofuranose was biosynthesised from chemosynthetic Galf-1-P 
using galactose-1-phosphate uridylyltransferase.  GDP-α-ᴅ-arabinopyranose and GDP-β-ʟ-
xylopyranose were proposed to be involved in the biogenesis of ʟ-xylofuranose, and were 
stereoselectively synthesised by direct displacement of an acylated glycosyl bromide with 
GDP.  Multiple reaction monitoring transitions for the NDP-sugars were recorded using 
porous graphitic carbon column based LC-MS, as standards for profiling algal cell extracts. 
Prymnesins share a conserved terminal bis-alkyne, which may prove a useful biomarker.  Bis-
alkyne standards were synthesised by Cadiot-Chodkiewicz coupling, and used to show that 
there was no appreciable difference in reactivity between terminal alkynes and bis-alkynes 
under CuAAC conditions.  CuAAC based toxin detection shows potential; coupling of 
authentic prymnesins with 3-azido-7-hydroxycoumarin gave fluorescent species which were 
separable by TLC and visible under UV-light.  Raman detection was also explored, but was 
dismissed due to fluorescent quenching by algal pigments. 
Sugar-glycerol compounds inspired by prymnesin’s glycosylated backbone were chemically 
synthesised.  Neighbouring group participation was utilised to synthesise 1,2-trans 
glycosides.  SnCl2 promoted glycosylation with furanosyl fluorides gave 1,2-cis furanosides 
with moderate stereocontrol, whilst TMSOTf promoted glycosylation with pyranosyl 
imidates gave 1,2-cis pyranosides with excellent stereocontrol.  1,2-trans Sugar-glycerol 
fragments gave NMR signals closer to prymnesin literature values than 1,2-cis fragments. 
Two fragments of prymnesin-1 glycosylated with α-ʟ-arabinopyranose and α-ᴅ-ribofuranose 
were chemically synthesised.  Possible CuAAC and carbodiimide conjugation of the 
fragments to a carrier protein for anti-prymnesin-1 antibody production was considered.  
Because the stereochemistry of the prymnesin backbones at this region is undefined, both 
the 2R- and 2S- glycerol isomers were synthesised.  The separated isomers were 
distinguished by comparing NOESY NMR with computational models. 
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List of Abbreviations 
 
[α]D specific rotation at 589 nm, 20 °C 
°C degree Celsius 
Å Ångstrom 
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Ac2O acetic anhydride 
AcOH acetic acid 
AgOTf silver triflate 
aq aqueous 
Ar aromatic  
Araf arabinofuranose 
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AuNP gold nanoparticle 
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bp boiling point 
BSA bovine serum albumin 
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COSY homonuclear correlation spectroscopy 
CuAAC Cu(I)-catalysed azido-alkyne cycloaddition  
d doublet 
DAST diethylaminosulfur trifluoride 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
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DCM dichloromethane 
dd doublet of doublets 
DMAP 4-dimethylaminopyridine 
DMF N,N-dimethylformamide 
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2D-NMR two-dimensional nuclear magnetic resonance spectroscopy 
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g grams 
× g times gravity 
Gal galactose 
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GC-MS gas chromatography–mass spectrometry  
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GT glucosyltransferase 
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Hex n-hexane from petroleum distillate 
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HRMS high resolution mass spectrometry 
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Hz Hertz 
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K Kelvin 
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L litre 
LC liquid chromatography 
LC-MS liquid chromatography–mass spectrometry  
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LRMS low resolution mass spectrometry 
m  multiplet 
M molarity 
mol moles 
m/z mass to charge ratio 
MALDI-TOF matrix-assisted laser desorption ionization time of flight 
Man D-mannose 
mCBPA meta-chloroperoxybenzoic acid 
MeOH methanol 
MeCN acetonitrile 
MHz megahertz 
min minutes 
MRM multiple reaction monitoring 
MQ Milli-Q® 
ms milliseconds 
MU mass units 
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NAD(P)H nicotinamide adenine dinucleotide phosphate 
NaOMe sodium methoxide 
NDP nucleotide diphosphate 
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note: R will be defined as necessary. 
NMR nuclear magnetic resonance 
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NOESY nuclear Overhauser effect spectroscopy 
NTP Nucleotide triphosphate 
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Pi Inorganic phosphate 
pKa acid dissociation constant 
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ppm parts per million 
n-PrOH 1-propanol 
PRM-1 prymnesin-1 
PRM-2 prymnesin-2 
PRM-B1 prymnesin-B1 
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Pyr pyridine 
qPCR quantitative polymerase chain reaction 
R generic group.  Note: may be defined in the text. 
Rf retention factor 
Ribf ribofuranose 
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SPC solid phase cytometry 
t triplet 
tR retention time 
T-7-HC 1,2,3-triazol-7-hydroxycoumarin 
TBAF tetrabutylammonium fluoride 
TES triethylsilyl 
TFA trifluoroacetic acid  
THF tetrahydrofuran 
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TLC thin layer chromatography 
TMS trimethylsilyl 
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UEA University of East Anglia 
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Xylf xylosfuranose 
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δ chemical shift 
λa absorption at give wavelength 
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General Experimental Conditions 
 
Reagents and anhydrous solvents were supplied by Sigma Aldrich, and were used without 
further purification.  Analytical grade solvents were supplied by Fischer Scientific.  Protected 
sugars which were not synthesised the lab were supplied by Carbosynth.  Glassware was 
oven-dried and purged with nitrogen immediately before use, and reactions requiring inert 
atmosphere were run under N2.   
Reactions were monitored by thin-layer chromatography (TLC) on aluminium-backed, pre-
coated silica gel plates (Silica Gel 60 F254, E. Merk) with the indicated eluents, and the TLC 
plates were visualised under UV light (λ 254 nm) and charring by dipping in ethanol-sulfuric 
acid (95:5, v/v) followed by heating.  Semi-preparative TLC was run on Analtech preparative 
uniplates (silica gel 1000 micron, 20 × 20 cm) and flash column chromatography (FCC) was 
performed on a Biotage Horizon Isolera One using pre-packed SNAP ULTRA 25 µm silica gel 
cartridges.   
NMR spectra were recorded using a Bruker Ultrashield Plus 400 spectrometer at 298 K and 
analysed using TopSpin 3.5pl5 software.  Chemical shifts (δ) are reported in parts per million 
(ppm) with respect to internal tetramethylsilane or the residual HOD signal in D2O.  NMR 
assignments were made with the aid of COSY and HSQCed experiments 
Optical rotation values were measured using a Perkin Elmer® Model 341 Polarimeter at 20 
°C at a wavelength of 589 nm (sodium D line) unless otherwise noted. Infrared spectra were 
recorded using a Perkin Elmer® SpectrumBX and UV-vis spectra using a Varian 50 Bio 
spectrometer.  
Low resolution mass spectrometry (LRMS) was employed for monitoring some reactions 
using an Advion Expression L CMS spectrometer by direct injection or extraction from a TLC 
plate using an Advion Plate Express, with methanol/formic acid (0.1%) (9:1) used as the 
mobile phase.  For high resolution mass spectrometry (HRMS), the samples were diluted into 
methanol/formic acid (0.1%) (1:1) and infused into a Synapt G2-Si mass spectrometer 
(Waters, Manchester, UK) at 5-10 µL min-1 using a Harvard Apparatus syringe pump. The 
mass spectrometer was controlled by Masslynx 4.1 software (Waters). It was operated in 
high resolution and positive ion mode and calibrated using sodium formate. The sample was 
analysed for 2 min with 1 s MS scan time over the range of 50-1200 m/z with 3.5 kV capillary 
voltage, 40 V cone voltage, 120°C cone temperature. Leu-enkephalin peptide (1 ng µL-1, 
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Waters) was infused at 10 µL min-1 as a lock mass (m/z 556.2766) and measured every 10 s. 
Spectra were generated in Masslynx 4.1 by combining a number of scans, and peaks were 
centred using automatic peak detection with lock mass correction.  
Ion exchange chromatography was performed using a Poros® HQ 50 strong anion exchange 
column on a Dionex™ Ultimate 3000 HPLC system running Chromeleon™ software.  Sugar 
nucleotide profiling was performed using a Hypercarb™ Porous Graphitic Carbon LC Column 
coupled to a Xevo® TQ-XS triple quadrupole mass spectrometer running Intellistart and 
MassLynx software.  The column conditions and gradient details are given in the appropriate 
experimental sections. 
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1.1 Prymnesium parvum 
Prymnesium parvum is a marine haptophyte which is ubiquitous in temperate and sub-
tropical climates around the globe.1  It is a unicellular alga which is usually 8-11 µm long and 
4-6 µm wide (Figure 1.1).2  P. parvum has two equal flagella of about 12-15 µm which it uses 
for mobility, and a haptonema of 3-5 µm which may be used for attachment.2,3  It is 
commonly known as ‘golden algae’ due to the gold yellow colour of blooms; this is a result 
of yellow pigments in the chloroplasts, which lie either side of the nucleus.4  P. parvum 
utilises chrysolaminarin (a mixed linkage β-1,3/6 glucan)5 instead of starch (an α-1,4/6 linked 
glucan used by plants) as the storage polysaccharide.  It is a mixotroph, storing energy 
photosynthetically when in the euphotic zone (upper layer of a waterbody with sufficient 
light for photosynthesis) and heterotrophically by phagotrophy when presented with algal 
prey.6  
 
Figure 1.1 - Left: schematic overview of P. parvum; Right: Optical microscopy image of P. parvum (used 
with permission from Ben Wagstaff, John Innes Centre) 
 
1.1.1 Toxic blooms world-wide 
P. parvum has been linked to harmful algal blooms resulting in large scale fish kills all around 
the world (Figure 1.2).  It is mainly found in cooler marine and brackish waters, and was first 
identified in Holland by Liebert and Deerns in 1920.7  It has since been attributed to 
numerous large scale fish kills which have been thoroughly reviewed by S. Watson at the 
Texas Parks and Wildlife department.4  What is striking is both the diversity in affected fish 
species and the geographical range of harmful P. parvum blooms.  Despite being classified as 
a marine alga, there is also a steady increase in the occurrence of harmful P. parvum blooms 
in inland brackish water systems.1  Whilst it is not immediately obvious why P. parvum is 
being found outside of the marine environment, proposed vectors for its introduction to 
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brackish systems include ship bilge water and encystment (the dispersion of dormant cysts 
which break down to active microbes under favourable conditions).2,8 
 
Figure 1.2 – The reported distribution of P. parvum around the globe.  Image used under a Creative 
Commons Attribution 3.0 Unported (CC BY 3.0) licence from Manning, S.R.; La Claire, J.W., II. 
Prymnesins: Toxic Metabolites of the Golden Alga, Prymnesium parvum Carter (Haptophyta). Mar. 
Drugs 2010, 8, 678-704.  Copyright 2010 S. Manning and J. La Claire. 
 
1.1.2 Threat to fish stocks and food security 
It is already well known that algal toxins can have serious impacts on food safety.  Common 
examples include okadaic acid and brevetoxins which can cause diahrretic and neurotoxic 
shell fish poisoning respectively.9,10  Whilst P. parvum doesn’t appear to pose a direct threat 
to food safety because the toxin is specific to gill breathers, its ability to devastate fish stocks 
is alarming.  Much recent research into P. parvum blooms has been focused on the impact 
on fish stocks in North America, and especially Texas.11  Here it has had a huge impact on 
sports fishing, and has been attributed to the death of over 34 million fish and tens of millions 
of dollars’ worth of damage in the one state alone.  Moving away from sports fishing, P. 
parvum has the potential to deliver a devastating impact on food security globally.  Global 
aquaculture provided 43% of aquatic animal food consumed by humans in 2007, and had a 
global value of $98.5 billion in 2008.12  Aquaculture is especially important in Asia, which 
accounts for 79% of the global market by value.12  As the global population continues to 
increase, there will continue to be a move towards aquaculture as a way of producing 
sustainable levels of aquatic animals for human consumption.  It is immediately obvious from 
Figure 1.2 that much of Asia lies within the northern zone where P. parvum blooms occur.1  
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For this reason it is perfectly feasible that harmful P. parvum blooms could prove a real threat 
to global food security in the future. 
 
1.2 Toxins reported to be responsible – prymnesins 
1.2.1 Prymnesin toxins 
The toxicity and associated threat to fish stocks in brackish waters of Prymnesium parvum 
has been known for over 50 years.13 Yariv and Hestrin coined the name ‘prymnesin’ for the 
cytotoxic material they noticed was excreted into the growth media of P. parvum.  Over the 
subsequent 30 years there was much speculation into the structure of the toxin, with various 
authors claiming the toxin to be a saponin, proteolipid or carbohydrate.4,14  In 1996 Igirashi 
et al.14 published the first structure of prymnesin-2 isolated from an Israeli strain of P. 
parvum, the structure of which is shown in Figure 1.3.  Prymnesin-2 has many noteworthy 
features, including a lipophilic head terminating in a vinyl chloride, a free amine, 14 polyether 
rings, several chlorines and a glycosylated tail terminating in a bis-alkyne.  Igarashi et al.15 
later reported P. parvum also produced a second more heavily glycosylated toxin which they 
named prymnesin-1.  This new toxin shared a conserved backbone with prymnesin-2.   
 
Figure 1.3 - The reported chemical structures of the prymnesin toxins.  Prymnesin-1 and prymnesin-2 
were originally reported by Igarashi et al.14,16  The structures of prymnesin-B1 and B2 were published 
by Rasmussen et al.17 *Rasmussen et al.17 have redrawn prymnesin-2 as being glycosylated with β-D-
Araf rather than α-L-Xylf as originally reported by Igarashi et al.14 
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It was noted in the literature that the newly published structures of prymnesin-1 and 
prymnesin-2 were not detectable in subsequent P. parvum blooms across the Southern 
states of the USA.  Between 1999 and 2013 the only reported isolation and detection of 
prymnesin-1 and prymnesin-2 was achieved by La Claire et al.18 using LC-HRMS on P. parvum 
cell extracts from lab grown cultures.  The use of toxin extracts of compounds soluble in polar 
organic solvents, rather than pure compounds for toxicity studies meant there was some 
debate in the literature as to whether prymnesin-1 and prymnesin-2 were the major toxic 
components of P. parvum; for example, fatty acids19 and fatty acid amides20 were proposed 
as the major toxic components of P. parvum.  However work by Blossom et al.21 has shown 
that the fatty acids and fatty acid amides reported were not ichthyotoxic at ecological 
concentrations.  The same group has recently proposed that the reason that prymnesin-1 
and prymnesin-2 had not been detected in P. parvum blooms in the USA was that there was 
structural diversity in prymnesin toxins between P. parvum strains from different locations.17  
Rasmussen et al.17 went on to isolate and characterise a new set of prymnesin toxins from a 
Danish strain of P. parvum (K-0081), which they named prymnesin-B1 and prymnesin-B2 
(Figure 1.3).  The prymnesin-B toxins have subtle variations from the original prymnesin 
toxins: they are glycosylated with a different set of sugars and are missing the H-I polyether 
rings which are substituted with a -CH(OH)-CH2 linker and the two alkyl chlorine atoms are 
replaced with hydroxyl groups.  The lipophilic head and bis-alkyne tail are conserved, as are 
most of the polyether rings.  Having isolated and characterised prymnesin-B1 and B2, 
Rasmussen et al.17 screened 10 strains of P. parvum from around the globe by LC-MS and 
found one produced the prymnesin-1/2 backbone and five produced the prymnesin-B1/B2 
backbone.  They also indicated that LC-MS suggested the presence of a third type of triply 
chlorinated prymnesin.17  Work by our group with natural samples collected during a recent 
harmful algal blooms has shown that the strain of P. parvum present in the Norfolk Broads 
also produces prymnesin-B1/B2 (ongoing unpublished work). 
 
1.2.2 Toxicity studies 
Prymnesins are characterised as extracellular ichthyotoxins, although their physiological 
purpose is unclear.1  It has been suggested that it may be defence related.3  For example, 
Tillmann3 has investigated the interaction between P. parvum and the heterotroph Oxyrrhis 
marina and found that under low toxicity conditions (nutrient-deficient cultures, low P. 
parvum cell counts and low light conditions) O. marina was able to graze on P. parvum.  
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However under high toxicity conditions (nutrient-normal cultures, higher P. parvum cell 
counts and ambient light) O. marina was observed to swell and lyse, and the debris were 
ingested by P. parvum.   
The exact mechanism of toxin release into waterways unclear, and it is perhaps strange that 
both toxic and non-toxic blooms of P. parvum have been reported.22  This suggests that there 
may be an ecological trigger which causes toxin release, and conditions such as light, pH, 
nutrient availability and temperature have all been explored.1,4  It has recently been 
suggested by Wagstaff et al.23 from our group that this toxicity is due to the mass collapse of 
a P. parvum population by cell lysis caused by viral infection of the algae by the newly 
discovered megavirus Prymnesium parvum DNA virus BW1 (ppDNAV) (Figure 1.4). 
 
Figure 1.4 - A) thin section of a health P. parvum cell; B) Thin section of a P. parvum cell 48 hours post 
infection with PpDNA virus BW1.  Figure used under a Creative Commons Attribution 4.0 Unported 
(CC BY 4.0) licence and adapted from Wagstaff, B.A.; Vladu, I.C.; Barclay, J.E.; Schroeder, D.C.; Malin, 
G.; Field, R.A. Isolation and Characterization of a Double Stranded DNA Megavirus Infecting the Toxin-
Producing Haptophyte Prymnesium parvum. Viruses 2017, 9, 40. 
 
The first study conducted with isolated prymnesin-1 and prymnesin-2 was by Igarashi et al.16 
who performed haemolytic and ichthyotoxic assays.  They also assessed the intravenous LD50 
concentration for mice, as well as Ca2+ influx assays and antifungal assays.  It was found that 
that the haemolytic potency HC50 (the toxin concentration required to cause 50% haemolysis 
as determined by a concentration-absorbance response curve) for PRM-2 ranged from 0.5 
nM with dog red blood cells through to 2.5 nM for mice.  The ichthyotoxic assay showed a 
strong enhancement of the toxicity of prymnesin-2 with increased Ca2+ concentration and 
elevated pH.  At pH 8.0 and 2 mM Ca2+ the LC50 against the fresh water fish Tanichthys 
albonubes was found to be 3 nM, which is twice as potent as brevetoxin-3 (Figure 1.5).16  
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Igarashi et al. also noted some clues as to the mode of toxicity.  First, protonation or 
acetylation of the free amine group on prymnesin-2 (Figure 1.3) led to a dramatic loss of 
ichthyotoxicity.  They therefore determined that the mode of toxicity required the free 
amine group to act as a proton acceptor.  Second, the addition of the lipids sphingomyelin 
and cholesterol reduced the haemolytic activity of the toxin, suggesting a direct action on 
cell membranes by the toxin.  Third, the large Ca2+ dependence on ichthytoxicity led the 
authors to cite the possibility of toxin interaction with Ca2+ ATPase which is a Ca2+ active-
transporter enzyme located in cell membranes.  Cation-pore formation24 at elevated pH may 
lead to the elevated concentration of Ca2+ ions in cells affected by prymnesins; the impaired 
activity of the calcium pump means the cell is unable to lower this ion concentration, leading 
to cell death. 
A more recent toxicity study by Rasmussen et al.17 compared the toxicity of prymnesin-2 with 
their newly characterised toxin prymnesin-B1.  A dose-dependence assay was performed 
with rainbow trout-gill-W1 cells to assess cell viability with toxin exposure.  This showed a 
half maximal effective concentration (EC50) for prymnesin-2 of 0.92 nM and prymnesin-B1 of 
5.98 nM.  The authors speculated that all prymnesins are ichthyotoxins, and it is mixtures of 
several of these toxins that are responsible for many recent global fish kills.17 
Prymnesins are not the only polyketide extracellular algal toxins.  Some examples of well 
documented algal toxins in the literature include okadiac acid,9 brevetoxins25 and 
maitotoxin26 (Figure 1.5).  Okadaic acid is a cytotoxin produced by several dinoflagellates 
which cause diarrhetic shell fish poisoning.9  Maitotoxin is a very large and very potent 
polyketide toxin derived from the dinoflagellate Gambierdiscus toxicus.  Like prymnesins it is 
a calcium channel antagonist, and it exhibits mouse toxicity at 0.13 µg/kg.27  Finally 
brevetoxins which are derived from the dinoflagellate Karenia brevis (formerly 
Gymnodiniuim breve) are a suite of neurotoxins.10  There is a marked similarity between the 
rings system A-E in prymnesin-1/2 and brevetoxin-B.  Igarashi et al.16 also used brevetoxin-3 
(PbTx-3) as a ichthyotoxin control for prymnesin toxicity studies, where they showed that 
when Ca2+ concentrations reached 3 nM, the toxicity of prymnesin-2 was twice that of PbTx-
3, with the latter not showing any calcium dependence on toxicity.  
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Figure 1.5 – Some examples of other algal polyketide toxins; Okadaic Acid9, Brevetoxin-B25 and 
Maitotoxin.26 
 
1.2.3 The biosynthesis of prymnesin toxins 
There is very little information in the literature about the in vivo synthesis of prymnesin 
toxins, although La Claire et al.1 noted that it is ‘very likely’ that prymnesins are derived from 
acetate-related metabolism based on their structural similarity to other cylic polyether 
toxins.  Much of what is published is derived from comparison of prymnesins with similar 
algal polyether ladder toxins such as brevetoxins and maitotoxins.  Like these toxins, 
prymnesins have trans-fused cyclic ether rings in the backbone structure, which coupled with 
the lack of aromatic rings is indicative of polyketides made by type 1 polyketide synthases.1,28  
Polyketide synthases perform successive condensation reactions of carboxylic acid derived 
extension units to a growing acyl chain, and may also perform some post-condensation 
reactions.28 
Following the elucidation of the structure of brevetoxin, Nakanashi29 proposed a cascade 
epoxide ring opening reaction as the biosynthetic mechanism for the polyether ladder in that 
toxin.  This seemed to be in contradiction of Baldwin’s rules of ring closure which, based on 
stereoelectronic considerations, would favour an epoxide ring opening cascade via the 5-
exo-tet intermediate.30  It was not until recently that Vilotijevic and Jamison31 noted that 
neutral water acts as a critical promotor for guiding endo selectivity during the ring opening 
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cascade (Scheme 1.1).31  The authors also noted that if the tetrahydropyran (THP) ring oxygen 
was replaced with CH2 then the endo selectivity was lost 
 
Scheme 1.1 – Mechanism for the endo stereoselectivity of cyclisation of templated epoxides in neutral 
water.  Figure used under a Creative Commons Attribution 3.0 Unported (CC BY 3.0) licence and 
adapted from Vilotijevic and Jamison, Synthesis of marine polycyclic polyethers via endo-selective 
epoxide-opening cascades, Marine Drugs, 2010, 8, 763-809.  © 2010 Vilotijevic and Jamison. 
 
The importance of the THP ring oxygen in ensuring endo ring closing selectivity was 
attributed to two factors.31  First the electron withdrawing effect of the ring oxygen is likely 
to reduce the nucleophilicity of the THP ring alcohol, which electronically biases it towards 
endo attack of the epoxide.  Second, as the reaction with the THP ring oxygen present is 
second order in water, it may be that the THP ring oxygen can facilitate a twist boat 
intermediate by hydrogen bonding with water, which better sets up the alcohol for endo 
attack of the epoxide. 
A tentative epoxide ring opening cascade for the cyclic polyether backbone of prymnesins-
1/2 is shown in Figure 1.6.  For the ring system A-E, the epoxide opening follows the same 
mechanism as for brevetoxins.  The epoxide at the junction between rings E and F must be 
cis to maintain the corrected stereochemistry.32  This however does not seem correct, given 
the trans orientation of every epoxide on the speculative biosynthesis of brevetoxins, as well 
as the trans orientation of every other epoxide in Figure 1.6.  It also leads to the opposite 
rotamer to that published Sasaki et al.32 between the protons on C36 and C37 (at the junction 
between the E & F rings). 
Working back from the reactive epoxide intermediate, a corresponding unsaturated 
backbone is also proposed in Figure 1.6.  Again, note that there is only one cis-alkene, whilst 
all other double bonds are trans orientated as might be expected. 
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Figure 1.6 - A tentative proposal for an epoxide ring opening cascade which might synthesise the 
polyether backbone of prymnesins-1/2.28,31 
 
The terminal bis-alkyne found on all prymnesin toxins will be of interest in Chapter 3.  
Acetylenic bonds in polyketide derived metabolites are usually derived from a reductive 
pathway as shown in Scheme 1.2.33  The literature offers very little insight into the 
biosynthesis of the terminal alkyne found on prymnesins.  Zhu et al.34 have recently 
characterised the first protein bound desaturase responsible for the biosynthesis of the 
terminal alkyne found on jamacamide B, a polyketide cytotoxin produced by the marine 
cyanobacteria Moorea producens.  The authors noted that the introduction of ferrodoxinase 
or NADPH increased the activity of the desaturation enzyme (JamB) by about 35%, indicating 
that ferredoxin is the likely electron donor for the desaturation reaction. 
 
Scheme 1.2 – Iron-catalysed dehydration of the alkene with molecular oxygen.33 
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Prymnesins are all reported to be glycosylated with a range of different carbohydrates.15,17  
Glycosylation can significantly increase the solubility of compounds in water.35  In the case 
of prymnesins, it might be imagined that the glycosylated end of the toxins leads to a 
lipophilic head and a polar tail, much like a detergent molecule.1  As such it has been 
suggested that prymnesins can form micelles, which in turn can aggregate in cell membranes 
to create negatively charged pores which are permeable to cations.1,13  Glycosylation of the 
prymnesin backbone is most likely achieved via the Leloir pathway after the biosynthesis of 
the polyketide backbone is complete.  A glycosyltransferase will take an activated sugar 
nucleotide donor and place the sugar onto the appropriate hydroxyl group on the toxin 
backbone.36  There is little insight in the literature into the specific enzymes responsible for 
the glycosylation of prymnesin toxins, and Chapter 2 discusses the synthesis of sugar 
nucleotide standards for use in a P. parvum sugar nucleotide profiling project. 
 
1.2.4 Chemistry inspired by prymnesin toxins. 
Initial chemistry relating to prymnesin toxins focused on their modification to assist in the 
elucidation of their structures.  In their initial structural elucidations Igarashi et al.14,15 
acetylated the toxin amine to aid solubility for NMR studies.  They also went on to acetylate 
the free alcohols to locate the hydroxyl groups by changes in 13C NMR chemical shifts.  The 
hydrolysed sugars were also trifluoroacetylated for GC analysis.  Igarashi et al.16 also used N-
acetylation  during toxicity studies to show that without the free amine, the ichthyotoxic 
effects of prymnesin-2 were essentially lost.16   
The free amine at C14 which is present on all reported prymnesin toxins has been used as a 
chemical handle for the semi-quantification of toxin concentration.  La Claire et al.37 have 
published a fluorometric assay which covalently labels free amine on prymnesin-1/2 with 
ninhydrin (NIN) combined with phenylacetaldehyde (PAA).  This PRM-NIN-PAA complex is 
fluorescent and as such can be used to semi-quantify toxin levels.  Rasmussen et al.17 have 
also utilised the direct covalent labelling of the primary amine on prymnesins-1/2 and 
prymnesin-B1 with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (Acc-Q tag), and the 
concentration of the fluorescent toxin derivative was calculated against an external 
standard.   
 
  P a g e  | 12 
Synthetic fragments of prymnesin toxins were first made and used by Morrohashi et al.38 to 
elucidate the stereochemistry at the C14 and C85 positions of prymnesin-2.  This work was 
published a couple of years after the initial elucidation of the polyether ring stereochemistry 
of the toxin backbones was published.15  The C85 position of prymnesins-1/2 is functionalised 
with a chlorine atom (Figure 1.3).  The stereochemistry of the chlorine atom was determined 
by comparing HPLC of the chiral fluorescent ester derived from a fragment of authentic toxin 
with corresponding synthetic compounds (Scheme 1.3). 
 
Scheme 1.3 – Key synthetic steps employed by Morohashi et al.38 to determine the absolute 
stereochemistry of the chlorine atom at position on C85 for prymnesins-1/2.  i) H2, Pd.OH, PrOH/H2O; 
ii) NaOI4, MeCN; iii) NaBH4, MeCN; iv) (S)-MNB-COOH, EDC, DMF, NEt3, DCM; v) CCl4, Ph3P, DCM, 130 
°C; vi) DIBAL, DCM, 0 °C; vii) (S)-MNB-COOH, EDC, DMF, NEt3, DCM. 
 
Morohashi et al.38 also determined the stereochemistry of the free amine at position C14 by 
amidation with (S)- and (R)- methoxy-(2-naphtyl)acetic acid (2MNA).  They noted that Trost 
et al.39 had reported that the absolute configuration of chiral amines is correlated to the 
relative change in 1H NMR shifts observed for the diastereotopic amides formed with (S)-
2NMA.  Building on this work, they compared the 1H NMR shifts for prymnesin-2 covalently 
N-labelled with (R)-2MNA and (S)-2MNA and used these to assign the absolute configuration 
of the amine at C14. 
Trost and Rhee40 have demonstrated the synthesis of the AB ring fragment in prymnesins 
using ruthenium catalysed cycloisomerization and oxidative cyclization.  The methodology 
(outlined in Scheme 1.4) is based around the cycloisomerisation of bis-homopropargylic 
alcohols, which may be used to iteratively build up polycyclic ethers or alternatively oxidised 
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to a cyclic ketone for further modification.40 The authors also utilised their methodology to 
synthesis a ring fragment from the polyether toxin yessotoxin. 
 
 
Scheme 1.4 – The key steps in Ru catalysed synthesis of transfused polycyclic ethers from Trost and 
Rhee.40  i) CpRu(PR3)2Cl, R3P, (C4H9)4NPF6, N-hydroxysuccinimide sodium salt,  DMF, 85°c; ii) DMDO, 
DCM, -78 °c; iii) H2C=C=C-MgBr; iv) Ru, NHS; v) CpRu(PR3)2Cl, R3P, (C4H9)4NPF6, N-hydroxysuccinimide 
sodium salt,  DMF, 85 °c; vi) repeat ii) – vi).  R = 4-fluorophenyl. 
 
Three sets of ring systems inspired by the polyether backbone of prymnesins-1/2 have been 
chemically synthesised by Sasaki et al (Figure 1.7).32,41,42  The group started with the synthesis 
of the HI/JK ring system.41  The 1H and 13C NMR for HI/JK analogue were found to be in 
agreement with the literature values for the analogous region of the whole toxin, confirming 
the earlier assignment.  Next the group synthesised the CDE/FG ring system.32  The group 
noted a difference of around 1 ppm in the 13C NMR spectrum between C36 and C37 in the 
whole toxin and the analogous carbons in the synthetic ring system.  By contrast inversion 
of the stereochemistry at C37 in the synthetic analogue brought the 13C NMR shifts to within 
0.5 ppm of the published whole toxin spectrum.  It was also noted by the authors that this 
inversion led to coupling constants for the synthetic analogue of J37/38 = 9.0 Hz and J38/39 = 2.5 
Hz which was in very close agreement with the published spectrum for prymnesin-2.15  As 
such the authors recommended the reassignment of the stereochemistry at C37.  Finally the 
group synthesised the JK/LM ring system, with the NMR values for the synthetic confirming 
the original structural elucidation for the whole toxin.42 
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Figure 1.7 - Ring systems inspired by prymnesins-1/2 synthesised by Sasaki et al.32,42  Clockwise from 
top left: HI/JK ring system41; CDE/FG ring system with anti linkage between E/F rings; CDE/FG ring 
system with syn linkage between E/F rings;32 JK/LM ring system.42 
 
1.3 P. parvum blooms on the Norfolk Broads 
1.3.1 Blooms on Norfolk Broads 
The Norfolk Broads are the United Kingdom’s largest protected inland wetland, and became 
a national park in 1989.  Situated in East Anglia, they cover an area of over 300 km2 between 
Norwich to the west and Great Yarmouth and Lowestoft to the east (Figure 1.8), which drains 
into seven rivers and over 50 individual shallow lakes or ‘broads’.22  The broads are believed 
to be the result of medieval peat diggings which subsequently flooded, and range in size from 
a couple of hectares up to Hickling Broad, which is the largest at over 140 hectares.43,44 
P. parvum is of concern on The Norfolk Broads which are local to our research group in the 
East of England.  Despite being a marine toxin, P. parvum can persist in the Norfolk Broads 
due to the brackish nature of the waters, which results from regular tidal surges, as well as 
the drainage to saline marshes for agricultural use.22  There are historic anecdotal records of 
large scale fish kills on the Thurne system coinciding with a brown colouration of the water 
(which could be attributed to a P. parvum bloom) in 1894, 1911, 1914, 1925, 1934, 1954, 
1966, and 1967.22  Bales et al.45 noted that there were several large-scale fish kills on the 
Upper Thurne system of the Norfolk Broads attributed to blooms of P. parvum between 1969 
and 1975.  This coincided with a loss of aquatic plant life and an explosion in phytoplankton 
populations, which was attributed to guano from high populations of blackheaded gulls 
(Larus ridibundus).45  There was also a phosphate contribution to the waterways by 
  P a g e  | 15 
agricultural run-off.  Since the 1970s there has been an effort to reduced phosphate levels in 
the Broads by reducing the discharge of sewage effluent into the waterways.46  Whilst this 
has been somewhat successful, it has been noted by Phillips et al.46 that the release of 
phosphate into the Broads can be an order of magnitude higher from sediment disturbance 
than that from catchment sources.   
 
 
Figure 1.8 – The location of the Norfolk Broads and River Thurne system.  Reprinted (adapted) with 
permission from P. Holdway et al., Freshwater Biology, 1978, 8, 295-311.  Copyright 1977 John Wiley 
and Sons. 
 
West Somerton 
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Whilst there has been drainage of marshes near to the sea-wall for well over a century, the 
intensity of pumping has increased significantly with the introduction of electric pumps in 
the 1960s.45  With this came an increase in the salinity of the Broads.  The brackish nature of 
the broads has been beneficial to marine algae in the water system such as P. parvum.  It has 
been noted by Igarashi et al.16 that prymnesins are much more potent ichthytoxins in the 
presence of elevated Ca2+ levels, and so the increased salinity of the Broads may have 
contributed to an exacerbation of the toxicity of harmful P. parvum blooms. 
 
1.3.2 Spring 2015 P. parvum bloom on the Upper Thurne 
The most recent significant fish kill attributed to P. parvum occurred in March 2015 in the 
Upper Thurne System at West Somerton, Martham, Horsey and Hickling (Figure 1.8).  It was 
estimated that 300-400 fish were killed and 230,000 were relocated to safer waters by the 
Environment Agency.47 When the harmful algal bloom occurred there was no program of 
actively monitoring P. parvum levels in the waterways, with P. parvum cell counts only being 
checked by optical microscopy when the navigable channels were maintained by dredging.  
The lack of active monitoring meant the Environment Agency was reliant on its public 
incident telephone number for being made aware of the problem, by which time there were 
already fish dying in the water. 
The mitigation strategy employed in the March 2015 blooms relied solely on the relocation 
of fish from the affected areas (Figure 1.9).  When we attended the site it was noted by 
Enivronment Agency staff that the fish were shoaling as though trying to move away from 
the algae, which resulted in them being trapped in large shoals at the far ends of the staithes.   
During these blooms optical microscopy of samples taken by us showed the presence of P. 
parvum in the staithes.  Furthermore liquid chromatography-mass spectrometry (LC-MS) 
analysis of extracts prepared from the gills of a deceased pike* (Esox Lucius) recovered from 
Hickling staithe were found to contain the toxin prymnesin-B1.17,18   
                                                          
* The gills were removed at the staithe and taken back to our lab in Norwich.  They were freeze ground 
in liquid nitrogen to a white powder and then extracted in a manor analogous to that described by La 
Claire et al.18 for extracting prymnesin toxins from harvested P. parvum lab cultures.  At the time we 
could not detect prymnesins-1/2 by LC-MS.  However the following year Rasmussen et al.17 published 
the structure of newly discovered prymnesin-B1.  On revisiting our LC-MS data we could detect the 
characteristic peaks for prymnesin-B1. 
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Figure 1.9 - The relocation of fish from the Upper Thurne river system by the Environment Agency 
(March 2015).  Clockwise from top left: 1) An example of the dead fish found at Hickling Staithe; 2) 
Netting of fish in the affected area.  Note the pump to try to maintain suitable dissolved oxygen levels 
for the high volume of fish; 3) Environment agency staff moving alive fish into oxygenated tanks on 
the back of trailers; 4) Road transport of netted fish to safer waters. 
 
1.3.3 Threat to tourism and leisure industry and local ecosystem 
In addition to the ecological impact of harmful P. parvum blooms in the Norfolk Broads, there 
are also severe economic impacts for the tourism and leisure industries.  The Norfolk Broads 
were designated a national park in 1989, and in 2017, despite having a permanent population 
of only 6,350 people, were estimated to draw over 7 million visitors and contribute in excess 
of £550 million per annum to the local economy, mainly through angling, boating and 
tourism.48  Although the fish found in the Norfolk Broads are no longer commercially caught 
for food, the Norfolk Broads are a popular leisure destination for anglers.  It is therefore 
obvious from the local economic benefit that it is of great concern locally to maintain healthy 
fish stocks in the Norfolk Broads.  
 
1. 2. 
3. 4. 
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1.3.4 Current P. parvum mitigation strategy 
Until recently cell counting has been the only method of measuring P. parvum levels in the 
Norfolk Broads.  There is however now ongoing qPCR based monitoring of P. parvum 
populations being carried out by J. Pratscher and co-workers at the University of East Anglia 
(UEA).  However, as it is possible to have non-toxic P. parvum blooms,22 elevated cell counts 
are not necessarily a reason to move fish, and so the Environment Agency can only act once 
there is clear evidence or dead or dying fish.  It would therefore be useful for all parties with 
a vested interest in maintaining healthy fish populations in the Norfolk Broads to have a 
portable system for the rapid detection of prymnesin toxins, rather than relying solely on 
algal cell counts. 
 
1.4 Overview of the project 
The emphasis of the project is on the synthesis of toxin fragments and related chemical tools, 
focussing on the terminal bis-alkyne and glycosylated regions of prymnesin toxins.  These 
tools will then be used to learn more about the biosynthesis of the prymnesin toxins, as well 
as working towards the development of a portable toxin detection device for use on the 
Norfolk Broads.  The project is split into four main sections. 
1.  The synthesis of sugar nucleotides relevant to prymnesin toxins for use as standards 
in an ongoing algal sugar nucleotide profiling project within the group.  Prymnesin-1 
is reported to be glycosylated with ᴅ-galactofuranose, and the synthesis of the 
corresponding sugar nucleotide as a standard for the project is described.15  
Prymnesin-2 is reported to be glycosylated with ʟ-xylofuranose.14  The literature 
offers no insight into the biogenesis of ʟ-xylofuranose, and so a possible biosynthetic 
pathway for a suitable ʟ-xylofuranose sugar nucleotide was proposed by Ben 
Wagstaff in the group.  The chemical synthesis of the sugar nucleotide intermediates 
in this proposed pathway is described. 
 
2. An investigation into whether the rare terminal bis-alkyne found on prymnesin 
toxins could be used as biomarker for the detecting and quantification of toxin levels 
in waterways without having to use expensive LC-MS equipment was performed.37  
Due to the reported difficulties in obtaining large quantities of prymnesin toxins,17 
synthetic bis-alkyne fragments were chemically synthesised as substitutes.  These 
were then used to evaluate the suitability of copper(I) catalysed alkyne-azide 
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cycloaddition (CuAAC) ‘click’ reactions of the bis-alkyne with an azide functionalised 
fluorophore.49  Similar experiments were repeated with LC-MS verified toxin 
extracts.  The synthesis of these fragments and fluorescent dye is described, and the 
suitability of CuAAC as a method of rapid toxin detection is explored.  The synthetic 
bis-alkyne toxin fragments were also used to assess the suitability of the terminal 
bis-alkyne towards a Raman spectroscopy based detection system.50  Bis-alkynes are 
reported to give very strong Raman signals in otherwise cellular silent regions, and 
Raman spectroscopy is compatible with aqueous solvent.51   
 
3. The chemical synthesis of a library of sugar-glycerol compounds inspired by the 
reported sugars found on prymnesin toxins is described.  This relies on a variety of 
glycosylation techniques, as a range of pyranoses and furanoses with both 1,2-cis 
and 1,2-trans glyosidic linkages are required.52  Glycerol is chosen as a simplified 
version of the prymnesin backbone, and is glycosylated at the 2° position with the 
sugars reported as being present on prymnesin toxins. The synthetic sugar-glycerol 
fragments are then compared with literature spectra for the whole toxin.  
 
4. Drawing on experienced gained in synthesising sugar-glycerol fragments, the 
synthesis of two larger diglycosylated prymnesin-2 fragments is described.  It is 
hoped that these fragments might prove useful for raising prymnesin-1 specific 
antibodies, and if so the fragment could also be incorporated into a lateral flow 
device (dip-stick) for rapid toxin detection in waterways.53  Such a device would be 
useful to the Environment Agency and those with a vested interest in the ecology of 
The Broads.  Because of the ambiguity in the stereochemistry of the backbone in the 
glycosylated region of prymnesin toxins, two diastereotopic fragments are required.  
These fragments need to be glycosylated with ʟ-arabinopyranose and ᴅ-ribose, and 
incorporate a suitable cross-coupling group for conjugation to a carrier protein. 
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2 The chemoenzymatic synthesis of 
sugar nucleotides to explore the 
biosynthesis of prymnesin toxins 
 
 
 
 
 
 
 
 
Parts of this chapter are in press: 
M. Rejzek, L. Hill, E. S. Hems, S. Kuhaudomlarp, B. A. Wagstaff, and R. A. Field, in Methods in 
enzymology, Elsevier Inc., 1st edn., 2017, pp. 1–30  
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2.1 Introduction 
2.1.1 Prymnesin Toxins 
Prymnesins are reported to be decorated with an interesting set of sugars (Figure 2.1).  
Prymnesin-1 is decorated with β-ᴅ-galactofuranose, α-ᴅ-ribofuranose and α-ʟ-
arabinopyranose.1  Prymnesin-2 is decorated with α-ʟ-xylofuranose which has not been 
reported in the literature before.2  Prymnesin-2 has also been drawn (albeit without 
comment) in a recent paper as glycosylated with α-ʟ-arabinofuranose rather than α-ʟ-
xylofuranose.3  The recently discovered prymnesin-B1 is reported to be glycosylated with α-
ᴅ-galactopyranose.3  Apart from the sugars, the main differences between prymnesins-1/2 
and prymnesin-B1 is that the latter is less chlorinated and the polyether backbone has a  
CH(OH)CH2 linker in place of the HI ring system.  The literature provides no insight regarding 
the biogenesis of ʟ-xylofuranose, so a tentative biosynthetic pathway is being proposed by 
our group. 
 
Figure 2.1 - The reported chemical structures of the reported prymnesin toxins.  Prymnesin-1 and 
prymnesin-2 were originally reported by Igarashi et al.2,4  The structures of prymnesin-B1 and B2 were 
published by Rasmussen et al.3 more recently. 
 
The two main carbohydrates of interest in this chapter are ᴅ-galactofuranose found on 
prymnesin-1 and ʟ-xylofuranose found on prymnesin-2.  Both of these sugars were identified 
by Igarashi et al.1 from chiral GC chromatograms of the carbohydrates hydrolysed from the 
toxin backbone (Figure 2.2), by comparison with chiral GC of sugar standards; comparison of 
the retention times was used to identify the carbohydrates on the toxin backbone.   
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Figure 2.2 - Chiral GC chromatograms showing sugar standards for ᴅ- & ʟ-xylose, ᴅ- & ʟ-arabinose and 
ᴅ- & ʟ-galactose.  On the bottom are the sugars ʟ-arabinose and ᴅ-galactose hydrolysed from 
prymnesin-1.  Peaks marked with an X are electrical noises from the instrument.  Reprinted (adapted) 
with permission from T. Igarashi et al., J. Am. Chem. Soc., 1999, 121 (37), pp 8499–8511 (supporting 
material).  Copyright 1999 American Chemical Society. 
 
Of the carbohydrates found on prymnesins-1/2, ᴅ-galactose, ᴅ-ribose and ʟ-xylose were 
found to be present on the toxin in the furanose form, whilst ʟ-arabinose was found in the 
pyranose form.  Igarashi et al.1 determined this by comparing the anomeric 13C NMR shifts 
of the sugars with literature values, as shown in Table 2.1.  The stereochemistry at the 
anomeric position was determined by J1,2 coupling constants.1  It may be noted that the 
literature 13C NMR shifts for the anomeric carbons for β-ʟ-xylofuranose and α-ᴅ-ribofuranose 
are ~3 ppm smaller than the shift recorded for the sugar on the toxins.  These sugars are 
both furanoses with 1,2-cis anomeric linkages, and this might be attributed to the flexibility 
of furanose rings when compared with pyranose rings.5  By contrast, the difference in 13C 
NMR shifts for the 1,2-trans furanose α-ᴅ-galactopyranose and 1,2-trans pyranose α-ʟ-
arabinopyranose are much closer to the literature values.   
Table 2.1 - 13C NMR shifts for the anomeric carbons found on prymnesins-1/2 and the literature 
values Igarashi et al.1 used as comparison to assign the ring as either furanose or pyranose form. 
13C NMR shift β-ʟ-Xylf α-ʟ-Arap α-ᴅ-Ribf β-ᴅ-Galf 
Toxin 106.2 106.1 106.0 110.4 
Lit. pyranose 100.6 105.1 100.4 Not given 
Lit. furanose 103.0 Not given 103.1 110.0 
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2.1.2 The origin of carbohydrates on prymnesin toxins 
Prymnesin toxins are in part characterised by a range of different sugar moieties which 
decorate the toxin backbone.1,3  Interestingly, different sugars can even be found on the 
same position of the same backbone, as is the case with prymnesin-1 and prymnesin-2 which 
are glycosylated at C82 with β-ʟ-xylofuranose and α-ᴅ-ribofuranose respectively.  
Glycosylation of prymnesins is most likely achieved via Leloir glycosylation by enzymes called 
glycosyltransferases (GTs), using nucleotide diphosphate (NDP) sugars as activated sugar 
donors (Scheme 2.1).6  It follows that the biosynthesis of glycosylated prymnesin toxins 
necessitates the presence of a range of corresponding NDP-sugars within the cell. 
 
 
Scheme 2.1 - Overview of an in vitro glycosyltransferase cycle.6  The sugar-1-phosphate is produced 
by a kinase, before being converted to the NDP-sugar by NDP-sugar pyrophosphorylase.  The by-
product of this reaction is pyrophosphate (PPi) which is hydrolysed to inorganic phosphate (Pi) by 
pyrophosphatase.  The NDP-sugar is then used as an activated sugar donor by the glycosyltransferase 
which transfers the sugar onto the aglycone (R-OH).  The residual nucleotide diphosphate (NDP) is 
regenerated to nucleotide triphosphate (NTP) with phosphenolpyruvate by a kinase. 
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Glycosyltransferases may be either retaining or inverting of the stereochemistry at the 
anomeric position with regards to the initial NDP orientation (Figure 2.3).7  For example, 
prymnesin-1 is glycosylated with β-ᴅ-galactofuranose, which would require an inversion of 
the stereochemistry of the α-linked  UDP-galactofuranose donor.  By contrast prymnesin-B1 
is glycosylated with α-ᴅ-galactopyranose, which would require a retention of the 
stereochemistry of the α-linked UDP-galactopyranose donor.  It is therefore clear that there 
is diversity in the carbohydrate-active enzymes present in P. parvum. 
 
 
Figure 2.3 – Inverting and non-inverting glycosyl transferase mechanisms, adapted from Lairson et al.7  
The inverting glycosylation mechanism a) proceeds through an oxocarbonium like intermediate, while 
the non-inverting glycosylation mechanism b) proceeds through a covalent glycosyl-enzyme 
intermediate. 
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2.1.3 Sugar nucleotide profiling 
In order to profile the sugar nucleotides present in P. parvum it is first necessary to grow an 
axenic (clean, single species) culture.8  The cells can then be easily harvested by 
centrifugation ready for extraction.9  It is important that any extraction technique minimises 
the degradation of extracted sugar nucleotides.  It is also necessary to inactivate 
carbohydrate-active enzymes from the organism which could degrade the extracted sugar 
nucleotides to essentially take a ‘snap-shot’ of the sugar nucleotides present in P. parvum at 
the time of extraction.  Fortunately P. parvum cell lysis with aqueous ethanol brings about 
concomitant protein precipitation without serious chemical degradation of the extracted 
sugar nucleotides.10 
After extraction, it is necessary to separate the sugar nucleotides from one another prior to 
detection.  This is because many sugar nucleotides are isobaric and contain the same 
chromophore.  For example, UDP-ᴅ-Glc, UDP-ᴅ-Galp and UDP-ᴅ-Galf are all indistinguishable 
by either UV detection or mass spectrometry.  Separation techniques broadly rely on liquid 
chromatography such as anion exchange, capillary electrophoresis, and ion-pair reverse 
phase methods.11–13   
Whichever separation technique is used, it is important that it is compatible with the 
detection technique to be employed.  UV detection is relatively robust with respect to a 
range of elution solvents and buffers and it is a good method for quantifying the levels of 
different sugar nucleotides in an extract.  For example, Manley and Burns11 made use of 
anion exchange chromatography coupled with a UV detector to quantify the levels of various 
NDP-sugars extracted from the red alga Pterocladiella capillacea when evaluating different 
extraction techniques.   By contrast, mass spectrometry is incompatible with the high salt 
conditions associated with anion exchange chromatography; Le Bizec et al.14 have discussed 
how ion pairing in LC-MS systems leads to the suppression of m/z signals by decreasing the 
evaporation efficiency of analytes so that they cannot enter the gas phase in electrospray 
ionisation (ESI) mass spectrometry.  There may also be neutralisation of ionised species in 
the gas phase.14  However, mass spectrometry can offer a much higher level of sensitivity 
and specificity than UV detection.  To alleviate the problems associated with LC-MS systems 
there has been a move towards volatile buffers working along a pH gradient, coupled with 
relatively new porous graphitic carbon (PGC) columns.15 
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Mass spectrometry can be used for targeting sugar nucleotides using electrospray ionization-
tandem mass spectrometry (ESI-MS/MS), using selected reaction monitoring (SRM) for single 
fragment ions or multiple reaction monitoring (MRM) for multiple daughter ion fragments.  
The specificity and sensitivity of MRM ESI-MS/MS is particularly high because fragmentation 
of the parent ion can be performed under optimised conditions, which can be developed 
using authentic standards of the analyte of interest.16  For example, MacRae et al.10 utilised 
LC-ESI MS/MS using MRM transitions to profile sugar nucleotides involved in the biosynthesis 
of cell surface glycoconjugates of trypanosomatid parasites.   If authentic standards cannot 
be obtained or there is a desire to search more broadly for generic groups (eg UDP-hexoses, 
GDP-pentoses etc) then MRM transitions can be predicted.16  The LC-MS/MS method used 
in this project utilised a PGC column coupled with a triple quadrupole mass spectrometer 
and is discussed in detail later in this chapter. 
 
2.1.4 Sugar nucleotide synthesis 
In order to profile sugar nucleotides from algal cell extracts, it was first necessary to have a 
set of standards in hand.  Not all the sugars found on prymnesin backbones have 
commercially available NDP-sugar derivatives, and as such they must be made either 
chemically, enzymatically or by a combination of both techniques.  Enzymatic synthesis is 
useful for synthesising natural NDP-sugars when the correct substrates and enzymes are 
available.  However, the synthesis of unnatural or novel NDP-sugars often requires a 
chemical approach.  
The chemical synthesis or NDP-sugars often relies on one of two pyrophosphate bond 
disconnections (Scheme 2.2).17 Route A relies on the pyrophosphate bond being formed by 
joining two monophosphate groups.  In order to enable the coupling to take place at 
relatively mild conditions and therefore prevent degradation of the NDP-sugar product, and 
also to prevent the production of dimers, one of the phosphate groups can be activated with 
a leaving group.17   
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Scheme 2.2 - Disconnection strategies for the chemical synthesis of NDP-sugars.17  Route A breaks the 
pyrophosphate bond, whilst route B removed the whole NDP group. 
 
Khorana et al.18 developed a reaction between a sugar-1-phosphate and nucleoside 
phosphomorpholidate which, although commonly used, does suffer from a long reaction 
time.  Bogachev et al.19 developed a quicker method of NDP-sugars using a sugar-1-
phosphate and nucleoside N-methylimidazolide.  An alternative method which does not rely 
on protecting groups is phosphate activation with carbonyldiimidazole (CDI), which was 
developed by Tennigkeit et al.20 as a method of pyrophosphate bond formation, and 
subsequently applied to the synthesis of NDP-sugars by Baisch and Öhrlein.21  All three 
methods have been reported in the literature for chemically synthesising UDP-α-ᴅ-
galactofuranose (UDP-Galf) and are discussed later in this chapter.22–24 
Route B relies on the direct glycosylation of a nucleoside diphosphates.  This was first 
reported by Arlt and Hindsgaul25 who coupled per-O-benzyl ᴅ-glycopyranosyl bromides with 
organic soluble tetrabutyl ammonium salts of UDP and GDP to give NDP-sugars with mixed 
α/β stereochemistry at the anomeric position.  This method was improved upon by Timmons 
and Jakeman,26 who utilised neighbouring group participation when reacting ester-protected 
glycopyranosyl bromides with organic soluble tetrabutyl ammonium salts of UDP and GDP 
to give NDP-sugars with 1,2-trans stereochemistry at the anomeric position. 
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Chemoenzymatic and enzymatic synthesis of NDP-sugars can be a more efficient way of 
synthesising NDP sugars.27  In some cases it is possible to use enzymes with broad substrate 
specificity.  For example Errey et al.28 were able to synthesise a broad range of UDP-sugars 
from the corresponding sugar-1-phosphate, using galactose-1-phosphate uridylyltransferase 
(GalPUT).  The authors commented on the exceptionally relaxed substrate specificity of this 
enzyme and were able to turn over a range of sugars, irrespective of the relative or absolute 
conformation, ring size or substitution pattern.28  Furthermore, work by Wagstaff et al.29 has 
shown that GalPUT will also synthesise nucleobase-modified UDP-sugars, turning over a 
range of 5-substituted UTP derivatives into the corresponding 5-substituted UDP-galactose.  
The application of the methodology by Errey et al.28 with regards to the chemoenzymatic 
synthesis of UDP-Galf is discussed in more detail later in this chapter. 
My contribution to the profiling of sugar nucleotides from P. parvum was the 
chemoenzymatic synthesis of UDP-α-ᴅ-galactofuranose (UDP-ᴅ-Galf), as well as the chemical 
syntheses of UDP-α-ᴅ-arabinopyranose (UDP-ᴅ-Arap) and UDP-β-ʟ-xylopyranose (UDP-ʟ-
Xylp) which are tentatively proposed to be involved in the biogenesis of ʟ-xylofuranose.  
Finally, a standard of UDP-α-ᴅ-mannopyranose (UDP-ᴅ-Man) was also synthesised to help 
account for an unidentified UDP-hexose detected in algal cell extracts.30 
 
2.2 ᴅ-Galactofuranose on prymnesin-1 
2.2.1 Biosynthesis of galactofuanose in nature 
β-ᴅ-Galactofuranose, while found on prymnesin-1,1 is also found in the cell wall or cell 
surface glycoproteins and glycolipids of many human pathogens;31,32 however, galactose is 
only found in the pyranose form in humans.  The corresponding activated furanose sugar 
donor used by glycosyltranferases is UDP-ᴅ-Galf, which is biosynthesised from UDP-ᴅ-Galp 
by the flavoenzyme UDP-galactopyranose mutase (UGM) (Scheme 2.3).33  The currently 
accepted main ring contraction step was proposed by Kiessling et al.34 The flavin cofactor is 
only active in the reduced form, and forms a galactose-flavin adduct (Scheme 2.3, E), and 
interconversion between galacropyranose and galactofuranose proceeds through a flavin-
derived iminium species (Scheme 2.3, F).34  UGM has also been shown to catalyse the 
interconversion between UDP-ʟ-arabinopyranose and UDP-ʟ-arabinofuranose, which only 
differ structurally from UDP-ᴅ-Gal by the absence of the C6 hydroxymethyl group.35 
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Scheme 2.3 – Flavin dependent UDP-galactopyranose mutase converting UDP-Galp to UDP-Galf 
(adapted from Tanner et al.33).  The UGM is activated by NADPH reduction of flavin (B).  Flavin 
covalently binds with UDP-Galp by attack of C1Galp by N5FAD, which in turn cleaves the anomeric bond 
(C).  Tautomerisation moves the proton shown in red from N5FAD to C4FAD=O (D), which facilitates 
opening of the Galp ring (E).  The proton shown in red is transferred from C4FAD=O to C2Gal, and the 
proton shown in blue is transferred from C4Gal to C4FAD=O during the key ring contraction step (F-G).  
Finally direct attack of the FAD-Gal adduct at the C1Galf position liberates UDP-Galf (I-J).  The oxidation 
of the reduced flavin (J-A) is slow and therefore the enzyme can turnover several hundred times 
before being inactivated by oxidation. 
 
The equilibrium between UDP-ᴅ-Galp and UDP-α-ᴅ-Galf (8) lies very much in favour of the 
pyranose form, in the ratio 11:1.36  Therefore it would not be feasible to make a useful 
quantity of UDP-α-ᴅ-Galf (8), from UDP-α-ᴅ-Galp, using UGM.  UDP-α-ᴅ-Galf (8) can, 
however, be made chemically22–24 or chemoezymatically.28  In both cases α-ᴅ-
galactofuranosyl phosphate (7) (Galf-1-P) must first be chemically synthesised; for the 
enzymatic synthesis of UDP-α-ᴅ-Galf (8) this is vital; for the chemical synthesis of UDP-α-ᴅ-
Galf (8) it is a useful starting point as the anomeric stereochemistry of the sugar-nucleotide 
is predetermined by the anomeric stereochemistry of the sugar phosphate.17 The chemical 
synthesis of Galf-1-P (7) was first reported by de Lederkremer et al.37  The first challenge in 
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the synthesis is fixing galactose in the five ring furanose form, which can be achieved in a few 
different ways.  The first is by hot benzoylation38 or refluxing in methanol in the presence of 
a Lewis acid.22  Both of these methods do, however, lead to a mixture of pyranose and 
furanose rings which must be separated before use.  An alternative method is the 
benozylation, reduction and subsequent benozylation of commercially available ᴅ-
galactono-1,4-lactone (1).24,38  This second method has the advantage of not forming 
mixtures of furanosyl and pyranosyl ring which require separation, and has proved effective 
in the current study for the synthesis of per-O-benzoyl galactofuranose (4).   
 
2.2.2 Chemoenzymatic synthesis of UDP-ᴅ-galactofuranose 
The chemical synthesis of Galf-1-P (7), shown in Scheme 2.4, essentially as described by 
Lederkremer et al.37  Commercial galactono-1,4-lactone (1) was benzoylated with benozyl 
chloride in pyridine, which was confirmed by the presence of four new C=O peaks in the 13C 
NMR spectrum between 165.9 and 165.0 ppm.  The resulting tetra-O-benzoyl-ᴅ-galacto-1,4-
lactone (2) was reduced to the hemiacetal (3) using L-selectride®.  When the reduction was 
judged to have gone to completion by TLC, due to consumption of the starting lactone spot 
(Rf 0.58, hexane/EtOAc 7:3) and a new less mobile spot (Rf 0.48 hexane/EtOAc 7:3), the crude 
reaction mixture was immediately treated with pyridine, DMAP and benozyl chloride in the 
same pot to give per-O-benzoyl-β-ᴅ-galactofuranose (4) with a yield of 76% over two steps.  
The 1H NMR showed a new H-1 anomeric signal in the 1H NMR at 6.78 ppm as a singlet, 
indicating exclusively the 1,2-trans β-anomer had been formed.39  By contrast, Zhang and 
Liu24 performed the reduction with disiamylborane, followed by benzoylation as two 
separate steps, with yield of 79% and 84% respectively.  Treatment of per-O-benzoyl-β-ᴅ-
galactofuranose (4) with 33% w/v HBr/AcOH afforded 2,3,5,6-tetra-O-benzoyl-β-ᴅ-
galactofuranosyl bromide (5) which was subjected to a fast work-up using ice cold sat. 
sodium bicarbonate solution, before being immediately reacted with dibenzyl phosphate in 
toluene.  This condensation gave a mixture of anomers α/β 1.8:1, as judged by integration of 
H-1’ 1H NMR signals.  The 1,2-cis α-anomer 2,3,5,6-tetra-O-benzoyl-α-ᴅ-galactofuranosyl 
dibenzylphosphate (6) was retained more strongly than the 1,2-trans β anomer by normal 
phase chromatography, as reported by Lederkremer et al.,37 which allowed the anomers to 
be separated.  The α anomer was identified by the H-1’ signal at 6.33 ppm as a doublet of 
doublets, with a J1,2 coupling value of 4.6 Hz and a J1,P coupling value of 5.7 Hz.37  Global 
deprotection was achieved by hydrogenation of the benzyl groups, followed by 
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debenzoylation using a mixture of 5/2/1 MeOH:H2O:Et3N to give α-ᴅ-galactofuranosyl 
phosphate, bis-triethylammonium salt (7) in 27% yield over two steps. 
 
 
Scheme 2.4 – The chemical synthesis of Galf-1-P; i) BzCl, DMAP, Pyr; ii) L-selectride™, THF; iii) BzCl, 
DMAP, Pyr; iv) 33% HBR/AcOH, DCM; v) Et3N, toluene; vi) H2, Pd/C, Et3N, EtOAc; vii) MeOH/H2O/Et3N 
(5:2:1) 
 
Although mass spectrometry showed complete deprotection, aromatic signals were still 
visible in the 1H NMR spectrum.  These were attributed to benzoic acid, the side product of 
hydrolysis caused by the presence of water during the debenozylation step.  An acceptable 
level of purification of α-ᴅ-galactofuranosyl phosphate, bis-triethylammonium salt (7) was 
achieved by simple partitioning between water and diethyl ether, which saved the need to 
purify by size exclusion or ion exchange chromatography. 
With Galf-1-P (7) in hand, it was next necessary to consider the synthesis of UDP-α-ᴅ-Galf 
(8).  The chemical synthesis of UDP-α-ᴅ-Galf (8) starting from Galf-1-P (7) was first reported 
by Tsvetkov and Nikolaev.23  The key pyrophosphorylation step in their synthesis was CDI-
activated coupling between UMP-imidazole and Galf-1-P (7), which gave an overall yield of 
23%.  Marlow and Kiessling22 subsequently published an improved chemical synthesis of 
UDP-α-ᴅ-Galf (8), where the key pyrophosphorylation step in their synthesis was the 
coupling between UMP-N-methylimidazolide and Galf-1-P (7), which gave an improved UDP-
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α-ᴅ-Galf (8) yield of 35%.  A more recent chemical synthesis of UDP-ᴅ-Galf (8) reported by 
Zhang and Liu24 relied on the coupling of Galf-1-P (7) with UMP-morpholidate, to give UDP-
ᴅ-Galf (8) with a yield of 20%. 
As an alternative route to chemical synthesis, Errey et al.28 have shown that it is possible to 
enzymatically synthesise UDP-ᴅ-Galf by using galactose-1-phosphate uridylyltransferase 
(GalPUT) to transfer uridinediphosphate from UDP-α-ᴅ-glucose (UDP-ᴅ-Glc) to Gal-1-P 
Scheme 2.5).  Because UDP-ᴅ-Glc and UDP-ᴅ-Galf are inseparable by strong anion exchange 
(SAX) chromatography, a catalytic amount of UDP-glucose was used.  UDP-ᴅ-Glc was 
regenerated from glucose-1-phosphate in situ with uridyltriphosphate using glucose-1-
phosphate uridylyltransferase (GalU).  The by-product of this regeneration is pyrophosphate, 
which was enzymatically removed by inorganic pyrophosphatase (IPP) to give inorganic 
phosphate.  It is this phosphate energy sink which drives the overall enzymatic reaction 
forwards.   
 
Scheme 2.5 – The enzymatic transformation of Galf-1P to UDP-ᴅ-Galf.28  UMP is transferred from UDP-
ᴅ-Glc onto Galf-1-P by the enzyme GalPUT.  UDP is then regenerated from Glc-1-P with UTP by the 
enzyme GalU; the by-product of this is PPi which is hydrolysed to Pi by the enzyme IPP.   
 
UDP-Galf was enzymatically synthesised following the protocol by Errey et al.28  The 
progression of the biotransformation was followed by SAX HPLC coupled with a UV-detector, 
using an ammonium bicarbonate buffer to elute the compounds (Figure 2.4).  After 24 hours 
there was a clear partial consumption of UTP, and an increase in the size of the peak relating 
to UDP-α-ᴅ-Galf (8) (Figure 2.4).  UDP-α-ᴅ-Galf (8) co-elutes with UDP-ᴅ-Glc, which is 
however only present in the mixture at a catalytic level. 
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Figure 2.4 – SAX chromatography analysis of the enzymatic synthesis of UDP-Galf. A no enzyme (NE) 
control as well as time points at 2, 17 and 24 hours were recorded.  The peaks on the chromatogram 
relate to: A) UDP-Glc tR 5.80; B) UDP, tR 7.35; C) UTP, tR 9.00; D) UDP-ᴅ-Galf + UDP-ᴅ-Glc, tR 5.70; See 
experimental section for column conditions. 
 
Whilst SAX coupled with UV-detection proved very convenient, unfortunately there were 
severe problems with compound degradation when trying to freeze dry UDP-α-ᴅ-Galf (8) 
which had been purified by SAX.  Fortunately it was possible to observe the characteristic 
peaks for UDP-α-ᴅ-Galf (8) in the NMR spectra, with the anomeric ribose H-1’ signal at 5.90 
ppm as a doublet with a J1’,2’ coupling value of 4.9 Hz, and the galactofuranose anomeric H-
1’’ signal at 5.55 ppm as a doublet of doublets with a J1’’,2’’ coupling value of 4.6 Hz and a J1’’,P 
coupling value of 5.2 Hz.  There were also two peaks in the 31P NMR at -11.3 ppm and -12.8 
ppm.  Whilst in the correct region for NDP-sugars, the overlap with UDP-glucose meant they 
appeared as multiplets.  To alleviate the problem of purification by SAX the 
biotransformation was instead quenched with methanol and centrifuged to remove the 
precipitated proteins, before being used crude for LC-MS method development. 
 
2.2.3 LC-MS analysis and profiling of UDP-α-ᴅ-Galf (8) 
The UDP-α-ᴅ-Galf (8) sample was used to determine multiple reaction monitoring (MRM) 
transitions on a Waters Xevo TQ-S tandem mass spectrometer using a Hypercarb™ porous 
graphitised carbon column, using a method previously published by us.40  The Waters Xevo 
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TQ-S tandem mass spectrometer is a triple quadrupole spectrometer which is set to search 
only for specific analytes of interest.  The first quadrupole is used as a filter to only allow 
parent ions of a specific mass/charge ratios through.  The second quadrupole is a collision 
chamber which fragments the parent ions into daughter ions.  The third quadrupole then 
filters again to allow through only daughter ions of specified mass/charge ratios.  Using the 
Intellistart™ function within the MassLynx™ software and electrospray ionisation in negative 
mode, the instrument searches for a combination of optimised parameters (cone voltage, 
collision energy) to achieve optimal detection limits for each authentic fragment and its 
fragments.  By only scanning for specified daughter ions, it also has the advantage of long 
dwell times, further increasing sensitivity.  Many sugar nucleotides are isobaric (species of 
the same mass) and they often produce identical fragment.  These species are differentiated 
based on their retention times.  This was achieved by coupling the spectrometer with a liquid 
chromatography system, using a Hypercarb™ porous graphitised carbon column (PGC).15  
PGCs are good at separating very polar analytes with closely related structures.  Compounds 
are eluted from PGC columns using an acetonitrile gradient against ammonium formate (pH 
9.0), a volatile buffer compatible with the LC-MS application.41  
After precipitating the enzymes from the biotransformation (Scheme 2.5) with methanol and 
removing them by centrifugation (10,000 × g), the crude mixture from the biotransformation 
of Galf-1-P (7) and UDP-α-ᴅ-Galf (8) was used as a standard to find the retention time and 
optimised mass spectrometry conditions for UDP-α-ᴅ-Galf (8).  The LC-MS results using a 
Hypercarb™ PGC column are shown in Figure 2.5; i) shows the result of the injection of the 
crude mixture giving two isobaric peaks, which was expected as the mixture contains both 
UDP-Glc and UDP-α-ᴅ-Galf (8).  ii) shows the UDP-ᴅ-Galp standard which elutes slightly 
earlier than either UDP-ᴅ-Glc or UDP-α-ᴅ-Galf (8).  As retention times can shift slightly with 
PGCs, some of the crude biotransformation mixture and UDP-ᴅ-Galp standard were mixed 
and co-injected which gave iii), showing all three isobaric species.  Finally, to determine 
which peak in the crude biotransformation mixture was which, iv) shows some of the crude 
mixture was spiked with UDP-ᴅ-Glc, and an increase in total ion count for the quicker eluting 
peak.  Coupled with the diagnostic 1H NMR peaks,24 we were confident that the 
biotransformation of Galf-1-P (7) into UDP-α-ᴅ-Galf (8) had been successful, and that UDP-
α-ᴅ-Galf (8) eluted after UDP-ᴅ-Galp and UDP-ᴅ-Glc. 
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Figure 2.5 –MRM chromatograms of the crude UDP-α-ᴅ-Galf (8) biotransformation mixture and 
comparison with authentic standards (UDP-Glc and UDP-Gal).  From this it was possible to show that 
(8) was the major species in the crude mixture, and its retention time added to the sugar nucleotide 
standards database.  See experimental section for column conditions. 
 
 
iv) 
iii) 
ii) 
i) 
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2.3 Chemical tools for exploring the biosynthesis of ʟ-xylofuranose 
2.3.1 Possible biosynthetic pathway for ʟ-xylofuranose on prymnesins 
Igarashi et al.1 have reported that prymnesin-2 is glycosylated with α-ʟ-xylofuranose.  They 
first identified the carbohydrate on PRM2 as ʟ-xylose by chiral GC analysis of the 
trifluoroacetate of the hydrolysed products of PRM2.  Igarashi et al.1 then determined that 
ʟ-xylose was present as a furanoside by comparison of the 13C NMR signals with literature 
values, and the 1,2-cis  stereochemistry at the anomeric from the J1,2 coupling constant of 4 
Hz in the 1H NMR.  This is the first time to our knowledge that a natural product has been 
reported as being glycosylated with ʟ-xylofuranose, and if correct then it follows that P. 
parvum must be producing an NDP-ʟ-Xylf derivative which is being used by a glycosyl 
transferase to glycosylate the toxin backbone.   
Work by Ben Wagstaff in our group produced a possible biosynthetic pathway for ʟ-
xylofuranose, shown in Scheme 2.6, using the following reasoning.  Xylose and arabinose are 
interconverting in nature due to epimerase activities.  Therefore, the biosynthetic pathway 
would likely start from either ʟ-xylose or ᴅ-arabinose. ʟ-Xylofuranose has not been reported 
in natural products, but ᴅ-arabinose is found in trypanosomes, with GDP-α-ᴅ-Arap (9) as the 
sugar nucleotide donor.16,42  The next likely step is an inversion of C4 to form GDP-β-ʟ-Xylp 
(10), in a manner analogous to the UDP-Glc/UDP-Gal epimerase mechanism; enzymes 
performing these C4 epimerisation reactions are abundant, although all known examples 
require an axial 4-OH group on the sugar, which is absent in GDP-β-ʟ-Xylf (11).43  Finally, 
presuming a similar reaction takes place to UGM, the 4-OH has to be above the plane of the 
sugar to facilitate top-side attack of the covalent adduct with the flavin cofactor during ring 
contraction (Scheme 2.3) to form GDP-β-ʟ-Xylf.33  Therefore the substrate of this reaction has 
to be GDP-β-ʟ-Xylp (10) and not GDP-α-ᴅ-Arap (9) which has a syn configuration between 4-
OH and O-GDP. 
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Scheme 2.6 – a possible biosynthetic pathway for GDP-β-ʟ-xylofuranose (11).  GDP-α-ᴅ-Arap (9) is 
biosynthesised from ᴅ-arabinose by a bifunctional kinase-GDP-Ara pyrophosphorylase.  A 4-epimerase 
inverts the 4-OH to give GDP-β-ʟ-Xylp (10), and the ring is contracted by a mutase to give GDP-β-ʟ-Xylf 
(11). 
 
Ben Wagstaff used BLASTp analysis to identify a putative trifunctional protein from P. parvum 
(Figure 2.6) (see Appendix for the translated trifunctional protein sequence).  A combined 
transcriptome data set for Prymnesium parvum isolated from lake Texoma was acquired 
from the publicly available MMETSP database,44 and UDP-galactopyranose mutase from 
Trypanosoma cruzi (AAX09637.1) was used as a reference sequence.  The resulting transcript 
translates to a 1210 AA protein with 3 clear domains. The N-terminal domain (14AA - 360AA) 
shares a high sequence identity with UDP-arabinose-4-epimerase isoform X3 from Ananas 
comosus (XP_020109800.1) - 45% sequence identity, 1e-93. The middle domain (390AA - 
867AA) shares high sequence identity to UGM from Trypanosoma cruzi (AAX09637.1) - 40% 
sequence identity, 1e-98.  There is also a clear third domain in the sequence although the C-
terminal domain has no clear homologues in the NCBI dataset which make defining the exact 
region difficult. 
 
Figure 2.6 – Graphical representation of trifunctional protein from P. parvum.  A) 14AA – 360AA; B) 
390AA – 867AA); C) third domain, with exact region undefined due to a lack of homology with the 
NCBI dataset 
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The epimerase shares a higher identity to arabinose 4-epimerases than respective galactose 
4-epimerases, suggesting arabinose or xylose as a substrate. So far, only mutases of this 
protein architecture have been discovered to act on galactose, so all homologues to the 
middle domain are UDP-galactopyranose mutases. However, Ben Wagstaff speculates an 
alternative substrate for this enzyme (i.e. UDP-ᴅ-Arap or UDP-ʟ-Xylp). The C-terminal domain 
has no clear homologues with known functions in the NCBI dataset. Due to the occurrence 
of similar trifunctional proteins in the genomes of other haptophytes Emiliania huxleyi and 
Chrysochromulina sp., hits are found to this domain.  
Because GDP-α-ᴅ-Arap (9) is known in trypanosomes it was proposed that the activating 
nucleotide base would be GDP rather than UDP.  This was supported by the fact that Ben 
Wagstaff noted the trifunctional protein has low homology to GDP-4,6-dehydratases, which 
suggested a role for GDP in the enzyme function. 
The proposed biosynthetic pathway to GDP-β-ʟ-Xylf (11) supported by the transcriptome 
data gave three 1,2-trans sugar nucleotide targets to synthesise for the NDP-sugar standards 
database (see Appendix, Table 1); GDP-α-ᴅ-arabinopyranose (9), GDP-β-ʟ-xylopyranose (10) 
and GDP-β-ʟ-xylofuranose (11).  In addition, sugar nucleotide profiling of algal extracts in the 
group had also found a UDP-hexose species which didn’t match to any standards in the NCBI 
database.  It was therefore also decided to make the 1,2-trans species UDP-α-ᴅ-mannose 
(12) as a further UDP-hexose standard. 
 
2.3.2 Chemical synthesis of 1,2-trans NDP-sugar standards 
A paper by Timmons et al.26 provided a convenient method for synthesising 1,2-trans sugar 
nucleotides by the direct displacement of glycosyl bromides with the desired NDP.  The key 
parameters for a successful 1,2-trans sugar nucleotide formation are that 1. the pH of the 
free acid of the NDP to be used should be adjusted to pH 6 for the optimum stability and 
nucleophilicty; 2. stereo-control at the anomeric position is imparted by the axial 
participating neighbouring group at C2’ (Scheme 2.7); 3. a 1/1/1 ratio of glycosyl bromide : 
nucleotide 5’-diphosphate : trimethylamine gives the best yield for the coupling reaction at 
80 °C in MeCN. 
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Scheme 2.7 – The influence of neighbouring group participation has been attributed to the 
stereoselective 1,2-trans configuration of sugar nucleotides synthesised from ester protected 
glycopyranosyl bromides26 
 
2.3.3 Preparation of NDP tetrabutyl ammonium salt 
NDP (disodium salt) was converted to the free acid by passing it through Amberlite® IR-120 
(H+ ion exchange resin.  The free acid was then titrated to pH 6 using tetrabutylammonium 
hydroxide (~40% in water) before being freeze dried for use in the phosphorylation.  
Integration of 1H NMR signals showed a ratio of about 2.8 Bu4N+ per equivalent of NDP (lit 
2.5 Bu4N+ per equivalent NDP).26  Although there was a slight shift in the peaks on exchanging 
the counterions, 31P NMR did not indicate any significant hydrolysis of NDP as a result of ion 
exchange. 
 
2.3.4 Chemical synthesis of 1,2-trans NDP-sugars 
 
Scheme 2.8 – Generic scheme for the stereoselective synthesis of 1,2-trans NDP sugars.26 
 
ᴅ-Mannose and ʟ-xylose were separately fully acetylated in acetic anhydride using a catalytic 
amount (0.7 mol%) of iodine to give per-O-acetyl-α-ᴅ-mannopyranose (13) and per-O-acetyl-
α,β-ʟ-xylopyranose (14) respectively.45  Comparison of the 1H NMR with literature values 
showed that the per-O-acetylated sugars had been synthesised in exclusively the pyranose 
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forms.46–48  For ᴅ-arabinose, iodine-catalysed per-O-acetylation, comparison of the 1H NMR 
signals with literature values showed a mixture of pyranose and furanose products had been 
formed.47,49  Therefore a low temperature per-O-benzoylation of ᴅ-arabinose using benzoyl 
chloride in pyridine with 1 mol% DMAP gave per-O-benzoyl-β-ᴅ-arabinopyranose (15) in 
>99% pyranose form.  Finally tetra-O-acetyl-α,β-ʟ-xylofuranose (16) was synthesised by 
subjecting ʟ-xylose to a hot (70 °C) per-O-acetylation using acetic anhydride in a mixture of 
acetic and boric acids.49  The protected sugars were converted to the corresponding glycosyl 
bromide donors by treatment with 33% w/v HBr in AcOH immediately before use. 
The same general protocol developed by Timmons et al.26 was used for the synthesis of 1,2-
trans sugar nucleotides.  In short, tetrabutylammonium NDP salt and trimethylamine were 
dissolved into MeCN over molecular sieves.  The triethylamine was added to neutralise the 
HBr liberated by the reaction. The sugar bromide was added and the reaction heated to 80 
°C for 30 minutes after which time TLC showed consumption of the starting bromide.  The 
solvent was removed under reduced pressure to give the crude reaction mixture.  Following 
Timmons et al.,26 at this point the crude mixture was dissolved in water and immediately 
adjusted to pH 8 with triethylamine.  Attempts to use alkaline phosphatase (100U) to remove 
any unreacted NDP led to degradation of the protected NDP-sugar.  Therefore, as unreacted 
NDP is readily removed from the NDP-sugar by SAX HPLC, I decided to omit the alkaline 
phosphatase step rather than trying to optimise it. 
The crude reaction mixture was then dissolved in a mixture of MeOH/H2O/Et3N (5:2:1) and 
stirred overnight at room temperature to remove the ester protecting groups and give the 
corresponding NDP-sugar.  The reaction mixture was analysed and subsequently purified by 
HPLC (SAX, UV 265 nm).  Strong anion exchange (SAX) separates compounds by their formal 
charge.  The higher the formal charge on a molecule, the more tightly retained it is by the 
anion exchange matrix.  To avoid lengthy desalting steps, for preparative purposes a volatile 
buffer was used which can be removed by freeze drying.  We have had a lot of success in the 
lab using ammonium bicarbonate as a volatile buffer for SAX HPLC purification of NDP-
sugars, as the buffer can be removed by extensive freeze drying. 
Any glycosyl bromide donor which had not reacted would have been hydrolysed to the sugar 
hemiacetal which does not carry a formal charge and as such is not retained by the SAX 
column.  The NDP-sugar carries a formal 2- charge and therefore elutes ahead of any 
unreacted NDP which carries a formal 3- charge respectively (Figure 2.7). 
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Figure 2.7 - SAX HPLC (UVabs 265 nm) analysis of the crude reaction mixture after the synthesis of GDP-
ᴅ-arabinopyranose.  The more mobile compound has a lower formal charge and is assigned as GDP-
ᴅ-Arap.  The second peak corresponds to a higher formal charge than the first and was assigned as 
unreacted GDP by comparison with a GDP standard.  See experimental section for column conditions. 
 
As both the NDP-sugar and unreacted NDP carry the same chromophore it was possible to 
compare the relative integration of both peaks in the UV-absorbance chromatogram.  It 
was therefore possible to calculate the conversion of NDP to NDP-sugar (Table 2.2).   
Table 2.2 – Conversion of NDP to 1,2-trans NDP-sugars 
Glycosyl bromide NDP Conversion 
2,3,4-Tri-O-benzoyl-β-D-arabinopyranosyl bromide (17) GDP 51%* 
2,3,4-Tri-O-acetyl-α-ʟ-xylopyranosyl bromide (18) GDP 23% 
2,3,4-Tri-O-acetyl-α-ʟ-xylofuranosyl bromide (19) GDP 0% 
2,3,4,6-tetra-O-acetyl-α-ᴅ-mannopyanosyl bromide (20) UDP 25% 
* Of which 16% was the 1,2-cis α-anomer as judged by integration of the H-1’ 1H NMR signals. 
 
No GDP-β-ʟ-xylofuranose was detected by SAX HPLC; this was attributed to instability of the 
1,2-trans NDP-furanoside under the reaction conditions.17  For the 1,2-trans NDP-
pyranosides, conversions of between 23% and 51% were obtained. 
The NDP-sugars were purified by SAX HPLC using ammonium bicarbonate as a buffer.  The 
buffer was removed by freeze drying to give the NDP-sugar in a form clean enough for NMR 
analysis and LC-MS profiling. 
 
GDP-ᴅ-Arap GDP 
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2.3.5 Sugar nucleotide profiling 
There is variation in the absolute retention times of species on the Hypercarb™ column.  
Pabst et al.15 have shown that there is a drift towards faster elusion of NDP-sugar with 
column reduction.  It was therefore important to keep the column earthed to minimise the 
drift in retention times. We have found that relative retention times compared with an 
internal UDP-Glc standard offer much better reproducibility.  Although only a single 
chromatogram is shown for each sugar nucleotides, the recorded relative retention time in 
the published database (Appendix, Table 1) is an average of three readings.40 
The synthetic GDP-ᴅ-Arap was analysed by LC-MS.  The Xevo TQ-S tandem mass 
spectrometer detected two isobaric peaks eluting from the Hypercarb™ PGC column (Figure 
2.8) at 19.80 and 20.30 minutes.  This could be explained by the presence of either a mixture 
of pyranose and furanose GDP-sugars, or a mixture of α and β anomers.  The small difference 
in retention times (1 minute) was too small to be attributed to a mixture of pyranose and 
furanose rings, and it was therefore more likely that a mixture of anomers had been 
formed.30  1H NMR showed a dominant H-1’’ signal as a doublet of doublets at 4.82 ppm with 
a J1’’,2’’ coupling value of 7.5 Hz (1,2-trans α-anomer) and a J1’’,P coupling value of 7.5 Hz.  There 
was also a minor H-1’’ signal as a doublet of doublets at 5.52 ppm with a J1’’,2’’ coupling value 
of 3.0 Hz (1,2-cis β-anomer) with a J1’’,P coupling value of 7.0 Hz.  This minor anomer was 
judged to have an abundance of 16% by integration of the H-1’’ signals.  This ratio was also 
in agreement with the integrals of the TIC peaks from the Xevo TQ-S mass spectrum.  As the 
two peaks could be distinguished from one another, the larger peak at tR 20.30 min was 
added to the sugar nucleotide profiling database as the characteristic peak for GDP-α-ᴅ-Arap 
(9). 
GDP-β-ʟ-Xylp (10) was analysed by LC-MS and the retention time and MRM transitions were 
added to the database.  This time a single peak was detected which meant that either a single 
anomer had been formed or there were two anomers with the same retention times (Figure 
2.8).  Analysis of the 1H NMR showed only a single H-1’’ signal at 4.86 ppm as a doublet of 
doublets with a J1’’,2’’ coupling value of 7.9 Hz (1,2-trans β-anomer) and a J1’’,P coupling value 
of 7.9 Hz.  The 31P NMR spectrum also showed two clean doublets at -11.2 ppm and -13.2 
ppm with JPα,Pβ coupling values of 20.2 Hz, which are signals characteristic of NDP-sugars.  
The NMR spectra, coupled with the LC-MS trace confirmed the presence of just the 1,2-trans 
β-anomer.  This is the first time that GDP-β-ʟ-xylopyranose (10) has been reported. 
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Figure 2.8 – MRM chromatograms (Xevo) for GDP-α-ᴅ-arabinopyranose (9) and GDP-β-ʟ-xylopyranose 
(10), as well as UDP-Glc against which the retention times are defined.  The relative retentions for 10 
and 11 were 1.53 and 1.52 respectively.  See experimental section for column conditions. 
 
UDP-Man (12) was also added to the sugar nucleotide profiling database.  Whilst not involved 
in the proposed biosynthetic pathway of GDP-ʟ-xylofuranose, there was an unaccounted for 
UDP-hexose species present in some sugar nucleotide profiles of P. parvum.30  Although the 
normal Leloir donor for mannose is GDP-mannose, it was decided worth-while adding UDP-
mannose to our database to help narrow down the possibilities for the unidentified UDP-
hexose.  The LC-MS trace from the Hypercarb™ PGC column coupled to a Xevo Q-TS mass 
spectrometer showed only a single peak (Figure 2.9).  Furthermore there was only H-1’’ signal 
in the 1H NMR spectrum at 5.42 ppm as a doublet of doublets with a J1’’,2’’ coupling value of 
1.8 Hz and a J1’’,P coupling value of 8.0 Hz.  To confirm the configuration at the anomeric 
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position a carbon proton-coupled spectrum was recorded which showed a 1JC1’’,H1’’ coupling 
value of 175.6 Hz which is in keeping with values expected of α-mannosides.50  Again the 31P 
NMR showed two doublets at -11.5 ppm and -13.6 ppm with a JPα,Pβ coupling value of 21.0 
Hz, which is in the range characteristic for NDP-sugars.   
 
Figure 2.9 - LC-MS (Xevo) TIC chromatogram for UDP-α-ᴅ-mannopyranose (12) and UDP-Glc reference.  
The relative retention time of 12 is 0.82. See experimental section for column conditions. 
 
The LC-MS experiments were run three times.  The average relative retention times when 
compared with UDP-α-ᴅ-Glc for the sugar nucleotides standards were calculated (Table 2.3).  
The characteristic MRM transitions were also recorded, and the data was added to our larger 
database of sugar nucleotides (Appendix, Table 6.1).40 
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Table 2.3 – Average relative retention times and MRM transitions for the sugar nucleotides 
synthesised in this chapter.40  
Sugar Nucleotide Relative 
Retention time 
MRM 
transitions 
Fragment 
UDP-α-ᴅ-Glucose (standard) 1.00 565 → 323 
565 → 79 
[NMP-H]- 
[H3PO4-H3O]- 
UDP-α-ᴅ-galactofuranose  1.10 565 → 323 
565 → 159 
[NMP-H]- 
[H4P2O7-H3O]- 
GDP-α-ᴅ-arabinopyranose  1.53 574 → 442 
574 → 362 
[NDP-H]- 
[NMP-H]- 
GDP-β-ʟ-xylopyranose  1.52 574 → 442 
574 → 424 
[NDP-H]- 
[NDP-H-H2O]- 
UDP-α-ᴅ-mannose 0.81 565 → 403 
565 → 159 
[NDP-H]- 
[H4P2O7-H3O]- 
 
2.4 Summary 
A sugar nucleotide profiling project for P. parvum is currently being carried out 
collaboratively between members of the lab.  My contribution to the project was the 
synthesis of non-commercially available nucleotide standards relating to selected 
carbohydrates reported as being present on the toxins prymnesin-1 and prymnesin-2.  UDP-
α-ᴅ-Galf (8) was synthesised chemoezymatically from synthetic Galf-1-P (7).  Although 
stability of 8 meant that it was not completely purified before use as a standard, it none the 
less gave a tR of 1.10 on our porous graphitic column relative to UDP-α-ᴅ-Glc, and was used 
to optimise the MRM transition detection parameters.  The 1,2-trans sugar nucleotides GDP-
α-ᴅ-Arap (9) and GDP-β-ʟ-Xylp (10) which are possible species in the biosynthetic pathway 
for ʟ-xylfuranose found on prymnesin-2 were synthesised by direct attack of the 
corresponding glycosyl bromides.  GDP -ᴅ-Arap was synthesised as a mixture of α/β isomers 
at the anomeric position, although the 1,2-trans sugar nucleotide has the major species and 
gave a relative tR of 1.53 for our database; the minor 1,2-cis isomer eluted slightly earlier 
with a relative tR of 1.49.  GDP-β-ʟ-Xylp (10) was synthesised with excellent stereochemical 
control and gave exclusively the 1,2-cis β anomer.  Again, this standard was added to the 
sugar nucleotide database and had a relative tR of 1.52.  Finally, UDP-α-ᴅ-Manp (12) was 
chemically synthesised to try and pin down an unknown UDP-hexose which was being 
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detected in P. parvum extracts.  This was synthesised by direct attack of the mannosyl 
bromide with UDP which proceeded with excellent stereochemical control to give only the 
1,2-trans α anomer, and UDP-α-ᴅ-Manp (12) was found to have a relative tR of 0.81.  The 
synthesis of GDP-β-ʟ-Xylf (11) is a challenge which still needs to be accomplished as a 
standard for the sugar-nucleotides profiling project.  If the method of synthesising 1,2-trans 
sugar-nucleotides developed by Timmons and Jakeman26 does not lend itself well to 
furanosyl bromides, one of the alternative methods of chemically synthesising sugar 
nucleotides discussed earlier in this chapter should be explored.17  If it were possible to 
express the trifunctional protein from P. parvum (Figure 2.6) then the synthetic 1,2-trans 
sugar nucleotides could also be tested as tentative substrates. 
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2.5 Experimental 
2.5.1 Enzymes 
Both galactose-1-phosphate uridylyltransferase (GalPUT, EC2.7.7.12) from Escherichia coli 
and Glucose-1-phosphate uridylyltransferase (GalU) from Escherichia coli had been over-
expressed and purified previously in the group by Ellis O’Neill.28,51 Inorganic pyrophosphatase  
(IPP) from Saccharomyces cerevisiae was purchased from Sigma Aldrich.  
 
2.5.2 NDP-Sugar Purification29 
NDP-sugar purification was performed using strong anion-exchange (SAX) HPLC. An aqueous 
solution of a sample was applied on a Poros® HQ 50 column (L/D 50/10 mm, CV = 3.9 mL). 
The column was first equilibrated with 4.5 CV of 5 mM ammonium bicarbonate buffer, 
followed by a linear gradient of ammonium bicarbonate from 5 mM to 250 mM in 13.5 CV.  
The gradient was then held for 4.5 CV, and finally followed a linear gradient back to 5 mM 
ammonium bicarbonate in 2.7 CV at a flow rate of 7.0 mL/min.  Eluted compounds were 
detected with an on-line detector monitoring absorption at 265 nm. After multiple injections, 
the column was washed with 3 CV of 1 M ammonium bicarbonate followed by 5 CV of Milli-
Q water. 
 
2.5.3 Sugar nucleotide profiling40 
We have recently reported our LC-MS/MS method for profiling sugar nucleotides.40  A Xevo 
TQ-S tandem quadrupole mass spectrometer (Waters) running in negative ion mode was 
used.  The capillary voltage was 1.5 kV, 500 °C desolvation temperature, 1000 L/h desolvation 
gas, 150 L/h cone gas, and 7 bar nebulizer pressure.  Sugar nucleotide standards (10 µM) 
were directly infused into the Xevo mass spectrometer at 10 µL/min.  The MRM transitions 
for the sugar nucleotides were generated and optimised using Intellistart software (Waters). 
Once optimised transitions were in place, the HPLC (Ultimate 3000, Dionex) retention times 
for the sugar nucleotides standards were determined on a porous graphitised carbon (PGC) 
column (Hypercarb, Thermo Scientific, dimensions 1 × 100 mm, particle size 5 μm) equipped 
with a column guard (Hypercarb, 5 μm, 1 × 10 mm).  Sugar nucleotides standards (5 μL, 10 
μM) were injected onto the column, and a multistep gradient of acetonitrile in water was 
run at 80 μL/min over 50 minutes.  0 min: 2% MeCN; 20 min: 15% MeCN; 26 min: 50% MeCN; 
27 min: 90% MeCN; 30 min: 90% MeCN; 31 min: 2% MeCN; 50 min: 2% MeCN. 
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The results of the LC-MS/MS were processed using MassLynx software (Waters).  We found 
that there could be significant variations in retention times between runs, but relative 
retention times compared against a standard of UDP-Glc were fairly stable. 
 
2.5.4 Chemical Synthesis 
2,3,5,6-Tetra-O-benzoyl-ᴅ-galacto-1,4-lactone (1)24 
 
 
Galactono-1,4-lactone (2.00 g, 11.2 mmol) and DMAP (20mg, 160 µmol) were dissolved into 
dry pyridine (30 mL) under N2.  BzCl (8.0 mL, 68 mmol) was added dropwise to the solution 
and the reaction mixture was stirred at room temperature for 2 hours.  The reaction mixture 
was diluted into DCM (50 mL) and washed with HCl (1.0 M, 2 × 10 mL) and brine (10 mL) 
before being dried over MgSO4, filtered and dried in vacuo.  The crude residue was purified 
by FCC to give the title compound (1) (6.6 g, 98%) as a yellow oil; Rf 0.45 (hexane/EtOAc 7:3);  
νmax/cm-1 (FTR-IR), 1720 (C=O), 1601 (C=C) 1245 (C-O), 1091 (C-O); δH(400 MHz; CDCl3) 8.17-
7.26 (m, 20H, Ar), 6.09 (d, J2,3 = 5.7 Hz, 1H, H-2), 6.08-6.04 (m, 1H, H-5), 5.87 (dd, J2,3 = 5.7 Hz, 
J3,4 = 5.7 Hz, 1H, H-3), 5.06 (dd, J3,4 = 5.7 Hz, J4,5 = 2.7 Hz, 1H, H-4), 4.78-4.70 (m, 2H, H-6a,6b); 
δC(100 MHz; CDCl3) 168.7 (C1), 165.9, 165.5, 165.2, 165.0 (4 × C=O), 134.6, 134.0, 133.8, 
133.8, 133.3, 130.6, 130.2, 130.1, 130.0, 129.8, 129.3, 128.9, 128.8, 128.7, 128.6, 128.5, 
128.4, 128.1, 127.9 (Ar), 79.5 (C4), 74.3 (C3), 72.3 (C2), 70.1 (C5), 62.4 (C6).  The 1H NMR data 
were in accordance with the literature.52 
 
Per-O-benzoyl-β-ᴅ-galactofuranose (4)39 
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A solution of 2,3,5,6-tetra-O-benzoyl-D-galacto-1,4-lactone (1) (6.0 g, 10 mmol) in THF (30 
mL) was cooled to -78 °C in a bath of dry ice and acetone.  L-Selectride® (1M in THF) (15 mL, 
1.5 mmol) was slowly added by syringe and the reaction mixture was stirred at -78 °C for 2h, 
after which time analysis by TLC showed consumption of the starting lactone (Rf 0.58, 
hexane/EtOAc 7:3) and a new spot (Rf 0.48 hexane/EtOAc 7:3).  Pyridine (4 mL) was added in 
a single portion followed the dropwise addition of benzoyl chloride (5 mL, 43 mmol).  The 
reaction mixture was then removed from the dry ice bath and allowed to warm to room 
temperature overnight.  The solvent was removed under reduced pressure and the crude 
reaction mixture purified by FCC to give the title compound (5.4 g, 76% over 2 steps) as a 
white powder; Rf 0.58 (hexane/EtOAc 7:3); δH(400 MHz; CDCl3) 8.12-7.26 (m, 25H, Ar), 6.78 
(s,1H, H-1), 6.15-6.11 (m, 1H, H-5), 5.80 (dd, J2,3 = 0.8 Hz, J3,4 = 4.1 Hz, 1H, H-3), 5.77 (d, J2,3 = 
0.8 Hz, 1H, H-2), 4.88 (dd, J3,4 = J4,5 = 4.1 Hz, 1H, H-4), 4.83-4.73 (m, 2H, H-6a,6b) ; 166.0, 
165.8, 165.4, 165.2, 164.5 (5 × C=O), 133.7, 133.7, 133.6, 133.3, 133.0, 130.0, 129.9, 129.7, 
129.5, 129.4, 129.3, 128.9, 128.6, 128.5, 128.5, 128.4, 128.3, 128.2 (Ar), 99.8 (C1), 84.3 (C4), 
81.0 (C2), 77.2 (C3), 70.3 (C5), 63.6 (C6); m/z (MALDI, DHB matrix) calc. for C41H32O11Na+ 
723.184 ([M+Na]+) found 723.116 [M+Na+], 739.199 [M+K+]; the 1H NMR data were in 
accordance with the literature.39 
 
2,3,5,6-Tetra-O-benzoyl-β-ᴅ-galactofuranosyl bromide (5)53 
 
Per-O-benzoyl-β-ᴅ-galactofuranose (4) (500 mg, 0.71 mmol) was dissolved into dry DCM (5 
mL) under N2.  The solution was cooled to 0 °C and HBr (30% w/v in AcOH, 2.0 mL, 7.4 mmol) 
added dropwise.  The reaction mixture was stirred for 1 hour at 0 °C.  TLC (hexane/EtOAc 
8:2) showed 4 had been consumed and the reaction was diluted with DCM (20 mL) and 
washed with sat. aqueous sodium bicarbonate solution (3 × 5 mL).  The organic layer was 
then dried over MgSO4, filtered and dried in vacuo to give the title compound as a colourless 
oil (410 mg, 88%) which was used in the next step without any further purification. Rf 0.33 
(hexane/EtOAc 8:2); δH(400 MHz; CDCl3) 8.12-7.23 (m, 20H, Ar), 6.66 (s, 1H, H-1), 6.20 (m, 
1H, H-5), 5.90 (s 1H, H-2), 5.70 (d, J3,4 = 4.8 Hz, 1H, H-3), 4.97 (t, J3,4 = 4.8 Hz, J4,5 = 4.8 Hz, 1H, 
H-4), 4.75-4.73 (m, 2H, H-6); δC(100 MHz; CDCl3) 166.0, 165.7, 165.6, 165.2 (4 × C=O), 133.8, 
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133.7, 133.5, 133.2, 130.1, 130.1, 129.9, 129.7, 128.6, 128.5, 128.4 (Ar), 88.5 (C1), 85.7 (C2), 
84.9 (C4), 76.6 (C3), 69.6 (C5), 63.4 (C6). 
 
2,3,5,6-Tetra-O-benzoyl-α-ᴅ-galactofuranosyl-dibenzyl phosphate (6)24 
 
Dibenzyl hydrogen phosphate (300 mg, 1.1 mmol) and Et3N (0.2 mL, 1.43 mmol) were 
dissolved into dry toluene (1.7 mL) under N2.  2,3,5,6-Tetra-O-benzoyl-β-D-galactofuranosyl 
bromide (5) (410 mg, 0.6 mmol) in dry toluene (4 mL) was added by syringe and the reaction 
mixture stirred at room temperature for 16 hours.  TLC (toluene/EtOAc 9:1) showed both α 
and β products which were separated by FCC (toluene/EtOAc 9:1) to give α-phosphate 
(170mg, 33%) as a white powder; Rf 0.26 (toluene/EtOAc 9:1); δH(400 MHz; CDCl3) 8.14-7.91 
(m, 8H, Ar), 7.55-7.05 (m; 22H, Ar), 6.33, (dd, J1,2 = 4.6 Hz, J1,P = 5.7 Hz, 1H, H-1), 6.17 (dd, J2,3 
= J3,4 = 7.2 Hz, 1H, H-3), 5.85-5.82 (m, 1H, H-5), 5.73 (ddd, J1,2 = 4.6 Hz, J2,3 = 7.2 Hz, J2,P = 1.9 
Hz, 1H, H-2), 5.05-4.70 (m, 6H, H-4,6a & 2 × PhCH2), 4.61 (dd, J5,6b = 6.2 Hz, 2J6a,6b = 12.0 Hz, 
1H, H-6b); δC (100 MHz; CDCl3), 165.9, 165.6, 165.5, 165.4 (4 × C=O), 133.7, 133.6, 133.2, 
133.1, 130.1, 130.0, 129.9, 129.7, 129.5, 129.4, 128.5, 128.5, 128.4, 128.4, 128.3, 127.8, 
127.6 (Ar), 97.7 (d, JC1,P = 4.9 Hz, C1), 80.0 (C4), 76.5 (d, JC2,P = 7.1 Hz, C2), 73.4 (C3), 70.8 (C5), 
69.4 (d, JPhCH2,P = 5.4 Hz, PhCH2), 69.3 (d, JPhCH2,P = 5.4 Hz, PhCH2), 62.7 (C6); LRMS (MALDI, 
DHB matrix) m/z calc. for C48H41O13PNa+ 879.218 ([M+Na]+) found 879.308 [M+Na+], 865.273 
[M.K+]; the 1H NMR data were in accordance with the literature.24 
 
2,3,5,6-Tetra-O-benzoyl-α-ᴅ-galactofuranosyl – phosphate, bis-triethylammonium salt24 
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Triethylamine (0.17 mL) and 2,3,5,6-tetra-O-benzoyl-α-ᴅ-galactofuranosyl-dibenzyl 
phosphate (6) (170 mg, 0.2 mmol) were dissolved in EtOAc (2.5 mL) under N2.  Pd/C (10%, 20 
mg) was carefully added and the system purged with N2.  The system was then purged with 
and left under H2 overnight at room temperature.  TLC  (tol/EtOAc 9:1) showed the 
consumption of 6 and the catalyst was removed by filtration and the solvent removed under 
in vacuo to give the title compound (73 mg, 41%) as a white powder; δH(400 MHz; CDCl3) 
8.11-7.17 (m, 8H, Ar), 7.50-7.23 (m, 12H, Ar), 6.23 (dd, J1,2 = J1,P = 7.0 Hz, 1H, H-1), 6.16 (dd, 
J2,3 = 7.4 Hz, J3,4 = 4.4 Hz, 1H, H-3), 5.87-5.84 (m, 1H, H-5), 5.64 (m, 1H, H-2), 4.90 (dd, J5,6a = 
3.6 Hz, J6a,6b = 12.1 Hz, 1H, H-6a), 4.75 (dd, J5,6b = 6.5 Hz, J6a,6b = 12.1 Hz, 1H, H-6b), 4.63 (dd, 
J3,4 = 4.4 Hz, J4,5 = 5.8 Hz, 1H, H-4), 3.04 (q, JCH2,CH3 = 7.3 Hz, 12H, 2 × N(CH2CH3)3), 1.31 (q, 
JCH2,CH3 = 7.3 Hz, 18H, 2 × N(CH2CH3)3); δC(100 MHz; CDCl3) 165.9, 165.8, 165.7, 165.4 (4 × 
C=O), 133.3, 133.1, 132.9, 131.2, 130.1, 130.1, 129.8, 129.6, 129.5, 129.5, 128.9, 128.4, 
128.3, 128.3, 128.2, 127.8, 126.8, 95.9 (d, JC1,P = 4.0 Hz, C1), 78.3 (C4), 76.6 (d, JC2,P = 7.5 Hz, 
C2), 73.9 (C3), 71.8 (C5), 62.9 (C6), 45.7 (2 × N(CH2CH3)3), 8.6 (2 × N(CH2CH3)3); δP(162 MHz; 
CDCl3) -1.0 (P); LRMS (ESI-) calc for C34H28O13P- 675.1 ([M-H]-), found 675.4 [M-H]-; the 1H and 
13C NMR were in accordance with literature values.24 
 
α-ᴅ-Galactofuranosyl phosphate, bis-triethylammonium salt (8)24 
 
2,3,5,6-tetra-O-benzoyl-α-ᴅ-galactofuranosyl-phosphate bis-triethylammonium salt (70 mg, 
80 µmol) was dissolved into a solvent system of MeOH/H2O/Et3N (5:2:1) (8 mL) and stirred 
for 4 days at room temperature.  The solvent was removed in vacuo and the products were 
partitioned between water and Et2O to remove benzoic acid.  The aqueous layer was 
separated and dried by lyophilisation to give the title compound (8) (24 mg, 66%) as a white 
powder; δH(400 MHz; D2O) 5.36 (dd, J1,2 = J1,P = 4.6 Hz, 1H, H-1), 4.09 (dd, J2,3 = 8.3 Hz, J3,4 = 
7.3 Hz, 1H, H-3), 3.97 (dd, J1,2 = 4.6 Hz, J2,3 = 8.3, Hz, J2,P = 2.2 Hz, 1H, H-2), 3.68-3.45 (m, 4H, 
H-4,5,6a,6b), 3.03 (q, JCH2,CH3 = 7.4 Hz, 12H, 3 × (NCH2CH3)3), 1.11 (t, JCH2,CH3 = 7.4 Hz, 12H, 3 × 
(NCH2CH3)3); δC (100 MHz; D2O) 96.6 (d, JC1,P = 5.7 Hz, C1), 81.4 (C4), 76.5(d, JC2,P = 7.8 Hz, C2), 
73.6 (C3), 71.8 (C5), 62.3 (C6), 46.6 (NCH2CH3), 8.2 (NCH2CH3); δP(162 MHz; D2O) -0.2; HRMS 
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(ESI-) m/z calc. for C6H11O9P- 259.0224 ([M-H]-) found 259.0220 [M-H]-. The 1H and, 13C and 
31P NMR data were in accordance with the literature.24 
 
UDP-α-ᴅ-Galactofuranose (9)28 
 
α-ᴅ-Galactofuranosyl phosphate, bis-triethylammonium salt (8) (1 mg, 2.2 µmol), UDP-
glucose disodium salt (41 µg, 65 nmol) and uridine triphosphate trisodium salt (1.2 mg, 2.2 
µmol) were dissolved into 500 µL of buffer (50 mM HEPES, 10 mM MgCl2 and 10 mM KCl 
adjusted to pH 8.0).  A small portion (20 µL) was separated, mixed with methanol (20 µL) and 
stored in the freezer as a no enzyme control.  Stock solutions of glucose-1-phosphate 
uridylyltransferase (2.4 mg/ml in 25% glycerol and 75% GF buffer (pH 7.5, 50 mM HEPES, 100 
mM NaCl) 5U, 50µL), galactose-1-phosphate uridylyl transferase (2.4 mg/ml, GF buffer, 75 U, 
50µL) and inorganic pyrophosphatase commercial (5U, 50µL) were all added and the reaction 
mixture was stirred at 30 °C for 8 hours. 
The reaction was subsequently quenched with methanol (500 µL) and centrifuged at 10,000 
× g for 2 minutes.  The supernatant was analysed by strong anion exchange HPLC but was 
not purified further as it was suitable for use as a sugar nucleotide standard as was.  The 
diagnostic signals are listed.  δH(400 MHz; D2O) 7.90 (d, J5,6 = 8.2 Hz, 1H, H-5), 5.90 (d, J1’,2’ = 
4.9 Hz, 1H, H-1’), 5.86 (d, J5,6 = 8.2 Hz, 1H, H-6), 5.55 (J1’’,2’’ = 4.6 Hz, J1’’,P = 5.2 Hz, 1H, H-1’’), 
4.31-3.96 (m, 7H, H-2’’,3’’,2’,3’,4’,5’a,5’b), 3.75-3.35 (m, 3H, 4’’,5’’,6’;a,6’b);  δP(162 MHz; 
D2O) -11.3 (m, Pβ), -12.8 (m, Pα); HRMS (ESI-) m/z calc. for C15H23N2O17P2- 565.0477 ([M-H]-) 
found 565.0477 [M-H]-.  The diagnostic 1H and 31P signals were in accordance with literature 
values.23 
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Per-O-acetyl-α-ᴅ-mannopyranose (13)54 
 
Iodine (0.7 mol %) was added to a suspension of ᴅ-Mannose (1.0 g, ) in acetic anhydride (10 
mL) under nitrogen.  The reaction mixture was stirred overnight at room temperature, before 
being diluted with EtOAc (100 mL) and washed with sat. Na2S2O3 (3 × 20 mL) and sat. NaHCO3 
(3 × 20 mL).  The organic layers were combined and dried over MgSO4, before being filtered 
and dried under reduced pressure to give the crude compound (13) as a brown oil.  This was 
used without further purification. Rf 0.19 (hexane/EtOAc 7:3); δH(400 MHz; CDCl3) 6.09 (d, 
J1,2 = 1.9 Hz, 1H, H-1), 5.36-5.34 (m, 2H, H-3,4), 5.26 (dd, J1,2 = 1.9 Hz, J2,3 = 2.3 Hz, 1H, H-2), 
4.28 (dd, J5,6a = 4.9 Hz, 2J6a,6b = 12.4 Hz, 1H, H-6a), 4.10 (dd, J5,6b = 2.5 Hz, 2J6a,6b = 12.4 Hz, 1H, 
H-6b), 4.09-4.04 (m, 1H, H-5); δC(100 MHz; CDCl3) 170.5, 169.9, 169.6, 169.5, 168.0, 166.4 (6 
× C=O), 90.5 (C1), 70.5 (C5), 68.7 (C3), 68.3 (C2), 65.5 (C4), 62.0 (C6), 22.1, 20.7, 20.7, 20.6, 
20.6, 20.5 (6 × OAc).  1H and 13C NMR were in agreement with literature values.48 
 
Per-O-acetyl-α,β-ʟ-xylopyranose (14)55 
 
Iodine (0.7 mol %) was added to a suspension of ʟ-xylose (200 mg, ) in acetic anhydride (6 
mL) under nitrogen.45  The reaction mixture was stirred overnight at room temperature, 
before being diluted with EtOAc (50 mL) and washed with sat. Na2S2O3 solution (3 × 10 mL) 
and sat. NaHCO3 solution (3 × 10 mL).  The organic layers were combined and dried over 
MgSO4, before being filtered and dried under reduced pressure to give the crude compound 
(14) as a yellow oil (α/β 1:5) as judged by 1H NMR;  Rf 0.32 (7:3 Hex:EtOAc); δH(400 MHz; 
CDCl3) 6.27 (d, J1,2 = 3.7 Hz, 1H, H-1β), 5.72 (d, J1,2 = 7.0 Hz, 1H, H-1α), 5.47 (dd, J2,3 = J3,4 = 9.7 
Hz, 1H, H-3β), 5.21 (dd, J2,3 = J3,4 = 8.6 Hz, 1H, H-3α), 5.06-4.97 (m, 4H, H-2α,4α,2β,4β), 4.15 
(dd, J4,5aα = 5.2 Hz, 2J5aα,5bα = 12.0 Hz, 1H, H-5aα), 3.94 (dd, J4,5aβ = 6.0 Hz, 2J5aβ,5bβ = 11.2 Hz, 
1H, H-5aβ), 3.71 (dd, J4,5bβ = 2J5aβ,5bβ = 11.2 Hz, 1H, H-5bβ), 3.53 (dd, J4,5bα = 8.5 Hz, 2J5aα,5bα = 
12.0 Hz, 1H, H-5bα) ; δC(100 MHz; CDCl3) 170.1, 169.8, 169.7, 169.0 (4 × C=O), 92.1 (C1α) 89.3 
(C1β), 71.1 (C3α), 69.6 (C4α), 69.3 (C3β), 69.4 (C4β), 67.9 (C2α), 68.7 (C2β), 61.7 (C5α), 60.7 
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(C5β), 20.7, 20.7, 20.5, 20.5 (4 × OAc).  The 1H and 13C NMR signals were in good agreement 
with literature values for the analogous ᴅ-enantiomers; 1,2-cis α-ʟ analogue,46 1,2-trans β-ʟ 
analogue.47 
 
Per-O-benzoyl-β-ᴅ-arabinopyranose (15)56 
 
A solution of ᴅ-arabinose (1.0 g, 6.7 mmol) and DMAP (8 mg, 1 mol%) in dry pyridine (15 mL) 
under nitrogen was cooled in an ice bath.  Benzoyl chloride (5.0 mL, 43 mmol) was added 
dropwise over 30 minutes and the reaction mixture was allowed to warm to room 
temperature and stirred overnight.  The solvent was removed under reduced pressure and 
the crude mixture was re-dissolved in EtOAc (30 mL) before being washed with 3M HCl (3M, 
2 × 10 mL), sat. NaHCO3 (2 × 5 mL) and brine (10 mL).  The organic layer was dried over 
MgSO4, filtered and the solvent was removed under reduced pressure to give a crude product 
as a yellow oil.  The crude compound was purified by FCC to give the title compound (15) (3.2 
g, 85%) as a white powder Rf 0.66 (n-Hex/EtOAc 7:3); δH(400 MHz; CDCl3) 8.1 – 7.2 (m, Ar-H, 
20H), 6.86 (1H, d, J1,2 = 1.5 Hz, H-1), 6.07 (2H, m, H-2, H-3), 5.89 (1H, m, H-4), 4.41 (1H, dd, 
J4,5 = 1.0 Hz, 2J5a,5b 13.4 Hz, H-5a), 4.18 (1H, dd, J4,5’ = 2.1 Hz, 2J5a,5b = 13.4 Hz, H-5b); δC(100 
MHz; CDCl3) 165.7, 165.7, 165.6, 164.7 (4 × C=O), 133.8, 133.6, 133.5, 133.4 (4 × Ar-C), 129.9 
– 128.4 (Ar), 91.1 (C1), 69.5 (C4), 68.2 (C3), 67.8 (C2), 63.0 (C5).  The 1H and 13C NMR signals 
were in good agreement with literature values for the analogous ʟ-enantiomer.56 
 
Per-O-acetyl-α,β-ʟ-xylofuranose (16)49 
 
ʟ-Xylose (1.0 g, 6.6 mmol) was suspended in AcOH (50 mL) under a nitrogen atmosphere.  
Boric acid (1.86 g, 30 mmol) was added in a single portion and the reaction mixture was 
heated at 70 °C for 2 hours.49  Acetic anhydride (50 mL) was slowly added over 30 minutes 
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and the reaction mixture stirred at 70 °C overnight.  The reaction mixture was then poured 
into water (120 mL) and the aqueous mixture was extracted with EtOAc (3 × 40 mL).  The 
organic layers were combined, washed with sat. aqueous NaHCO3 solution (3 × 30 mL), dried 
over MgSO4 and filtered.  The solvent was then removed under reduced pressure to give the 
crude product (16) (2.16 g, 52%) (α/β 1:1 as judged by 1H NMR) as a yellow oil; Rf 0.15 
(hexane/EtOAc 7:3); δH(400 MHz; CDCl3) 6.43 (d, J1α,2α = 4.5 Hz, 1H, H-1α), 6.12 (s, 1H, H-1β), 
5.34 (dd, J2α,3α = J3α,4α = 6.8 Hz, 1H, H-3α), 5.38 (dd, J2β,3β = 1.6 Hz, J3β,4β = 5,6 Hz, 1H, H-3β), 
5.31 (dd, J1α,2α = 4.5 Hz, J2α,3α = 6.3 Hz, 1H, H-2α), 5.22 (d, J2β,3β = 1.6 Hz, 1H, H-2β), 4.67-4.61 
(m, 2H, H-4β,4α), 4.26-4.21 (m, 3H, H-5aβ, 5bβ, 5aα), 4.13 (dd, J4α,5bα = 4.3 Hz, J5aα,5bα = 12.3 
Hz, 1H, H-5bα), 2.13-2.08 (m, 24H, 8 × OAc); δC(100 MHz; CDCl3) 170.5, 170.4, 170.2, 169.7, 
169.5, 169.3, 169.3, 169.2 (8 × C=O), 98.8 (C1β), 92.8 (C2α), 79.9 (C2β), 79.4 (C4β), 75.4 (C4α), 
75.2 (C2α), 74.3 (C3β), 73.8 (C3α), 62.4 (5β), 61.6 (C5α), 21.1, 20.9, 20.8, 20.8, 20.7, 20.6, 
20.6, 20.4 (8 × OAc); NMR values are in agreement with literature values.49 
 
2,3,4-Tri-O-benzoyl-β-D-arabinopyranosyl bromide (17) 
 
Per-O-benzoyl-β-D-arabinopyranose (15) (100 mg, 0.18 mmol) was dissolved in dry DCM (3 
mL) under a nitrogen atmosphere.  33% w/v HBr in AcOH (0.5 mL) was added and the 
reaction mixture was stirred at room temperature for 3 hours.  Residual HBr was blown out 
of the reaction flask with a compressed air line, and the solvent was removed under reduced 
pressure.  The crude mixture was re-dissolved in EtOAc (15 mL) and washed with ice cold sat. 
aqueous NaHCO3 (3 × 5 mL).  The organic layer was dried over MgSO4, filtered and the solvent 
evaporated under redcued pressure to give the crude title compound (17) as a colourless oil 
which was used immediately in the next step without further purification. Rf 0.40 
(hexane/EtOAc 3:1); δH(400 MHz; CDCl3) 8.11-8.08 (m, 1H, Ar), 8.03-8.01 (m, 1H, Ar), 7.87-
7.85 (m, 1H, Ar), 7.63-7.30 (m, 9H, Ar), 6.93 (d, J1,2 = 3.8 Hz, 1H, H-1), 6.00 (dd, J2,3 = 10.5 Hz, 
J3,4 = 3.8 Hz, 1H, H-3), 5.84-5.83 (m, 1H, H-4), 5.71 (dd, J1,2 = 3.9 Hz, J2,3 = 10.5 Hz, 1H, H-2), 
4.47 (dbs, 2J5a,5b = 12.9 Hz, 1H, H-5a), 4.23 (dd, J4,5b = 1.9 Hz, 2J5a,5b = 12.9 Hz, 1H, H-5b); δH(100 
MHz; CDCl3) 165.6, 165.5, 165.4 (3 × C=O), 133.8, 133.7, 133.4, 130.0, 129.9, 129.8, 128.7, 
  P a g e  | 59 
128.6, 128.4 (12 × Ar) 89.8 (C1), 68.9 (C4), 68.7 (C2), 65.0 (C3), 60.4 (C5).  The 1H NMR values 
were in agreement with those for the analogous ʟ-enantiomer.57 
 
2,3,4-Tri-O-acetyl-α-ʟ-xylopyranosyl bromide (18) 
 
Per-O-acetyl-α,β-ʟ-xylopyranose (100 mg, 0.3 mmol) was dissolved in dry DCM (3 mL) under 
a nitrogen atmosphere.  33% w/v HBr in AcOH (0.5 mL) was added and the reaction mixture 
was stirred at room temperature for 3 hours.  Residual HBr was blown out of the reaction 
flask with a compressed air line, and the solvent was removed under reduced pressure.  The 
crude mixture was re-dissolved in EtOAc (15 mL) and washed with ice cold sat. aqueous 
NaHCO3 solution (3 × 5 mL).  The organic layer was dried over MgSO4, filtered and the solvent 
evaporated in vacuo to give the crude title compound as a colourless oil (18) which was used 
immediately in the next step.  Rf 0.55 (hexane/EtOAc 7:3); δH(400 MHz; CDCl3) 6.59 (d, J1,2 = 
4.0 Hz, 1H, H-1), 5.57 (dd, J2,3 = 10.0 Hz, J3,4 = 10.0 Hz, 1H, H-3), 5.08-5.01 (m, 1H, H-4), 4.78 
(dd, J1,2 = 4.0 Hz, J2,3 = 10.0 Hz, 1H, H-2), 4.05 (dd, J4,5a = 6.0 Hz 2J5a,5b = 11.4 Hz, 1H, H-5a), 3.88 
(dd, J4,5b = 11.4 Hz, 2J5a,5b = 11.4 Hz, 1H, H-5b); δC(100 MHz; CDCl3); 169.4, 169.4, 169.7 (3 × 
C=O); 87.5 (C1), 70.9 (C2), 69.5 (C3), 68.1 (C4), 62.5 (C5), 20.7, 20.7, 20.6, (3 × OAc). 
 
2,3,4-Tri-O-acetyl-α-ʟ-xylofuranosyl bromide (19) 
 
Per-O-acetyl-α,β-ʟ-xylofuranose (200 mg, 0.6 mmol) was dissolved in dry DCM (3 mL) under 
a nitrogen atmosphere.  33% w/v HBr in AcOH (0.5 mL) was added and the reaction mixture 
was stirred at room temperature for 3 hours.  Residual HBr was blown out of the reaction 
flask with a compressed air line, and the solvent was removed under reduced pressure.  The 
crude mixture was re-dissolved in EtOAc (15 mL) and washed with ice cold sat. aqueous 
NaHCO3 solution (3 × 5 mL).  The organic layer was dried over MgSO4, filtered and the solvent 
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evaporated in vacuo to give the crude title compound (19) as a colourless oil which was used 
immediately in the next step; δH(400 MHz; CDCl3) 6.81 (d, J1,2 = 4.7 Hz, 1H, H-1), 5.62, (dd, J2,3 
= J3,4 = 6.8 Hz, 1H, H-3), 5.03 (dd, J1,2 = 4.7 Hz, J2,3 = 6.8 Hz, 1H, H-2), 4.75-4.71 (m, 1H, H-4), 
4.31 (dd, J4,5a = 5.5 Hz, 2J5a,5b = 12.4 Hz, 1H, H-5a), 4.15 (dd, J4,5b = 4.0, 2J5a,5b = 12.4 Hz, 1H, H-
5b); δC(100 MHz; CDCl3) 170.3, 170.1, 170.0, 169.5 (4 × C=O), 98.6 (C1), 78.2 (C2), 76.3 (C4), 
73.5 (C3), 60.6 (C5), 20.9, 20.8, 20.7, 20.6 (4 × C=O).  
 
2,3,4,6-penta-O-acetyl-α-ᴅ-mannosyl bromide (20) 
 
Per-O-acetyl-α-ᴅ-mannose (13) (100 mg, 0.3 mmol) was dissolved in dry DCM (3 mL) under 
a nitrogen atmosphere.  33% w/v HBr in AcOH (0.5 mL) was added and the reaction mixture 
was stirred at room temperature for 3 hours.  Residual HBr was blown out of the reaction 
flask with a compressed air line, and the solvent was removed under reduced pressure.  The 
crude mixture was re-dissolved in EtOAc (15 mL) and washed with ice cold sat. aqueous 
NaHCO3 solution (3 × 5 mL).  The organic layer was dried over MgSO4, filtered and the solvent 
evaporated in vacuo pressure to give the crude title compound as a colourless oil (20) which 
was used immediately in the next step without further purification; Rf 0.35 (hexane/EtOAc 
7:3); δH(400 MHz; CDCl3) 6.31 (d, J1,2 = 1.0 Hz, 1H, H-1), 5.72 (dd, J2,3 = 3.4 Hz, J3,4 = 10.1 Hz, 
1H, H-3), 5.45 (dd, J1,2 = 1.0 Hz, J2,3 = 3.4 Hz, 1H, H-2), 5.37 (dd, J3,4 = 10.1 Hz, J4,5 = 10.1 Hz, 
1H, H-4), 4.33 (dd, J5,6a = 5.0 Hz, J6a,6b = 12.5 Hz, 1H, H-6a), 4.25-4.21 (m, 1H, H-5), 4.14 (dd, 
J5,6b = 2.1 Hz, J6a,6b = 12.5 Hz, 1H, H-6b), 2.18 (s, 3H, OAc), 2.11 (s, 3H, OAc), 2.08 (s, 3H, OAc), 
2.01 (s, 3H, OAc); δH(100 MHz; CDCl3) 170.4, 169.6, 169.5, 169.5 (4 × C=O), 83.1 (C1), 72.8 
(C2), 72.1 (C5), 67.9 (C3), 65.3 (C4), 61.1 (C6), 20.7, 20.6, 20.6, 20.5 (4 × OAc).  The 1H and 13C 
NMR values were in agreement with published literature values.26 
 
General method: 1,2-trans NDP-sugar synthesis26 
NDP-sugar (Bu4N+ salt titrated to pH 6, 2.3 – 2.6 eq Bu4N+ per eq. of NDP, 0.1 mmol) and 
trimethylamine (14 µL, 0.1 mmol) was dissolved in anhydrous MeCN (10 mL) under nitrogen 
in a flask containing ~10 4ÅMS.  Sugar bromide (0.1 mmol) in anhydrous MeCN (5 mL) was 
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added and the reaction mixture heated at 80 °C for 30 minutes.  The molecular sieves were 
filtered off and the MeCN removed under reduced pressure before the reaction was re-
dissolved in water /methanol/triethylamine 2:2:1 (10 mL) and stirred overnight at room 
temperature.  The reaction was again dried under reduced pressure and re-dissolved in 
water (2 mL).  The aqueous solution was passed through a 0.22 µm filter and purified by 
strong anion exchange HPLC using a gradient of 5 mM – 250 mM NH4HCO3 over 10 minutes 
at a flow rate of 7.0 mL/min.  Fractions containing NDP-sugar were combined and the 
ammonium bicarbonate buffer removed by lyophilisation to give purified NDP-sugar as a 
white powder.   
Note that we struggled to record 13C NMR without long experiment times which we were 
keen to avoid due to the unknown stability of these species.  Therefore, 13C NMR shifts were 
obtained from HSQCed spectra.  As a result, not all the aromatic carbons on the bases could 
be assigned.   The sugar ring carbons are however all present. 
 
GDP-α-ᴅ-arabinopyranose (9)58 
 
The reaction returned a 5:1 mixture of α:β sugar nucleotides as judged by integration of the 
H-1’’ NMR signals.  It was however possible to assign NMR peaks for the major desired α-
anomer (9). δH(400 MHz; D2O) 8.06 (s, 1H, H-8), 5.86 (d, J1’,2’ = 6.4 Hz, 1H, H-1’), 4.82 (dd, J1’’,2’’ 
= 7.5 Hz, J1’’,P = 7.5 Hz, 1H, H-1’’), 4.72 (dd, J1’,2’ = 6.4 Hz, J2’,3’ = 5.3 Hz, 1H, H-2’), 4.46 (dd, J2’,3’ 
= 5.3 Hz, J3’,4’ = 3.3 Hz, 1H, H-3’), 4.29-4.26 (m, 1H, H-4’), 4.14-4.12 (m, 1H, H-5’), 3.87-3.82 
(m, 2H, H-4’’,5’’a), 3.64-3.54 (m, 3H, H-2’’,3’’,5’’b); δC(100 MHz; D2O) 114.6 (C6) 98.5 (C1’’), 
86.7 (C1’), 83.9 (C4’), 73.4 (C2’), 72.0 (C3’’), 71.1 (C2’’), 70.4 (C3’), 67.5 (C4’’), 66.5 (C5’’), 65.4 
(C5’); δP(162 MHz; D2O) -11.2 (d, JPα,Pβ = 19.6 Hz, Pβ), -13.0 ((d, JPα,Pβ = 19.6 Hz, Pα); HRMS (ESI-
) m/z calc. for C15H22N5O15P2- 574.0593 ([M-H]-) found 574.0597 ([M-H]-).  1H, 13C and 31P NMR 
were in agreement with literature values.58  
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GDP-β-ʟ-xylopyranose (10) 
 
[α]D – 2.0 (c 0.1, H2O), [α]365 = -41 (c 1.0, H2O) ; δH(400 MHz; D2O) 8.03 (s, 1H, H-8), 5.86 (d, 
J1’,2’ = 6.3 Hz, 1H, H-1’), 4.86 (dd, J1’’,2’’ = 7.9 Hz, J1’’,P = 7.9 Hz, 1H, H-1’’), 4.71 (dd, J1’,2’ = 6.3 Hz, 
J2’,3’ = 5.1 Hz, 1H, H-2’), 4.45 (dd, J2’,3’ = 5.1 Hz, J3’,4’ = 3.2 Hz, 1H, H-3’), 4.28-4.27 (m, 1H, H-4’), 
4.14-4.12 (m, 2H, H-5’a,5’b), 3.87 (dd, J4’’,5’’a = 5.4 Hz, 1H, H-5’’a), 3.55-3.51 (m, 1H, H-4’’), 
3.49 (dd, J2’’,3’’ = 9.2 Hz, J3’’,4’’ = 9.2 Hz, 1H, H-3’’), 3.29-3.23 (m, 2H, H-2’’,5’’b); δH(100 MHz; 
D2O) 98.5 (C1’’), 86.6 (C1’), 83.8 (C4’), 75.1 (C3’’), 73.5 (C2’), 73.3 (C2’’), 70.4 (C3’), 69.0 (C4’’), 
65.4 (C5’’), 65.2 (C2’); δP(162 MHz; D2O) -11.2 (d, JPα-Pβ = 20.2 Hz, Pβ), -13.1 (d, JPα-Pβ = 20.2 Hz, 
Pα); HRMS (ESI-) m/z calc. for C15H22N5O15P2- 574.0593 ([M-H]-) found 574.0594 ([M-H]-). 
 
UDP-α-ᴅ-mannopyranose (12)26 
  
[α]D + 20 (c 0.1, H2O); δH(400 MHz; D2O) 7.88 (d, J5,6 = 8.1 Hz, 1H, H-6), 5.91 (d, J1’,2’ = 3.6 Hz, 
1H, H-1’), 5.89 (d, J5,’6 = 8.1 Hz, 1H, H-5), 5.42 (dd, J1’’,2’’ = 1.8 Hz, J1’’,P = 8.0 Hz, 1H, H-1’’), 4.29-
4.27 (m, 2H, H-2’,3’), 4.21-4.20 (m, 1H, H-4’), 4.16-4.11 (m, 2H, H-5’a,5’b), 3.97 (dd, J1’’,2’’ = 
1.8 Hz, J2’’,3’’ = 3.4 Hz, 1H, H-2’’), 3.85-3.75 (m, 3H, H-3’’,5’’,6’’a), 3.68 (dd, J5’’,6’’b = 5.5 Hz, 
J6’’a,6’’b = 12.4 Hz, 1H, H-6’’b), 3.60 (dd, J3’’,4’’ = 9.8 Hz, J4’’,5’’ = 9.8 Hz, 1H, H-4’’); δC(100 MHz; 
D2O) 114.6 (C6),  102.7 (C5), 96.2 (C1’’), 88.2 (C1’), 83.2 (C4’), 73.8 (C2’), 73.6 (C5’’), 70.2 
(C2’’), 69.8 (C3’’), 69.6 (C3’), 66.4 (C4’’), 64.9 (C5’), 60.8 (C6’’); δP(162 MHz; D2O) -11.5 (d, 
JPα,Pβ = 21.0 Hz, Pβ), -13.6 (d, JPα,Pβ = 21.0 Hz, Pα); HRMS (ESI-) m/z calc. for C15H24N2O17P2- 
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564.0477 ([M-H]-) found 564.0477 [M-H]-.  1H and 13C NMR were in agreement with literature 
values.26 
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3 Exploring the reactivity and 
spectroscopy of terminal bis-alkynes   
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3.1 Introduction 
3.1.1 Alkynes in prymnes in toxins 
Multiple large scale fish kills have been attributed to the particularly bioactive prymnesin 
ichthyotoxins (Figure 3.1).1–3  Igarashi et al.4 have shown that the concentration of 
prymnesin-1 and prymnesin-2 required to cause 50% lethality (LC50 values) are 8 nM and 9 
nM respectively towards the fresh water fish Tanichthys albonubes.  Furthermore Rasmussen 
et al.3 have demonstrated that prymnesin-B1 and prymnesin-2 will lyse rainbow trout gill-
W1 cells with EC50 values of 5.98 nM and 0.92 nM respectively. The low concentrations of 
prymnesins required to cause fish kills makes their detection in waterways a challenge.  
Current toxin detection methods rely on LC-MS analysis of P. parvum cell extracts.5,6   This 
requires expensive and specialist lab-based equipment, which makes detection difficult for 
fisheries management staff in either the public or private sectors.  We have therefore been 
exploring whether it would be possible to develop a sensitive portable toxin detection 
system which could be easily used by fisheries staff.  Any system needs to be able to detect 
toxins in field samples at sub-nanomolar concentrations to be of practical use. 
 
Figure 3.1 – The reported structures of the known prymnesin toxins.3,4  The internal alkynes are shown 
in blue, and the terminal bisalkynes are shown in red.  Note that despite the variation between 
prymnesin and prymnesin-B toxins, the number and relative locations of the alkynes are conserved. 
 
Prymnesin toxins all conserve a terminal bis-alkyne in their backbone structures.2,3  The 
presence of a terminal bis-alkyne in prymnesin-2 was first deduced by Igarashi et al.7 in their 
initial elucidation of the planar structure of this part of the toxin (Figure 3.2), where they 
found three quaternary carbons by 13C NMR, which showed HMBC cross-peaks with H-86.  
They also found a terminal acetylenic proton which gave a signal in acidic solvent (CD3OD/ 
  P a g e  | 69 
CD3OOD 19:1) at 2.63 ppm (t, 6J86,90 = 1.2 Hz, H-90), but which slowly disappeared in basic 
solvent (CD3OD/C5D5N 1:1) over 12 hours.  By comparing the chemical shift of the terminal 
acetylenic proton with literature values, along with the coupling which is appropriate for 6JH-
H through two triple bonds, they assigned the terminal bis-alkyne region of the toxin 
backbone.  Due to the similarity in NMR spectra for the backbones of prymnesin-1 and 
prymnesin-2, Igarashi et al.2 also found the same terminal bis-alkyne moiety conserved in 
PRM-1 too. 
The internal alkynes at the other end of the toxin were found by disconnections in the spin 
system between C1 and C10 due to found quaternary carbons.  HMBC correlations shown in 
Figure 3.2, along with long range 5J2,5 coupling of 2 Hz and 5J6,9 coupling of 3 Hz, UV maxima 
and 1H and 13C NMR shifts were indicative of the presence of the reported internal alkynes.7 
 
Figure 3.2 – The structure of the termini of prymnesin-2 were elucidated by Igarashi et al.7 using HMBC 
and chemical shifts.  The arrows represent the long-range coupling between the carbon atom (arrow 
head) and the protons (arrow tail).  Normal numbers are proton shifts and underlined numbers are 
the carbon shifts.  Reprinted (adapted) with permission from T. Igarashi et al. J. Am. Chem. Soc., 1996, 
118 (2), pp 479–480.  Copyright 1996 American Chemical Society. 
 
More recently Rasmussen et al.3 have also reported the presence of a terminal bis-alkyne in 
the newly characterised toxin prymnesin-B1 as well as the tentatively characterised toxin 
prymnesin-B2.  However, they did not have enough compound in solution to detect the 
quaternary C81, 82, 83 or the acetylenic C84 C-H in the HMBC spectrum.  Their assignment 
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is therefore partially inferred from the high-resolution mass spectrum and comparison with 
published prymnesin structures. 
Terminal bis-alkynes are not unique to prymnesin toxins (Figure 3.3).  For example, the 
marine sponge Callyspongia sp. produces the C21 polyacetylene callyberyne A.8  PQ-8 is 
produced by the American white ginseng plant (P. quinquefolius),9 and the wood rotting 
fungus Sistotrema raduloides produces sistodiolynne which is a very unstable polyketide 
metabolite.10   
 
Figure 3.3 - From left, examples of marine, plant and microbe bis-alkynes.11 
 
Nevertheless, terminal bis-alkynes are sufficiently rare moieties in natural products to offer 
a biomarker with interesting chemical and spectroscopic properties.11,12  The first thing we 
explored was the possibility of labelling these terminal bis-alkynes via the ubiquitous bio-
orthogonal copper-catalysed alkyne-azide cycloaddition (CuAAC) ‘click’ reaction.13,14  We also 
found some previous research which showed that bis-alkynes are good targets for Raman 
spectroscopy.15  For example, Yamakoshi et al.15 explored a structure – Raman shift/intensity 
relationship for a series of alkynes, and showed that bis-alkynes gave stronger Raman signals 
than single alkynes, with shifts in the cellular silent region of the Raman spectrum. 
To explore the possibility of using a CuAAC click reaction or Raman-based methods for the 
detection of prymnesin toxins in water ways, it was first necessary to have either the 
authentic toxin or a suitable analogue in hand.  Lab grown P. parvum cultures were grown to 
extract authentic samples of the prymnesin toxins.  It is very challenging to obtain more than 
trace quantities of prymnesin toxin on a laboratory scale.2,3  Therefore it was also decided to 
perform detection method development using synthetic terminal bis-alkyne analogues.  
These analogues were prepared chemically, and the authentic toxin extracts were used 
where an experiment with the synthetic bis-alkyne analogue showed potential. 
  P a g e  | 71 
 
3.2 Extracting prymnesin toxins from P. parvum cell cultures 
Prymnesin toxins were extracted from lab grown P. parvum cell cultures following a protocol 
developed by La Claire et al.5 (Figure 3.4). Healthy three-week-old P. parvum cell cultures 
were harvested by centrifugation and the supernatant discarded.  The pellet was washed 
with cold acetone, and extracted with MeOH and n-PrOH.  The solvent extracts were 
combined and dried before being re-suspended in water.  The aqueous suspension was 
defatted with EtOAc before being freeze dried to give the crude prymnesin extract for LC-MS 
analysis. 
 
Figure 3.4 - Extraction of prymnesin toxins, following the protocol developed by La Claire et al.5  i) A 
P. parvum culture is harvested by centrifugation; ii) The cell pellet is lysed and washed with acetone 
(× 3); iii) The cell pellet is extracted with MeOH (× 3); iv) The cell pellet is extracted with n-PrOH (× 3); 
v) The MeOH and n-PrOH extracts are combined and dried, before being re-suspended in water; vi) 
The aquoues suspension is de-fatted with EtOAc (× 3); vii) The aqueous layer is recovered and dried. 
 
The extracted-ion chromatogram (EIC) for m/z of 919.9 ([PRMaglyc + 2H+], [C91H130Cl3NO31]2+ 
calcd. 919.882+) shows two peaks originating from PRM-1 and PRM-2 toxins (Figure 3.5).  In 
both cases, some of the toxin has fragmented to the aglycone form.  Because of the 
conserved backbone structure, this gives the same mass to charge ratio for both toxins. 
Figure 3.6 shows the m/z spectra under the EIC peak for PRM-1 and Figure 3.7 shows the m/z 
spectra under the EIC peak for PRM-2.   
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Figure 3.5 – Mass spectra for the P. parvum extracts confirms the presence of PRM-1 and PRM-2; the 
EIC for m/z 919.9 relates to [PRMaglc + 2H]2+.5  The assignment of PRM-1 and PRM-2 is based on the 
distribution of partially glycosylated toxin fragments under each of the peaks. 
 
 
 
Figure 3.6 - m/z under the two EIC peaks relating to PRM-1 shown in Figure 3.5; the spectra show 
characteristic ion fragments for PRM-1 as described by La Claire et al.5; The peak marked * is not 
mentioned in the literature, but could correspond to [PRM-1 – pentose + 2H]2+.   
 
The peak marked with an asterisk (*) is not reported as a diagnostic peak in the literature, 
but it does align with the assignment [PRM-1 – pentose + 2H]2+.  This would make it an 
additional good characteristic peak for distinguishing between PRM-1 and PRM-2.  Overall 
the LC-MS showed that both PRM-1 and PRM-2 had been successfully extracted from lab 
grown P. parvum cultures. 
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Figure 3.7 – m/z under the two EIC peaks shown in Figure 3.5; the spectra show characteristic ion 
fragments for PRM-1 and PRM-2 as described by La Claire et al.5 
 
3.3 Chemistry 
3.3.1 Chemical synthesis of hepta-4,6-diyn-1-ol (4) 
A glycosylated bis-alkyne was synthesised to act as a toxin substitute for CuAAC click 
chemistry and Raman spectroscopy studies.  A simple bis-alkyne (4) was synthesised in 3 
steps with an overall yield of 15% (Scheme 3.2).  Triethylsilyl acetylene was selected as an 
acetylene donor, as a previous literature report had suggested that the more common 
protecting group trimethylsilane was liable to base catalysed cleavage under Cadiot–
Chodkiewicz conditions.16  Triethylsilyl acetylene (1) was treated with N-bromosuccinimide 
in the presence of silver nitrate to give (bromoethynyl) triethylsilane (2) in good yield, as 
confirmed by the loss of the acetylenic proton at 2.35 ppm by 1H NMR.  The commercial 
alkyne 4-propyn-1-ol was chosen because like prymnesins this has 3 carbons between the 
alkynes and first hydroxyl groups.  We omitted the chlorine atom found on prymnesins for 
simplicity.  Coupling was carried out under Cadiot–Chodkiewicz reaction conditions (Scheme 
3.1), to give 7‐(triethylsilyl)hepta‐4,6‐diyn‐1‐ol (3).16  This was confirmed by a loss of the 
acetylenic proton from 4-propan-1-ol and the addition of ethyl groups from the TES 
protecting group as a quartet at 0.61 ppm and triplet at 0.99 ppm by 1H NMR.   
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Scheme 3.1 – mechanism for the copper(I) catalysed Cadiot-Chodkiewicz coupling reaction.17  i) 
removal of the acetylenic proton with a base; ii) formation of a copper-acetylide; iii) oxidative addition; 
iv) reductive elimination. 
 
Tetrabutylammonium fluoride (TBAF) was used to remove the triethylsilyl protecting group.  
After purification, the removal of the silyl protecting group to give hepta‐4,6‐diyn‐1‐ol (4) 
was confirmed by 1H NMR by the presence of an acetylenic proton at 2.00 ppm as a triplet 
with 6JH-H coupling value of 1.2 Hz, which is reasonable for coupling through two triple bonds.7  
Furthermore, comparison of the 13C NMR with the HSQCed spectra confirmed the presence 
of three quarternary carbons which make up the bis alkyne system. 
 
Scheme 3.2 – The chemical synthesis of hepta‐4,6‐diyn‐1‐ol: i) AgNO3, NBS, 3h. ii) 4-propyn-1-ol, 
Cu(I)Cl, BuNH2. iii) TBAF, THF. 
 
It was found that the free bis-alkyne proceeded to rapidly decompose to a red oil.  A similar 
phenomenon was reported by Tykwinski et al.18 who noted that a range of terminal bis-
alkynes they had synthesised decomposed if concentrated to dryness.  The same group also 
showed with terminal tri-ynes that decomposition greatly increases once a protecting group 
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is removed to leave an acetylenic proton.19  Some work has been carried out by Bryce et al.20 
exploring the stability of terminal bis-alkynes, which found that the shelf life of bis-alkynes 
can be increased by keeping them as a dilute solution.  However there is ambiguity in the 
literature about the ‘decomposition’ pathway for such compounds.  It could tentatively be 
attributed to UV-catalysed 1,4-addition polymerisation as shown in Figure 3.8.21 
  
Figure 3.8 – A possible bis-alkyne decomposition pathway (from Nie and Wang)21 and the red bis-
alkyne sample (hepta‐4,6‐diyn‐1-ol) after it had arrived at our collaborator’s lab. 
 
3.3.2 Chemical synthesis of hepta‐4,6‐diyn‐yl- β-ᴅ-galactoside 
Following on from the experience gained in synthesising and handling hepta‐4,6‐diyn‐1‐ol 
(4), a more water soluble substrate for Raman spectroscopy studies was synthesised 
(Scheme 3.3).  This was achieved by synthesising a glycosylated form of hepta‐4,6‐diyn‐1‐ol 
(4).  A survey of the literature showed that some 4-pentyn-1-yl glycosides had been 
reported.22,23  In these examples, BF3.OEt2-promoted glycosylation of 4-pentyn-1-ol was 
achieved directly from the per-O-acetylated sugar.  Due to the problems experienced with 
the degradation of hepta‐4,6‐diyn‐1‐ol (4) it was decided to perform the glycosylation step 
with a bench stable terminal alkyne, and then install the second alkyne unit via the Cadiot-
Chodkiewicz coupling reaction, rather than attempt a direct glycosylation of hepta‐4,6‐diyn‐
1‐ol (4).  This order of reactions is in keeping with similar literature examples.23 
β-ᴅ-Galactose pentacetate was used to glycosylate pentyn-1-ol using BF3.OEt2 as the 
promotor.  This gave pent-4-yn-1-yl 2’,3’,4’,6’-tetra-O-acetyl-β-ᴅ-galactopyranoside (6) with 
the stereochemistry at the anomeric position confirmed by the 1H NMR H-1’ anomeric signal 
(doublet with a J1’,2’ coupling value of 8.0 Hz).  From this point forward, two different 
synthetic pathways were evaluated as shown in Scheme 3.3.   
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Scheme 3.3 - i) 4-pentyn-1-ol, BF3.Et2O. ii) Br-C≡C-TES, Cu(I)Cl, BuNH2. MeOH iii) Na, MeOH. iv) 
NEt3.3HF. v) Na, MeOH. vi) Br-C≡C-TES, Cu(I)Cl, BuNH2 MeOH. vii) Et3N.3HF 
 
Route 1 covers steps ii – iv.  The Cadiot–Chodkiewicz coupling reaction was first employed to 
synthesise the triethyl silyl protected bis-alkyne (7).11,23  It was found that this worked well 
in dry methanol, which dispensed with the need to degas water to use as a solvent in the 
reaction.  Low resolution mass spectrometry direct from TLC analysis showed that whilst the 
coupling had been successful, a range of partially deacteylated compounds had been formed.  
This was attributed to the presence of BuNH2 which would have served as a nucleophile to 
produce AcNHBu.  Rather than try and separate all the components, it was felt more useful 
to combine them and place them in a methoxide solution overnight to remove all of the 
remaining acetate groups (Step iii, Scheme 3.3). Whilst this was successful in removing the 
acetate groups, it also led to partial removal of the triethylsilyl protecting group from the bis-
alkyne.  This isn’t a problem if the globally deprotected compound hepta‐4,6‐diyn‐yl-β-ᴅ-
galactoside (9) is required for immediate use.  If, however, the compound needs to be stored 
for a period of time, it is best to do so with the terminal TES protecting groups still on the 
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bis-alkyne, as this prevents the polymerisation described earlier.20 The mixtures of protected 
and deprotected bis-alkyne were again pooled and the remaining triethylsilyl protecting 
group removed with Et3N.3HF to give hepta‐4,6‐diyn‐yl-β-ᴅ-galactoside (9). It was clear at 
this point that Route 1 was not a particularly useful synthetic route to synthesise hepta‐4,6‐
diyn‐yl-β-ᴅ-galactoside (9) because of the mixtures of compounds being synthesised, as well 
as the problem with decomposition of the terminal bis-alkyne. 
An alternative synthetic approach is shown in Route 2 (Scheme 3.3, steps v – vii). Here the 
acetate protecting groups were removed from galactose before the modified Cadiot–
Chodkiewicz coupling, as they were no longer required after the initial glycosylation.  The 
successful coupling with triethylsilyl acetylene was confirmed by the additional ethyl signals 
in the 1H NMR spectrum as well as the new C6 and C7 signals in the 13C NMR at 67.6 ppm and 
65.0 ppm respectively. This gave a TES protected bis-alkyne (11) which required only a single 
deprotection step prior to use. 
Silyl protecting groups are routinely removed using a fluoride source, the high affinity 
between silicon and fluorine driving the reaction.  TBAF or NaF are both common fluoride 
sources for this reaction, but these present the problem of having to desalt the reaction 
mixture.24  As an alternative to fluoride salts, Et3N.3HF was used.  This has the advantage that 
work-up is achieved simply by evaporation and chromatography.24  Et3N.3HF also has the 
advantage of being much less aggressive than Pyr.HF, and as such it may be used with 
borrosilicate glassware up to 150 °C.25  This final deprotection step worked well, to give 
hepta‐4,6‐diyn‐yl-β-ᴅ-galactoside (9), and the presence of the terminal bis-alkyne as 
confirmed by the acetylenic proton at 2.41 ppm as a triplet with 6JH-H coupling of 1.2 Hz.7  
Hepta‐4,6‐diyn‐yl-β-ᴅ-galactoside (9) also degraded to a red/brown oil on standing, and so 
the TES group was only removed immediately before use. 
Two different routes were explored to synthesise hepta‐4,6‐diyn‐yl-β-ᴅ-galactoside (9) 
(Scheme 3.3).  Route 1 was problematical; the acetate protecting groups on the sugar were 
incompatible with the BuNH2 used in the Cadiot-Chodkiewicz coupling reaction, and the 
deacetylation of the sugar also partially deprotected the bis-alkyne, leading to rapid 
decomposition.  By contrast, route 2 solved these problems by removing the acetate 
protecting groups from the sugar before installing the bis-alkyne.  Route 2 had an overall 
yield of 17%, which is four times greater than the 4% overall yield recorded for route 1. 
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3.4 Evaluating the bis-alkyne as a biomarker for prymnesins. 
3.4.1 Click Chemistry with synthetic toxin analogues 
La Claire et al.6 recently described a semi-quantitative chemical assay for the detection of 
prymnesin toxins.  This fluorometric assay relied on the specific binding of ninhydrin (NIN) 
and phenylacetaldehyde (PAA) to the primary amine groups present on all reported 
prymnesin toxins.2,3  This creates a fluorescent compound which could be used to semi-
quantify the total amount of prymnesin toxins in a sample (Figure 3.9).  Manning and La 
Claire5 have also shown that it is possible to stain prymnesin toxins run up a TLC plate with 
ninhydrin.  A draw back to this method is that there will likely be other compounds with 
amine groups in the P. parvum cell extracts. 
 
Figure 3.9 – Reaction of ninhydrin (NIN), phenylacetaldehyde (PAA) and the primary amine on 
prymnesin toxins (R-NH2).26 
 
Following on from this work, we were interested to see whether the terminal bis-alkynes 
present on prymnesin toxins could be utilised for covalent binding an azide functionalised 
fluorophore via a CuAAC reaction.13,14  Given the instability of terminal bis-alkynes, we were 
also interested to see whether they were more reactive than terminal alkynes with regards 
to azide-alkyne cycloaddition click reactions.  If so, this could lead to a simple chemical 
method of selectively labelling the terminal bis-alkyne conserved across all prymnesin toxins 
with a reporter molecule for detection.  Previous work by Tykwinski et al.18 has shown that 
CuAAC reactions of poly-alkynes with benzyl azide gave regioselective coupling at the 
terminal alkyne only (Figure 3.10). 
 
Figure 3.10 – Tykwinski et al.18 have shown that CuAAC with poly-alkynes is regioselective, only 
generating a triazole ring at the terminal alkyne.  They did not find multiple azide addition to the poly-
alkyne framework. 
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3-Azido-7-hydroxycoumarin (12) was chosen as a clickable reporter molecule as it is a dye 
which only fluoresces after it has been clicked with an alkyne to form a triazole ring.27  A 
similar approach has been used in our group before by Ivanova et al. who used 12 to quantify 
alkyne labelled mannosides.28  3-Azido-7-hydroxycoumarin was synthesised following the 
protocol published by Sivakumar et al.27 (Scheme 3.4).  The presence of the azide group was 
confirmed by ATR-IR, with a strong peak at 2107 cm-1, and the 1H NMR agreed with published 
literature values.27 
 
 
Scheme 3.4 – the chemical synthesis of 3-azido-7-hydroxycoumarin (12).27  i) NaOAc, Ac2O, reflux; ii) 
EtOH/HCl (1:1), reflux; iii) NaNO2, 0 °C; iv) NaN3. 
 
3-Azido-7-hydroxycoumarin (12) was coupled pent-4-yn-1-yl β-ᴅ-galactoside (10) and hepta‐
4,6‐diyn‐yl-β-ᴅ-galactoside (9) separately under CuAAC conditions to give 3-[1-(7-hydroxy-
coumarin)-1H-1,2,3-triazol-4-yl] propyl β-ᴅ-galactopyranoside (13) and 5-[1-(7-hydroxy-
coumarin)-1H-1,2,3-triazol-4-yl] pent-4-yn-1-yl β-ᴅ-galactopyranoside (14) respectively 
(Scheme 3.5).  The new ‘clicked’ products (13 & 14) showed a loss of the acetylenic protons 
and the formation of diagnostic triazole signals between 8.5 ppm and 8.7 ppm (H-5, Scheme 
3.5).  There was also a diagnostic downfield shift in the 1H NMR signal for H-8’’ on the 
coumarin chromophore.  Importantly, mass-spectrometry analysis of the crude mixture after 
the reaction of the terminal bis-alkyne (9) with the azide (12) showed that CuAAC had 
occurred selectively and exclusively at the terminal alkyne, which is in agreement with details 
published by Tykwinski et al.18  Both the H-5’ and H-8’’ shifts for (14) were shifted further 
down field than for (13), which may be attributed to the anisotropic effect of the p-electrons 
in the residual alkyne system. 
  P a g e  | 80 
 
Scheme 3.5 – The chemical synthesis of 3-[1-(7-hydroxy-coumarin)-1H-1,2,3-triazol-4-yl] propyl 
β-ᴅ-galactopyranoside (13) and 5-[1-(7-hydroxy-coumarin)-1H-1,2,3-triazol-4-yl] pent-4-yn-1-
yl β-ᴅ-galactopyranoside (14). 
 
In order to assess whether there was a marked difference in the rates of CuAAC between the 
terminal mono- and bis-alkyne galactosides, a mixture of mono-alkyne (10)/bis-alkyne 
(9)/dye (12) of 1:1:0.9 was dissolved into DMSO (700 µL) in an NMR tube.  The ratios of the 
starting materials were checked by integration in the 1H NMR spectrum of the acetylenic 
protons on the alkyne galactosides (9 & 10) and the aromatic H-5 signal on the dye (12) 
(Figure 3.11).  The ratio of the components was judged to be alkyne (10)/bis-alkyne (9)/dye 
(12) 1.0:0.95:0.91. 
 
 
Figure 3.11- Judging the ratios of the starting materials (9, 10, 12) by integration of the 1H NMR signals. 
 
12 
9 
10 
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 A freshly prepared solution of 0.1 M aqueous copper sulfate and 0.2 M aqueous sodium 
ascorbate (10 µL) was added to start the coupling reaction (Scheme 3.5).  After 2 hours, the 
azide (12) was judged to have been consumed by a loss of the H-5 signal at 6.82 ppm in the 
1H NMR spectrum.  A quantitative 1H NMR was recorded and the spectra compared with the 
1H NMR spectra of 3-[1-(7-hydroxy-coumarin)-1H-1,2,3-triazol-4-yl]propyl β-ᴅ-
galactopyranoside (13) and 5-[1-(7-hydroxy-coumarin)-1H-1,2,3-triazol-4-yl]pent-4-yn-1-yl 
β-ᴅ-galactopyranoside (14) standards (Scheme 3.5). 
  
 
Figure 3.12 - 1H NMR spectra showing the H-5 and H-8’’ signals of 3-[1-(7-hydroxy-coumarin)-1H-1,2,3-
triazol-4-yl]propyl β-ᴅ-galactopyranoside (13) (green), 5-[1-(7-hydroxy-coumarin)-1H-1,2,3-triazol-4-
yl]pent-4-yn-1-yl β-ᴅ-galactopyranoside (14) (red) and a mixture of both compounds from the CuAAC 
rate reaction shown in Scheme 3.5 (blue). 
 
Integration of the H-5 and H-8’’ signals showed that the ratio of (13)/(14) was 1.0:0.87.  
Correcting for the initial concentration ratios of the terminal alkyne (10) and terminal bis-
alkyne (9) analogues, this suggested that the terminal alkyne analogue (10) had reacted 
about 5% faster than the terminal bis-alkyne analogue (9) with 3-azido-7-hydroxycoumarin 
(12) under CuAAC conditions.  As such it was found that there was no noteable difference in 
the rate between terminal alkynes and terminal bis-alkynes reacting with azides under 
CuAAC conditions. 
 
 (13) H-5 
 (14) 
Rate reaction 
(13) + (14) 
H-8’’ 
H-5 
H-8’’ 
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3.4.2 Click chemistry with prymnesin toxin extracts 
Ivanova et al.28 have recently shown that the limit of detection for 1,2,3-triazol-7-
hydroxycoumarins (T-7-HC) is pH dependent, with the intensity of fluorescence doubling 
from pH 6 to pH 9.  They found a detection limit from a TLC plate visualised by UV irradiation 
at 365 nm was ca 160 pmol, and ca 100 nM when detected in solution by fluorimeter.28  
Whilst the detection limit for 1,2,3-triazole-7-hydroxycoumarins is too high as is for detecting 
prymnesin toxins at sub-lethal concentrations in water samples,4 solid phase extraction may 
be a way to concentrate the toxins from a known volume of water.   
Preliminary testing was performed using LC-MS verified prymnesin extracts.  A CuAAC 
reaction was performed with 3-azido-7-hydroxycoumarin (12) and toxin extracts.  The crude 
mixture was then run on a TLC plate using the conditions described by Igarashi et al.2 and the 
TLC plate visualised under a UV-light (Figure 3.13).   
 
 
Figure 3.13 – TLC plate visualised under a UV lamp showing the crude products of a CuAAC of 
prymnesin extracts 3-azido-7-hydroxycoumarin.  A. unreacted 3-azido-7-hydroxycoumarin; B. 
PRM(aglyc)- (T-7-HC); C. PRM-2-(T-7-HC); D. PRM-1-(T-7-HC). 
 
 
A 
 
B 
 C 
 
D 
 
  P a g e  | 83 
In Figure 3.13, spot A is unreacted 3-azido-7-hydroxycoumarin (12), and spots B, C and D 
showed pale blue under a UV-light.  The Rf values of the fluorescent spots were compared 
with the literature values for prymnesins, and due to the added lipophilicity of the aromatic 
coumarin fluorophore for the fluorescent spots, all ran slightly faster than the free toxins.5  
Spot B (Rf 0.78) was possibly an unrelated alkyne containing metabolite or perhaps more 
plausibly the aglycone form of prymnesin-(T-7-HC) (lit.5 for PRMaglyc Rf 0.7).  Spot C (Rf 0.64) 
probably relates to prymnesin-2-(T-7-HC) (lit.5 for PRM-2 Rf 0.6) and Spot D (Rf 0.57) probably 
relates to prymnesin-1-(T-7-HC) (lit.5 for PRM-1 Rf 0.5). 
It would make sense that the more carbohydrate moieties there are on the toxin backbone, 
the more tightly it is retained by silica gel due to the increased polarity of the glycosylated 
compound.  It would be useful to confirm the identities of each of the three major 
fluorescent species at least by LC-MS, and work is currently underway in the lab to extract 
the fluorescent compounds and obtain HRMS for these compounds.  Overall the CuACC 
coupling of 3-azido-7-hydroxycoumarin (12) with prymnesins shows promise for developing 
a cheap and rapid chemical method of detecting prymnesin toxins.  
 
3.5 Efforts towards the development of a Raman spectroscopy 
based prymnesin detection system 
3.5.1 Raman spectroscopy and bis-alkynes 
Raman spectroscopy measures the frequency shift of inelastically scattered light.29  When a 
photon hits a molecule it may excite an electron to a higher energy state.  The excited 
molecule may relax straight back to the original ground state by emitting a photon of the 
same energy, which is described as Rayleigh scattering, and is not observed by Raman 
spectroscopy.  Alternatively, the emitted photon may fall to a higher or lower energy state 
than it started in, which may be described as Stokes or anti-Stokes scattering respectively 
(Figure 3.14).   
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Figure 3.14 - The excitation and relaxation of electrons between vibrational and virtual energy levels. 
 
One of the endearing features of Raman spectroscopy is that it requires very little sample 
preparation and is almost completely insensitive to aqueous absorption bands.30  This makes 
it a potentially useful tool for the detection of analytes in water samples.31  For example, 
Raman spectroscopy has been used to identify algal species and even locate biomolecules in 
algal cells.32  It has also been used to detect and quantify levels of the algal neurotoxin 
domoic acid in shell fish tissue.33 
Alkynes have recently been used as tags for imaging small molecules using Raman 
microscopes.30  As well as their small size and low molecular weight when compared with 
many fluorescent dyes, alkynes have an advantage of giving signals in the normally cellular 
silent region of a Raman spectrum.  Yamakoshi et al.15 recently explored the suitability of a 
range of alkynes and bis-alkynes for use as Raman tags to track the mobility of small molecule 
in living cells.  The authors showed that bis-alkynes give much higher intensities 
(approximately 5 times greater) than comparable single alkyne units.15  They also noted a 
characteristic shift for bis-alkynes of around 2200 cm-1.  However, the limit of detection for 
the bis-alkynes most sensitive to Raman spectroscopy was found to be about 0.1-0.2 mM,15  
which is about three orders of magnitude too high for the detection of prymnesin toxins.3,4  
If these limits of detection can be enhanced, Raman spectroscopy an interesting candidate 
for the detection of the rare terminal bis-alkyne biomarker found on prymnesins. 
Raman signals can be greatly improved by using techniques such as Surface-Enhanced Raman 
Scattering (SERS),34 which uses the excitement of surface plasmon electrons on metal 
nanoparticles to enhance Raman signals.  The principals of SERS are reviewed in great detail 
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by Stiles et al.35  From a pragmatic standpoint, it is important to note that SERS can offer 
Raman signal enhancements in the order of ten orders of magnitude, which can be sufficient 
for single molecule detection.  So long as a well-defined and consistent SERS substrate is 
used,35 we were hopeful that this might be a useful means to detect and quantify prymnesin 
toxin levels in waterways, by using the terminal bis-alkyne as toxin bio-marker.  SERS is 
compatible with a range of handheld Raman spectrometers which could feasibly be used for 
taking field measurements.  There are also a range of commercially available gold and silver 
substrates deposited onto disposable silicon or paper ‘chips’, which could be used by an end 
user with very little training. 
 
3.5.2 Raman Spectroscopy of 7‐(Triethylsilyl)hepta‐4,6‐diyn‐yl-β-ᴅ-
galactoside (11) 
Hepta‐4,6‐diyn‐yl- β-ᴅ-galactoside (9) was not stable enough to survive the time required to 
courier it to our collaborator’s lab (Duncan Graham, University of Strathclyde) and had 
decomposed to a red oil by the time it arrived.  Bis-alkynes are notorious for being unstable 
to decomposition or polymerisation.36  
To circumnavigate this problem 7‐(triethylsilyl)hepta‐4,6‐diyn‐yl- β-ᴅ-galactoside (11) was 
sent to our collaborator as the bis-alkyne was much more stable with a terminal triethylsilyl 
protecting group in place.  However, as our collaborator did not have the facilities to perform 
the fluoride mediated removal of the TES group, a spectrum was obtained with triethylsilyl 
protecting group still in place using 1 µg of bis-alkyne in 100 µl of MeOH + 900 µl AuNP 
suspension in water which after background subtraction gave the Raman spectrum shown in 
Figure 3.15. 
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Figure 3.15 - Background subtracted SERS Raman spectrum of the TES protected bis-alkyne (11) at 2.5 
mmol/mL.  The * denotes the peak that was assigned to the terminal bis-alkyne.   
 
3.5.3 Raman Spectroscopy of prymnesin toxin extracts 
The LC-MS verified prymnesin toxin extracts were used to try and record surface enhanced 
Raman spectra (SERS).  The spectra were first recorded using a Snowy Range Instruments 
Benchtop Raman spectrometer.  Alkyne Raman bands appear at around 2250 cm-1.15  The 
only benchtop spectrometers available at our collaborator’s lab that could read above 2000 
cm-1 used a 532 nm excitation laser.  This green light caused the Raman signals to be 
quenched by fluorescence caused by organic pigmants from the alga such as chlorophylls,32 
meaning a Raman spectrometer with a longer wavelength excitation laser was required. 
The substrate based experiments were later repeated using a Raman microscope with an 
excitation wavelength of 633 nm.  Both gold and silver nanoparticle slide mounted P-SERSTM 
substrates from Diagnostic anSERSINC were tried, as well as gold and silver nanoparticle slide 
mounted RAM-SERS substrates from OceanOptics.  Despite there being less fluorescence, it 
still wasn’t possible to detect any bis-alkyne bands in the spectrum due to quenching of the 
signals by fluorescence. 
Experiments were also carried out by adding toxin extract to aqueous gold nanoparticle 
suspensions.  However, even at very low extract concentrations, the nanoparticles 
flocculated and fell out of suspension, meaning that no useable Raman spectrum could be 
recorded.  To this end, it was obvious that with the equipment available to us it would 
unfortunately not be possible to use Raman spectroscopy as a viable method of detecting 
prymnesin toxins. 
 
* 
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3.6 Summary 
This chapter aimed to explore whether it was possible to develop a pragmatic chemical 
answer to the problem faced by fisheries and environmental staff in monitoring the levels of 
prymnesin toxins in water ways.  Cultures of P. parvum were grown and the presence of 
prymnesin toxins from the harvested cell extracts were confirmed by LC-MS. Two bis-alkyne 
containing toxin analogues (hepta‐4,6‐diyn‐1‐ol (4) and hepta‐4,6‐diyn‐yl-β-ᴅ-galactoside 
(9)) were chemically synthesised, and the synthetic pathway of hepta‐4,6‐diyn‐yl-β-ᴅ-
galactoside (9) was optimised after it was found that the alkyne coupling conditions were 
not compatible with acetate protecting groups.  It was also found that the terminal bis-
alkynes were prone to quick degradation once the silicone protecting groups had been 
removed from them, which made work with collaborators in a different institute challenging.  
Leading on from the apparent instability of the terminal bis-alkynes when compared with 
bench stable terminal alkynes, the question of reactivity towards azides under CuACC 
conditions was explored, and it was found that there was very little difference in reaction 
rates, with terminal alkyne reacting about 5% more quickly. How terminal bis-alkynes react 
with azides was explored, and it was found that only a single terminal triazole ring was 
formed at the terminal alkyne under CuACC conditions.  After the experiments with synthetic 
bis-alkyne analogues, 3-azido-7-hydroxycoumarin (12) was added to P. parvum cell extracts 
which had been verified as containing prymnesin-1 and prymnesin-2 by LC-MS.  TLC analysis 
of this click reaction showed three fluorescent spots which Rf values slightly higher than 
those reported for PRM-1, PRM-2 and PRMaglycone.  Attempts to extract these compounds for 
LC-MS analysis were unsuccessful, but nevertheless, given the very low limit of detection for 
the UV-fluorescence detection of 1,2,3-triazole-7-hydroxycouamrin labelled compounds on 
TLC plates, this shows some promise as a method for rapid chemical detection of prymnesin 
toxins in waterways.  Finally work with collaborators at the University of Strathclyde was 
conducted to explore the possibility of SERS based Raman detection of prymnesin toxins in 
waterways.  Problems with fluorescent compounds in P. parvum cell extracts along with the 
degradation of terminal bis-alkynes in transit, meant that it was not possible to obtain a 
useable set of reference spectra with a view to developing a Raman based toxin detection 
system. 
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3.7 Experimental 
3.7.1 Extraction of prymnesin toxins from P. parvum cell cultures 
Prymnesin toxin extractions were performed using the protocol developed by La Claire et al.5 
Cultures of Prymnesium parvum (100 mL) were grown in 5PSU f/2 media at room 
temperature in a 16/8 h (light/dark) cycle.  After 3 weeks, the cells were harvested by 
centrifugation (4000 × g for 5 minutes) and the supernatant discarded.  The cells were 
suspended in cold acetone (20 mL, -20 °C) and subject to vortex mixing for two minutes.  The 
resulting suspension was split into two equal portions and centrifuged at 4000 × g for 5 
minutes.  The supernatant was discarded, being careful not to disturb the cell debris, and the 
pellets were subject twice more to the same acetone wash.  The cell pellets were then 
suspended in MeOH (10 mL) and vortex mixed for two minutes, after which time the cell 
debris was pelleted by centrifugation (4000 × g for 5 minutes) and the supernatant was 
collected.  This methanol extraction was repeated twice more, followed by three rounds of 
analogous extraction using n-PrOH.  The MeOH and n-PrOH extracts were combined, dried 
in vacuo and re-suspended in Milli-Q® water (10 mL) before being defatted with EtOAc (3 × 
5 mL).5  The aqueous fraction was then dried by lyophilisation to give the prymnesin toxins 
extract.  
 
3.7.2 LC-MS detection of prymnesin toxins 
The P. parvum extracts were analysed by LC-MS on a Synapt G2-Si mass spectrometer 
coupled to an Acquity UPLC system (Waters, Manchester, UK). The extracts were first 
dissolved into 50 µL of Milli-Q water. Aliquots of 2 µL sample were injected onto an Acquity 
UPLC® BEH C18 column, 1.7 µm, 1x100 mm (Waters) and eluted with a gradient of 10-90% 
acetonitrile in 0.1% formic acid in 12 min at a flow rate of 80 µL min-1. The mass spectrometer 
was controlled using Masslynx 4.1 software (Waters) and operated in positive MS-Tof and 
resolution mode with a capillary voltage of 2.5 kV and a cone voltage of 40 V in the m/z range 
of 200-2000. Leu-enkephalin peptide (1 ng mL-1, Waters) was infused at 3 µl min-1 as a lock 
mass and measured every 20 s.  
 
3.7.3 Raman Spectroscopy 
Raman spectroscopy of 7‐(triethylsilyl)hepta‐4,6‐diyn‐yl-β-ᴅ-galactoside (11) was performed 
using a hand-held Snowy Range instruments 638 nm Raman spectrometer.  The spectrum 
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was recorded by dissolving 1 µg of 11 in 100 µl of MeOH, before adding this to 900 µl AuNP 
suspension in water.  Raman spectroscopy of toxin extracts from SERS substrates were 
attempted using a Renishaw spectrometer coupled with a Leica DMLM microscope, using a 
633 nm excitation laser.  Toxin extract was dissolved into 100 µL of water, and 10 µL was 
then deposited on the test SERS substrates. 
 
3.7.4 Chemistry 
(Bromoethynyl) triethylsilane (2)37 
 
 
Triethylsilyl ethyne (1) (1.0 mL, 5.58 mmol) and AgNO3 (190 mg, 1.1 mmol) were dissolved 
into dry acetone (30 mL) under N2.  The reaction mixture was stirred vigorously in the dark 
for 20 minutes after which time the reaction mixture had turned a milky white colour.  N-
Bromosuccinimide (1.1g, 6.1 mmol, 1.1 eq) was added and the reaction mixture was stirred 
for a further 3 hours in the dark.  TLC (neat hexane) showed complete consumption of the 
starting material and the reaction mixture was filtered and the solvent was removed under 
reduced pressure. The crude mixture was purified on a short silica column using pure n-
hexane to give (bromoethynyl) triethylsilane (2) (1.0 g, 84%) as a colourless oil; Rf 0.84 (neat 
hexane); δH(400 MHz; CDCl3) 0.99 (t, J = 8.1 Hz, 9H, Si(CH2CH3)3), 0.61 (q, J = 8.1 Hz, 6H, 
Si(CH2CH3)3); δC (100 MHz; CDCl3) 84.6 (Si-C≡C-Br), 61.6 (Si-C≡C-Br), 7.3 (Si(CH2CH3)3), 4.3 
(Si(CH2CH3)3). The 1H and 13C NMR data were in accordance with the literature. 
 
7‐(Triethylsilyl)hepta‐4,6‐diyn‐1‐ol (3)37 
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CuCl (40 mg) and BuNH2 (4.5 mL) were added to degassed water (15 mL) under N2.  Whenever 
the water started to turn blue a spatula tip of NH2OH.HCl was added to reduce any Cu(II).  
The suspension was cooled in an ice bath and 4-pentyn-1-ol (0.41 mL, 0.38 g, 4.47 mmol) was 
added, at which point the reaction mixture went bright yellow.  (Bromoethynyl) triethylsilane 
(2) (1.0g, 4.9 mmol) in Et2O (2.5 mL) was added by syringe over 5 minutes.  After 30 minutes, 
TLC showed consumption of the terminal alkyne.  The reaction mixture was washed with 
Et2O (3 × 15 mL), and the organic layers were combined and dried over MgSO4, filtered and 
the solvent removed in vacuo.  The crude product was purified by FCC (8:2 n-hex:EtOAc) to 
give the title compound (3) (355 mg, 36%) as a brown oil (n.b. if deprotecting with fluoride 
in the next step there is no need to purify as excess bromo ethyne is a gas at room 
temperature and so will evaporate). Rf 0.45 (hexane/EtOAc 8:2); δH(400 MHz; CDCl3) 3.77-
3.73 (m, 2H, H-1), 2.42 (t, J2,3 = 6.5 Hz, 2H, H-3), 1.82-1.76 (m, 2H, H-2), 1.58 (bs, 1H, OH), 
0.99 (t, J = 7.7 Hz, 9H, Si(CH2CH3)3), 0.61 (q, J = 7.7 Hz, 6H, Si(CH2CH3)3); δC (100 MHz; CDCl3) 
89.2 (C6), 81.4 (C7), 78.4 (C4), 66.1 (C5), 61.3 (C-1), 30.8 (C-2), 15.8 (C-3), 7.3 (Si(CH2CH3)3), 
4.2 (Si(CH2CH3)3); (MALDI-TOF) m/z calc. for C13H23OSi 223.152 ([M.H]+) found 223.138 
[M.H]+. The 1H and 13C NMR data were in accordance with the literature.37 
 
Hepta‐4,6‐diyn‐1‐ol (4)37 
 
 
7‐(Triethylsilyl)hepta‐4,6‐diyn‐1‐ol (3) (360 mg, 1.6 mmol) was dissolved into dry THF (5 mL) 
under N2 and cooled in an ice bath.  1M TBAF (in THF) (1.9 mL, 1.9 mmol) was added and the 
reaction mixture was allowed to warm to room temperature and was stirred for 1 hour.  TLC 
showed consumption of 3.  The reaction mixture was quenched with saturated NH4Cl and 
extracted with DCM (3 × 5 mL).  The organic layers were combined and dried over MgSO4, 
filtered and the solvent was removed in vacuo.  Purification by FCC (10-25% n-Hex/EtOAc) 
returned hepta‐4,6‐diyn‐1‐ol (4) (80 mg, 46%) as a colourless oil. Rf 0.29 (hexane/EtOAc 8:2); 
δH(400 MHz; CDCl3) 3.73 (t, J1,2 = 7.0 Hz, 2H, H-1); 2.40 (J2,3 = 7.0 Hz, 5J3,7 = 1.2 Hz, 2H, H-3), 
2.38 (br, 1H, OH), 2.00 (t, 6J3,7 = 1.2 Hz, 1H, H-7), 1.82-1.76 (m, 2H, H-2), δC (100 MHz; CDCl3) 
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77.6 (C4), 68.3 (C6), 65.1 (C5), 64.8 (C7), 61.1 (C-1), 30.6 (C-2), 15.5 (C-3); νmax/cm-1 (ATR-IR) 
3286 (O-H), 2360, 2339, 2225 (C≡C), 1054 (C-OH), 621 (C≡C); HRMS (TOF MS ESI-) m/z calc. 
for C7H7O- 107.0502 ([M-H]-) found 107.0640 [M-H]-.  (n.b. this oil very quickly turns into a 
brown syrup if left neat.  The compound should be stored as a dilute ether solution or 
preferably with the protecting TES group being removed immediately before subsequent 
use.)   
 
Pent-4-yn-1-yl 2’,3’,4’,6’-tetra-O-acetyl-β-ᴅ-galactopyranoside (6)22 
 
 
β-ᴅ-Galactose pentaacetate (5) (1.0 g, 2.6 mmol) and 4-pentyn-1-ol (1 mL, 10.7 mmol) were 
dissolved in anhydrous DCM (20 mL) and the solution was cooled to 0 °C. BF3.Et2O (2 mL, 16 
mmol) was slowly added and the reaction mixture was stirred overnight at room 
temperature.  TLC (hexane/EtOAc 8:2) showed complete consumption of the donor and the 
reaction mixture was quenched with sat. aqueous NaHCO3 (20 mL).  The reaction mixture 
was extracted with DCM (3 × 10 mL) and the organic layers were combined and dried over 
MgSO4, before being filtered and concentrated in vacuo to give crude product which was 
purified by FCC to give the title compound (6) (450 mg, 71%) as a yellow oil. Rf 0.1 
(hexane/EtOAc 8:2); [α]D +2.8 (c 1.0 CHCl3); δH(400 MHz; CDCl3) 5.40 (dd, J3’,4’ = 3.4 Hz, J4’,5’ = 
1.1 Hz, 1H, H-4’), 5.21 (dd, J1’,2’ = 8.0 Hz, J2’,3’ = 10.5 Hz, 1H, H-2’), 5.03 (J2’,3’ = 10.5 Hz, J3’,4’ = 
2.3 Hz, 1H, H-3’), 4.47 (d, J1’,2’ = 8.0 Hz, 1H, H-1’), 4.22-4.11 (m, 2H, H-6’a,b), 3.99 (dt, J1a,1b = 
9.7 Hz, H-1a, J1a,2a = 5.2 Hz, 1H, H-1a), 3.93-3.90 (m, 1H, H-5’) 3.67-3.61 (m, 1H, H-1b), 2.29-
2.25 (m, 2H, H-3), 2.16 (s, 3H, OAc), 2.08 (s, 3H, OAc), 2.06 (s, 3H, OAc), 1.99 (s, 3H, OAc), 
1.95 (t, 4J3,5 = 2.7 Hz, 1H, H-5), 1.89-1.71 (2H, m, 2a,b); δC(100 MHz; CDCl3) 170.4, 170.3, 170.2, 
169.5 (4 × C=O), 101.6 (C1’), 83.4 (C4), 70.9 (C3’), 70.6 (C5’), 68.9 (C2’), 68.8 (C5), 68.3 (C1), 
67.0 (C4’), 61.3 (C6’), 28.2 (C2), 20.7, 20.7, 20.6, 20.6 (4 × Ac), 14.8 (C3);  HRMS (ESI+) m/z 
calc. for C19H26O10Na+ 437.1418 ([M+Na]+) found 437.1421 [M+Na]+.  1H and 13C NMR values 
were in agreement with literature values.22 
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Pent-4-yn-1-yl β-ᴅ-galactoside (10)22 
 
 
A piece of sodium metal (5 mg, 0.2 mmol) was placed in dry MeOH (10 mL).  After the 
cessation of effervescence, the solution of sodium methoxide was added by syringe to a 
solution of pent-4-yn-1-yl 2’,3’,4’,6’-tetra-O-acetyl-β- ᴅ-galactopyranoside (6) (750 mg, 1.8 
mmol) in MeOH (10 mL) under N2 and the reaction mixture was left to stir overnight.  Low 
resolution mass spectrometry showed only the desired product, and the reaction mixture 
was neutralised to pH 7.0 with Amberlite® 120 H+ resin, before being filtered and 
concentrated under reduced pressure to give the title compound (10) (370 mg, 83%)  as a 
yellow oil; [α]D -13.0 (c = 1.0, MeOH) (lit.38 [α]D26 -24.6 (c = 0.85, MeOH)); δH(400 MHz; CD3OD) 
4.23 (d, J1’,2’ = 7.2 Hz, 1H, H-1’), 3.98 (dt, 2J1a,1b = 12.4 Hz, J1a,2 = 6.3 Hz, 1H, H-1a), 3.86 (dd, 
J3’,4’ = 3.1 Hz, J4’,5’ = 1.0 Hz, 1H, H-4’), 3.77-3.75 (m, 2H, H-6’a,b), 3.67 (dt, 2J1a,1b = 12.4 Hz, J1a,2 
= 6.3 Hz, 1H, H-1b), 3.55-3.46 (m, 3H, H-2’,3’,5’), 2.35-2.30 (m, 2H, H-3), 2.22 (4J3,5 = 2.8, 1H, 
H-5), 1.86-1.81 (m, 1H, H-2); δC(100 MHz; CD3OD) 103.7 (C1’), 83.4 (C4), 75.2 (C3’), 73.6 (C5’), 
71.2 (C2’), 68.9 (C4’), 68.2 (C5), 67.9 (C1), 61.1 (C6’), 28.7 (C2), 14.4 (C3); HRMS (ESI+) m/z 
calc. for C11H18O6Na+ 269.0996 ([M+Na]+) found 269.0990 [M+Na]+.  The 1H and 13C NMR 
spectra were in agreement with literature values.22 
 
7‐(Triethylsilyl)hepta‐4,6‐diyn‐yl-β-ᴅ-galactoside (11) 
 
 
4-Pentyn-yl-β-ᴅ-galactoside (10) (370 mg, 1.5 mmol), BuNH2 (7 mL), H2O (3 mL) and 
NH2OH.HCl (35 mg, 0.5 mmol) were dissolved in MeOH (20 mL).  The reaction mixture was 
cooled to 0 °C and CuCl (15 mg, 0.15 mmol) was added in a single portion.  
(Bromoethynyl)(triethyl)silane (2) (1.0 g, 4.9 mmol) was added dropwise by syringe.  The 
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reaction mixture immediately went bright orange, and after stirring at 0 °C for 1 hour the 
reaction mixture was a dark blood red.  The reaction mixture was diluted with EtOAc (50 mL) 
and washed with sat. aqueous NH4Cl solution (3 × 10 mL).  The aqueous layer was then 
extracted with EtOAc (3 × 5 mL) and the organic layers were combined, dried over MgSO4, 
filtered and concentrated in vacuo.  The crude residue was purified by FCC (gradient of 0% 
to 20% MeOH in DCM) to return the title compound (11) (135 mg, 23%) as a yellow powder; 
Rf 0.44 (DCM/MeOH 9:1); [α]D = +10 (c 1.0, MeOH); δH(400 MHz; CD3OD) 4.12 (d, J1’,2’ = 7.2 
Hz, 1H, H-1’), 3.86 (dt, 2J1a,1b = 10.1 Hz, J1a,2 = 4.1 Hz, 1H, H-1a), 3.74 (dd, J3’,4’ = 3.1 Hz, J4’,5’ = 
1.0 Hz, 1H, H-4’), 3.68-3.60 (m, 2H, H-6’a,b), 3.55 (dt, 2J1a,1b = 10.1 Hz, J1a,2 = 4.1 Hz, 1H, H-1b), 
3.43-3.35 (m, 3H, H-2’,3’,5’), 2.36 (t, J2,3 = 7.1 Hz, 2H, H-3), 1.77-1.71 (m, 2H, H-2), 0.91 (t, J8,9 
= 8.0 Hz, 9H, 3 × CH3), 0.52 (t, J8,9 = 8.0 Hz, 6H, 3 × CH2) δC(100 MHz; CD3OD) 101.3 (C1’), 87.1 
(C6), 77.2 (C4), 76.18 (C7), 72.8 (C3’), 71.2 (C5’), 68.8 (C2’), 66.5 (C4’), 65.4 (C1), 62.8 (C5), 
58.7 (C6’), 26.0 (C2), 12.8 (C3) 3.9 (CH3), 1.4 (CH2); HRMS (ESI+) m/z calc for C19H32O6SiNa+ 
407.1861 ([M+Na]+) found 407.1859 [M+Na]+. 
 
Hepta‐4,6‐diyn‐yl-β-ᴅ-galactoside (9) 
 
 
To a solution of 7‐(triethylsilyl)hepta‐4,6‐diyn‐yl-β-ᴅ-galactoside (11) (34 mg, 90 µmol) in 
anhydrous THF (3 mL) was added Et3N.3HF (145 µL, 0.9 mmol).  The reaction mixture was 
stirred over night at room temperature, after which time TLC (DCM/MeOH 9:1) showed the 
reaction had gone to completion.  The crude mixture was dried under reduced pressure and 
purified by FCC to give the title compound (9) (20 mg, 88%) as a pink powder. Rf 0.16 
(DCM/MeOH 9:1); [α]D = -13.0 (c = 1.0, MeOH); δH(400 MHz; CD3OD) 4.11 (d, J1’,2’ = 7.1 Hz, 
1H, H-1’), 3.85 (dt, 2J1a,1b = 10.2 Hz, J1a,2 = 6.0 Hz, 1H, H-1a), 3.73 (dd, J3’,4’ = 3.1 Hz, J4’,5’ = 1.0 
Hz, 1H, H-4’), 3.65-3.63 (m, 2H, H-6’a,b) 3.54 (dt, 2J1a,1b = 10.2 Hz, J1a,2 = 6.0 Hz, 1H, H-1b), 
3.43-3.34 (m, 3H, H-2’,3’,5’), 2.41 (t, 6J3,7 = 1.2 Hz, 1H, H-7), 2.33 (t, J2,3 = 7.1 Hz, 2H, H-3), 
1.77-1.70 (m, 2H, H-2); δC(100 MHz; CD3OD) 103.7 (C1’), 76.8 (C4), 75.2 (C3’), 73.6 (C5’), 71.2 
(C2’), 68.9 (C4’), 67.7 (C1), 67.6 (C6), 65.0 (C7), 64.4 (C5), 61.0 (C6’), 28.3 (C3), 14.9 (C2); 
HRMS (ESI+) m/z for C13H18O6Na+ 293.0996 ([M+Na]+), found 293.0995  [M+Na]+. 
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3-azido-7-hydroxycoumarin (12)27 
 
 
A suspension of 2,4-hydroxybenzaldehyde (4.2 g, 30 mmol), N-acetylglycine (3.5 g, 30 mmol) 
and sodium acetate (12.5 g, 150 mmol) in acetic anhydride (100 mL) was heated to reflux 
overnight.  The reaction mixture was poured onto ice and the resulting yellow solid was 
filtered off and dissolved in a 1:1 mixture of EtOH/HCl (conc.) (50 mL) and heated to reflux 
for 1 hour.  The resulting mixture was then cooled in an ice bath and NaNO2 (4.2 g, 61 mmol) 
in ice cold water (40 mL) was added in a single portion.  After 10 minutes NaN3 (6.5 g, 100 
mmol) was added in small portions and the reaction mixture was stirred for 1 hour.  The 
resulting precipitate was filtered off, washed with ice cold water and dried in vacuo before 
being purified by FCC to give crude 3-azido-7-hydroxycoumarin (12) (410 mg, 7%) as a brown 
powder.  Rf 0.53 (hexane/EtOAc 6:4); νmax/cm-1 (ATR-IR) 3292 (br, OH), 2107 (s, N3), 1676 (m, 
C=O), 1621, 1594, 1342 (m, Ar-O), 1317 (s, C=O), 1258, 1220, 1120, 926, 836, 624; δH(400 
MHz; DMSO-d6) 10.53 (s, 1H, OH), 7.61 (s, 1H, H-4), 7.49 (d, J5,6 = 8.5 Hz, 1H, H-6), 6.82 (dd, 
J5,8 = 2.2 Hz, J5,6 = 8.5 Hz, 1H, H-5), 6.76 (d, J5,8 = 2.2 Hz, 1H, H-8); δC(100 MHz; DMSO-d6) 106.2 
(C7), 152.7 (C2), 129.1 (C6), 127.8 (C4), 121.1 (C3), 113.8 (C5), 111.3 (C5), 111.3 (C10), 102.0 
(C8); The 1H NMR data were in accordance with the literature.27 
 
3-[1-(7-Hydroxy-coumarin)-1H-1,2,3-triazol-4-yl] propyl β-ᴅ-galactopyranoside (13) 
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4-Pentyn-yl-β-ᴅ-galactoside (10) (25 mg, 0.1 mmol) and 3-azido-7-hydroxycoumarin (12) (32 
mg, 0.1 mmol) were dissolved in MeOH/H2O (1:1) (2 mL).  The reaction was initiated by 
adding 1M aqueous copper sulfate solution (20 µL) and 1M aqueous sodium ascorbate 
solution (50 µL) and then stirred at room temperature for 2 hours before being concentrated 
in vacuo.  The crude residue was purified by semi-prep TLC (CHCl3/MeOH 85:15) to give the 
title compound (13) as a yellow powder (25 mg, 56%); Rf 0.53 (CHCl3/MeOH 85:15); [α]D -
12.6 (c = 0.5, MeOH); UV-vis (DMSO) λabs = 393 nm; δH(400 MHz; CD3OD) 8.36 (s, 1H, H-5), 
8.27 (1H, s, H-8’’), 7.54 (d, J6’’,7’’ = 8.8 Hz, 1H, H-7’’), 6.80 (dd, 4J4’’6’’ = 2.4 Hz, J6’’,7’’ = 8.8 Hz, 1H, 
H-6’’), 6.72 (d, J4’’,6’’ = 2.4 Hz, 1H, H-4’’), 4.14 (d, J1’,2’ = 7.6 Hz, 1H, H-1’), 3.87 (dt, J1a,1b = 9.9 
Hz, J1a,2 = 6.3 Hz, 1H, H-1a), 3.74 (dd, J3’,4’ = 3.1 Hz, J4’,5’ = 1.0 Hz, H-4’), 3.69-3.62 (m, 2H, H-
6’a,b), 3.52 (dt, J1a,1b = 9.9 Hz, J1b,2 = 6.3 Hz, 1H, H-1b), 3.48-3.36 (m, 3H, H-5’,2’,3’), 2.83 (t, 
J2,3 = 7.4 Hz, 2H, H-3), 1.96-1.90 (m, 2H, H-2); δC(100 MHz; DMSO) 156.9 (C=O), 155.2 (C4), 
147.2 (Ar), 136.7 (C5), 131.3 (C7’’), 123.5 (C8’’), 115.0 (C6’’), 104.0 (C1’), 102.7 (C4’’), 75.6 
(C3’), 73.8 (C5’), 71.0 (C2’), 68.7 (C4’), 68.1 (C1), 60.9 (C6’), 29.6 (C2), 22.0 (C3); HRMS (ESI+) 
m/z calcd. for C20H24N3O9+ 450.1507 ([M.H]+) found 450.1505 [M.H]+. 
 
5-[1-(7-Hydroxy-coumarin)-1H-1,2,3-triazol-4-yl] pent-4-yn-1-yl β-ᴅ-galactopyranoside 
(14) 
 
 
Hepta‐4,6‐diyn‐yl-β-ᴅ-galactoside (9) (27 mg, 0.1 mmol) and 3-azido-7-hydroxycoumarin (12) 
(32 mg, 0.1 mmol) were dissolved in MeOH/H2O (1:1) (2 mL).  The reaction was initiated by 
adding 1M aqueous copper sulfate solution (20 µL) and 1M aqueous sodium ascorbate 
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solution (50 µL) and then stirred at room temperature for 2 hours before the mixture was 
concentrated in vacuo.  The crude residue was purified by semi-prep TLC (CHCl3/MeOH 
85:15) to give the title compound (14) as a yellow powder (25 mg, 53%); Rf 0.72 (CHCl3/MeOH 
85:15); [α]D = -1.0 (c = 1.0, MeOH), [α]436 = -27.4 (c = 1.0, MeOH); UV-vis (DMSO) λabs = 349 
nm; δH(400 MHz; CD3OD) 8.49 (s, 1H, H-5), 8.41 (1H, s, H-8’’), 7.55 (d, J6’’,7’’ = 8.3 Hz, 1H, H-
7’’), 6.80 (dd, 4J4’’6’’ = 2.4 Hz, J6’’,7’’ = 8.3 Hz, 1H, H-6’’), 6.73 (d, J4’’,6’’ = 2.4 Hz, 1H, H-4’’), 4.15 
(d, J1’,2’ = 7.5 Hz, 1H, H-1’), 3.99-3.92 (m, 1H, H-1), 3.74 (dd, J3’,4’ = 3.2 Hz, J4’,5’ = 1.0 Hz, H-4’), 
3.70-3.60 (m, 4H, H-1b,5’,2’,3’), 2.53 (t, J2,3 = 7.4 Hz, 2H, H-3), 1.88-1.81 (m, 2H, H-2); δC(100 
MHz; DMSO) 156.8 (C=O), 137.9 (C8’’), 131.4 (C7’’), 130.4 (C6), 128.4 (C7), 115.4 (C6’’), 104.0 
(C1’), 102.8 (C4’’), 94.4 (C4), 75.6 (C5’), 73.9 (C2’), 71.1 (C3’), 70.5 (C5), 68.6 (C4’), 67.6 (C1), 
60.9 (C6), 28.8 (C2), 15.9 (C3); HRMS (ESI+) m/z calcd. for C22H24N3O9+ 474.1507 ([M.H]+) found 
474.1510 [M.H]+. 
 
3.7.5 CuAAC coupling of prymnesin extracts with 3-azido-7-
hydroxycoumarin 
The crude prymnesin extract was mixed with 3-azido-7-hydroxycoumarin (100 µg) in a 
mixture of H2O/EtOH 1:1 (100 µL).  A freshly prepared solution of 0.1M aqueous copper 
sulfate and 0.2M aqueous sodium ascorbate (10 µL) was added to start the coupling reaction.  
After 2 hours, the crude reaction mixture was separated by TLC under the conditions 
described by Igarashi et al.2  The TLC plate was dried and visualised under a UV lamp.   
3.8 References 
1. S. R. Manning and J. W. La Claire, Mar. Drugs, 2010, 8, 678–704. 
2. T. Igarashi, M. Satake, and T. Yasumoto, J. Am. Chem. Soc., 1999, 121, 8499–8511. 
3. S. A. Rasmussen, S. Meier, N. G. Andersen, H. E. Blossom, J. Ø. Duus, K. F. Nielsen, P. 
J. Hansen, and T. O. Larsen, J. Nat. Prod., 2016, 79, 2250–2256. 
4. T. Igarashi, S. Aritake, and T. Yasumoto, Nat. Toxins, 1998, 6, 35–41. 
5. S. R. Manning and J. W. La Claire II, Anal. Biochem., 2013, 442, 189–195. 
6. J. W. La Claire, S. R. Manning, and A. E. Talarski, Toxicon, 2015, 102, 74–80. 
7. T. Igarashi, M. Satake, and T. Yasumoto, J. Am. Chem. Soc., 1996, 118, 479–480. 
8. A. Umeyama, C. Nagano, and S. Arihara, J. Nat. Prod., 1997, 60, 131–133. 
9. Y. Fujimoto, H. Wang, M. Satoh, and N. Takeuchi, Phytochem, 1994, 35, 1255–1257. 
10. A. K. Amegadzie, W. A. Ayer, and L. Sigler, Can. J. Chem., 1995, 73, 2119–2125. 
  P a g e  | 97 
11. A. L. K. Shi Shun and R. R. Tykwinski, Angew. Chem - Int. Ed., 2006, 45, 1034–1057. 
12. R. E. Minto and B. J. Blacklock, Prog. Lipid Res., 2008, 47, 233–306. 
13. V. V. Rostovtsev, L. G. Green, V. V. Fokin, and K. B. Sharpless, Angew. Chem - Int. Ed., 
2002, 41, 2596–2599. 
14. C. W. Tornøe, C. Christensen, and M. Meldal, J. Org. Chem., 2002, 67, 3057–3064. 
15. H. Yamakoshi, K. Dodo, A. Palonpon, J. Ando, K. Fujita, S. Kawata, and M. Sodeoka, J. 
Am. Chem. Soc., 2012, 134, 20681–20689. 
16. J. P. Marino and H. N. Nguyen, J. Org. Chem., 2002, 67, 6841–6844. 
17. K. S. Sindhu, A. P. Thankachan, P. S. Sajitha, and G. Anilkumar, Org. Biomol. Chem., 
2015, 13, 6891–6905. 
18. T. Luu, R. McDonald, and R. R. Tykwinski, Org. Lett., 2006, 8, 6035–6038. 
19. T. Luu and R. R. Tykwinski, J. Org. Chem., 2006, 71, 8982–8985. 
20. K. West, C. Wang, A. S. Batsanov, and M. R. Bryce, J. Org. Chem., 2006, 71, 8541–
8544. 
21. X. Nie and G. Wang, J. Org. Chem., 2006, 71, 4734–4741. 
22. F. Pertici and R. J. Pieters, Chem. Commun., 2012, 48, 4008–4010. 
23. B. W. Gung and R. M. Fox, Tetrahedron, 2004, 60, 9405–9415. 
24. M. C. Pirrung, S. W. Shuey, D. C. Lever, and L. Fallon, Bioorg. Med. Chem. Lett., 1994, 
4, 1345–1346. 
25. A. L’Heureux, F. Beaulieu, C. Bennett, D. R. Bill, S. Clayton, F. LaFlamme, M. 
Mirmehrabi, S. Tadayon, D. Tovell, and M. Couturier, J. Org. Chem., 2010, 75, 3401–
3411. 
26. M. Weigele, S. L. DeBernardo, J. P. Tengi, and W. Leimgruber, J. Am. Chem. Soc., 
1972, 94, 5927–5928. 
27. K. Sivakumar, F. Xie, B. M. Cash, S. Long, H. N. Barnhill, and Q. Wang, Org. Lett., 
2004, 6, 4603–4606. 
28. I. M. Ivanova, S. A. Nepogodiev, G. Saalbach, E. C. O’Neill, M. D. Urbaniak, M. A. J. 
Ferguson, S. S. Gurcha, G. S. Besra, and R. A. Field, Carbohydr. Res., 2017, 438, 26–
38. 
29. P. Rostron, S. Gaber, and D. Gaber, Int. J. Eng. Tech. Res., 2016, 1, 50–64. 
30. L. Wei, F. Hu, Y. Shen, Z. Chen, Y. Yu, C.-C. Lin, M. C. Wang, and W. Min, Nat. 
Methods, 2014, 11, 410–412. 
31. T. Murphy, S. Lucht, H. Schmidt, and H.-D. Kronfeldt, J. Raman Spectrosc., 2000, 31, 
943–948. 
32. V. Tomar, J. Nanomed. Nanotechnol., 2012, 3, 131–142. 
  P a g e  | 98 
33. H. Neson and J. F. Sperry, Proc. SPIE, 2002, 4577, 193–204. 
34. Y. Chen, J.-Q. Ren, X.-G. Zhang, D.-Y. Wu, A.-G. Shen, and J.-M. Hu, Anal. Chem., 
2016, 88, 6115–6119. 
35. P. L. Stiles, J. A. Dieringer, N. C. Shah, and R. P. Van Duyne, Annu. Rev. Anal. Chem., 
2008, 1, 601–626. 
36. Y. Morisaki, T. Luu, and R. R. Tykwinski, Org. Lett., 2006, 8, 689–692. 
37. K. P. Wang, E. J. Cho, S. Y. Yun, J. Y. Rhee, and D. Lee, Tetrahedron, 2013, 69, 9105–
9110. 
38. W. Y. Lu, X. W. Sun, C. Zhu, J. H. Xu, and G. Q. Lin, Tetrahedron, 2010, 66, 750–757. 
 
 
  
  P a g e  | 99 
 
 
 
 
 
 
 
 
 
 
 
4 The chemical synthesis of glyceryl 
glycosides inspired by prymnesin 
toxins 
  
  P a g e  | 100 
4.1 Introduction 
4.1.1 Carbohydrates present on reported prymnesin toxins 
There are currently two different prymnesin backbone structures reported in the 
literature;1,2 with variation in glycosylation patterns, there are four different reported 
prymnesin toxins (Figure 4.1).   
 
Figure 4.1 – The reported structures of the prymnesin toxins.  Prymnseins-1 (PRM-1) and prymnesin 
(PRM-2) have a conserved backbone with a variation in sugars.  Prymnesin-B1 (PRM-B1) and 
prymnesin-B2 (PRM-B2) also share a conserved backbone which is slightly shorter than that for PRM-
1 and PRM-2, and are each decorated with a single sugar at the same position. 
 
Igarashi et al.3 first deduced that the backbone of prymnesin-2 is glycosylated at C77 with α-
ʟ-xylofuranose.  The glycosylation position on the backbone and the pentose ring size were 
elucidated by HMBC NMR cross peaks between H1’/C4’ and H1’/C77.  The carbohydrate on 
prymnesin-2 was then hydrolysed, trifluoroacetylated and identified as ʟ-xylose by chiral GC.  
The carbohydrate moieties on prymnesin-1 were identified in a later paper by Igarashi et al.1  
When comparing the 1H and 13C NMR spectra for PRM-1 and PRM-2, they noticed that all of 
the chemical shifts were within 0.1 ppm (for proton NMR) and 1.0 ppm (for carbon NMR), 
with the exception of the region C78 – C82.  From this, it was deduced that PRM-1 and PRM-
2 shared a conserved backbone but were glycosylated with different sugars.  The two extra 
carbon sequences due to the sugar rings, plus an additional molecular mass of 294 MU when 
compared with PRM-2, suggested that PRM-1 was glycosylated with an additional hexose 
and pentose.1  Chiral GC of the sugars from the hydrolysed toxins was compared with sugar 
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standards and as such ʟ-arabinose, ᴅ-galactose were assigned from the GC chromatogram 
(Figure 2.2).   
 
 
Figure 4.2 – The top chiral GC chromatogram shows the sugar standards for ᴅ- & ʟ-xylose, ᴅ- & ʟ-
arabinose and ᴅ- & ʟ-galactose.  The bottom chiral GC chromatogram show the sugars ʟ-arabinose and 
ᴅ-galactose which were hydrolysed from prymnesin-1.  Peaks marked with an X are electrical noises 
from the instrument.  Reprinted (adapted) with permission from T. Igarashi et al., J. Am. Chem. Soc., 
1999, 121 (37), pp 8499–8511 (supporting material).  Copyright 1999 American Chemical Society. 
 
The remaining pentose was identified as ribose by chiral GC.  Because the standards for ᴅ-
ribose and ʟ-ribose have very similar retention times under the column conditions Igarashi 
et al.1 were using, it was necessary to co-inject the unidentified pentose hydrolysed from 
prymnesin-1 with ᴅ-ribose and a mixture of ᴅ- & ʟ-ribose.  The co-injection with ᴅ-ribose led 
to an increase of the intensity of the prymnesin-1 hydrolate peaks, whilst the addition of a 
mixture of ᴅ- & ʟ-ribose led to both an enhancement of the prymnesin-1 hydrolate peaks 
and an additional (ʟ-ribose) peak (Figure 4.3).  From this information, the final assignment 
for this pentose on prymnesin-1 was ᴅ-ribose. 
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Figure 4.3 - GC chromatograms used to identify ᴅ-ribose on prymnesin-1.  Clockwise from top left: GC 
chromatogram of the unidentified sugar in prymnesin-1; hydrolysed sugars spiked with ᴅ-ribose; 
hydrolysed sugars spiked with ᴅ- & ʟ-ribose; standards for ᴅ- & ʟ-ribose.  Peaks marked with an X are 
electrical noises from the instrument.  Reprinted (adapted) with permission from T. Igarashi et al., J. 
Am. Chem. Soc., 1999, 121 (37), pp 8499–8511 (supporting material).  Copyright 1999 American 
Chemical Society. 
The position of the carbohydrates on the backbone of prymnesin-1 was determined by HMBC 
and nOe coupling, and the stereochemistry at the anomeric position and the ring size were 
determined by comparison of 13C NMR chemical shifts and 1H NMR coupling constants with 
literature values, to identify α-ʟ-arabinopyranose, α-ᴅ-galactopyranose and α-ᴅ-
ribofuranose (Table 4.1).  As already discussed in Chapter 2, the literature 13C shifts for the 
anomeric carbons of the 1,2-cis sugars for β-ʟ-xylofuranose and α-ᴅ-ribofuranose are ~3 ppm 
smaller than the shift recorded for the sugar on the toxins.  This might be attributed to the 
flexibility of furanose rings when compared with pyranose rings.4  The difference in 13C NMR 
for the 1,2-trans sugars α-ᴅ-galactopyranose and α-ʟ-arabinopyranose are much closer to 
the literature values.   
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Table 4.1 - 13C NMR shifts for the anomeric carbons found on prymnesins-1/2 and the literature 
values Igarashi et al.1 used as comparison to assign the ring as either furanose or pyranose form. 
13C NMR shift α-ʟ-Xylf α-ʟ-Arap α-ᴅ-Ribf β-ᴅ-Galf 
Toxin 106.2 106.1 106.0 110.4 
Lit. pyranose 100.6 105.1 100.4 Not given 
Lit. furanose 103.0 Not given 103.1 110.0 
 
More recently Rasmussen et al.2 have reported two new prymnesin toxins, prymnesin-B1 
and prymnesin-B2, which share a conserved backbone.  These toxins have a slightly different 
backbone to the original pyrmnesin-1/2 toxins; they are missing the H and I polyether rings 
which are replaced by a -CH(OH)-CH2- linker, and have two less chlorine atoms than PRM-
1/2.  Prymnesin-B1 has been fully characterised and the carbohydrate was identified as a 
hexose by the difference in mass between the glycosylated and aglycone forms of the toxin.  
Chiral GC was used to identify the sugar as ᴅ-galactose, and the ring identified as being in the 
pyranose form by 13C NMR values (Figure 4.4).  The stereochemistry at the anomeric position 
was found to be 1,2-cis by the J1,2 coupling value of 4 Hz.  Finally, the toxin was found 
glycosylated at C-71 by HSQC NMR, and this was reinforced by nOe and a deshielded 13C NMR 
shift for C-71.  Prymnesin-B2 was only present in trace amounts and so could not be fully 
characterised by the authors.  They also found an additional carbohydrate had been liberated 
by hydrolysis in the chiral GC, which was assigned as ᴅ-ribose (Figure 4.4).  The chiral GC-MS 
conditions used by Rasmussen et al.2 removed the ambiguity between ᴅ-ribose and ʟ-ribose 
which was a problem encountered by Igarashi et al.1 when assigning a pentose on prymnesin-
1. The authors suggested that prymnesin-B2 is also glycosylated at C-71, which would be 
analogous with the position ᴅ-ribose is found on prymnesin-1.1 It is also worth noting that 
Rasmussen et al.2 have re-drawn pyrmnesin-2 as being glycosylated with β-ᴅ-
arabinofuranose.  However, they offer no written remark or explanation for this in either 
their paper or supplementary material, and this anomaly is dealt with later in this chapter.  
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Figure 4.4 - Chiral GC-MS trace for prymnesin-B1/B2 hydrolate along with standards of ᴅ-galactose, ʟ-
galactose, ᴅ-ribose and ʟ-ribose.  Reprinted (adapted) with permission from S. Rasmussen et al., J. 
Nat. Prod., 2016, 79 (9), pp 2250–2256 (supporting material).  Copyright 2016 American Chemical 
Society and American Society of Pharmacognosy.  
http://pubs.acs.org/doi/full/10.1021/acs.jnatprod.6b00345 
 
Prymnesin-1 and prymnesin-2 have a conserved backbone, and the region between C76 – 
C84 is heavily hydroxylated.  Determining the position of the hydroxyl groups was achieved 
by Igarashi et al.3 by comparison of proton shifts before and after per-O-acetylation.  In a 
later paper by Igarashi et al.1 where the stereochemistry of the toxin backbones was derived, 
they were unable to specify the specific stereochemistry for the hydroxylated region C-76 – 
C-84, most likely due to the flexibility in the backbone structure in this region.  A similar story 
is true for Rasmussen et al.2 who, in their much more recent paper characterising prymnesin-
B1, were also unable to specify the stereochemistry in the flexible hydroxylated region of the 
toxin.  This means that there is an ambiguity in desired structure if synthesising chemical 
fragments of prymnesins inspired by this region of the toxin. 
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4.1.2 Target glyceryl glycoside fragments 
In order to gain insight into the structure and properties of prymnesin toxins, a library of 
glyceryl glycosides was synthesised as model fragments of the prymnesin toxins (Figure 4.5).  
The glyceryl glycoside 2-O-(α-ᴅ-glucopyranosyl) glycerol is known and is an osmolyte used by 
cyanobacteria to combat the effects of salt-stress and drought.5  Glyceryl glycosides have 
also found use as moisturising ingredients in cosmetics.6  Two of the glyceryl glycosides in 
our library have previously been reported in the literature.  The first isolated algal glyceryl 
glycoside was ‘floridoside’ (1,3-dihydroxypropan-2-yl α-ᴅ-galactopyranoside) (7) from the 
red alga Mastocarpus stellatus.7  Floridoside has been found to be a potent activator of the 
classical complement pathway,7 and this chemical synthesis has been reported in the 
literature.8,9  1,3-Dihydroxypropan-2-yl α-ʟ-arabinopyranoside (2) has been synthesised as a 
reference compound in an old project determining the glycosidic linkages of disaccharides. 
However, (2) has only been characterised by melting point and optical rotation.10,11  The 
other glyceryl glycosides have not been reported before. 
 
Figure 4.5 – Target sugar glycerol fragments inspired by PRM-1, PRM-2, PRM-B1 and PRM-B2.   
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4.2 Chemistry 
4.2.1 Choosing a protected glycerol acceptor 
Glycerol was glycosylated at the 2° hydroxyl position to synthesise small analogues of the 
prymnesin toxins glycosylated backbones.  Due to flexibility in the backbone of the 
glycosylated region of prymnesin toxins, the stereochemistry in this region is so far 
undefined.  Using glycerol as a small fragment of the toxin backbone eliminated the need to 
define the stereochemistry at the 2-O- position of the acceptor after glycosylation. A second 
benefit of synthesising the library shown in Figure 4.5 was that it helped to develop 
glycosylation techniques for larger diglycoside fragments inspired by the toxins (Chapter 5).  
Due to the increased reactivity of 1° alcohols compared with 2° alcohols, it was necessary to 
have protecting groups on the glycerol 1,3-O positions for the glycosylation step.  Using the 
same protecting groups on the glycerol 1,3-O- positions ensured symmetry across the 
acceptor.  This prevents the complication of purifying mixtures of isomers which differ at the 
stereochemistry of the acceptor as well as the anomeric position after glycosylation. 
cis-1,3-O-Benzylideneglycerol (9) is commercially available and was considered as a 
protected glycerol acceptor.  It has also been used by Perlin et al.11 to synthesise 3-
dihydroxypropan-2-yl α-ʟ-arabinopyranoside (2). However, preliminary attempts to 
glycosylate cis-1,3-O-benzylideneglycerol (9) using acetobromo ᴅ-glucose (12) under 
Koenigs-Knorr conditions were unsuccessful.12  This is perhaps because of the axial 
orientation of the hydroxyl group makes cis-1,3-O-benzylideneglycerol a relatively 
unreactive donor.  The hydroxyl group was therefore inverted from an axial to an equatorial 
orientation by sequential oxidation and reduction.13 (Scheme 4.1).   
 
  
Scheme 4.1 – Chemical synthesis of trans-1,3-O-benzylidene glycerol (11) by inversion of the hydroxyl 
group on cis-1,3-O-benzylidene glycerol via oxidation and reduction.13 i) DMP, DCM. ii) NaBH4, 
THF/H2O. 
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Cis-1,3-O-benzylideneglycerol (9) was treated with Dess-Martin periodinane (DMP) in DCM 
to give 2-phenyl-1,3-dioxan-5-one (10) in very good yield.  The oxidation of the alcohol to a 
ketone was confirmed by loss of the 2H proton by 1H NMR and a new carbonyl signal in the 
13C NMR at 204.2 ppm.  Reduction of the ketone was performed using sodium borohydride 
which gave trans-1,3-O-benzylideneglycerol (11) in very good yield.  This reduction requires 
hydride attack the ketone from the more hindered face of 10.  Houk et al.14 have used 
computational modelling to explain that axial attack reduces torsional strain in the transition 
state, whilst equatorial attack of the ketone would require rotation of the Cα-CCO bond 
leading to torsional strain (Figure 4.6).   The successful reduction was accompanied by a loss 
of the carbonyl signal in the 13C NMR and the 1H and 13C NMR values agreed with the 
published literature for trans-1,3-O-benzylideneglycerol (11).15 
 
Figure 4.6 – Steric effects leading to the axial attack of the ketone 10, which lead to the equatorial 
hydroxyl group on 11. 
 
trans-1,3-Di-O-benzylideneglycerol (11) acceptor was mixed with acetobromo ᴅ-glucose (12) 
and silver carbonate in DCM.  Again, no glycosylation was seen, which may be due to the 
noted instability of 11.13  As such it was decided a better acceptor needed to be found.  1,3-
Di-O-benzyl glycerol (13) is a commercially available symmetrical glycerol acceptor.  It is 
relatively inexpensive, stable at room temperature, and the lack of acid labile groups make 
it compatible with a range of glycosylation conditions.  1,3-Di-O-benzyl glycerol (13) was 
mixed with acetobromo ᴅ-glucose (12) and silver carbonate in DCM to give 1,3-
bis(benzyloxy)propan-2-yl 2’,3’,5’,6’-tetra-O-acetyl-β-ᴅ-glucopyranoside (14) as exclusively 
the 1,2-trans β-anomer, as judged by the 1H NMR H-1’ signal which was a doublet at 4.80 
ppm with a J1’,2’ coupling of 8.0 Hz (Scheme 4.2).  1,3-Di-O-benzyl glycerol (13) was therefore 
used as the protected glycerol acceptor for the synthesis of the sugar glycerol fragments. 
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Scheme 4.2 - Trialling protected glycerol acceptors by glycosylation with acetobromo ᴅ-glucose under 
Koenigs–Knorr conditions.12 
 
4.2.2 Synthesis of 1,2-trans glyceryl glycoside fragments 
The synthesis of 1,2-trans glycosides is often achieved by utilising neighbouring group 
participation.16  Here the oxocarbenium cation is formed by abstraction of a leaving group at 
the anomeric position of the sugar.  This can be achieved by the abstraction of bromide with 
silver carbonate as per the Koenig-Knor reaction, or direct abstraction of an ester from the 
anomeric position using a Lewis acid.12,17  The oxocarbenium cation is then stabilised by the 
carbonyl oxygen lone pairs of the ester protecting group at C2, which in turn sterically blocks 
attack by the acceptor alcohol from the same face as the protecting group, leading to 
exclusively 1,2-trans product (Scheme 4.3). 
 
 
Scheme 4.3 – Mechanism by which neighbouring group participation by an ester group at the 2 
position on a glycosidic donor leads to 1,2-trans glycosylation.16 
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4.2.2.1 1,3-Dihydroxypropan-2-yl-β-ᴅ-galactofuranoside (1) 
The synthesis of per-O-benzoyl-ᴅ-galactofuranose (15) was described earlier on in the 
project (Chapter 2), using a modified protocol by Zhang and Liu.18  As there are no acid labile 
groups present on either the donor or the acceptor, SnCl4 promoted glycosylation of 1,3-di-
O-benzyl glycerol (13) with per-O-benzoyl-ᴅ-galactofuranose (15) was employed for the 
initial reaction step (Scheme 4.4).17,19   
 
Scheme 4.4 – The chemical synthesis of 1,3-dihydroxypropan-2-yl β-ᴅ-galactofuranoside (1). i) SnCl4, 
DCM. ii) H2, 10% Pd/C, EtOAc. iii) MeOH/H2O/Et3N (5:2:1) 
 
Neighbouring group participation by the benzoyl ester protecting group ensured that only 
the 1,2-trans β-anomer (16) was produced, and the configuration at the anomeric position 
was confirmed by the presence of a single H-1’ signal as singlet in the 1H NMR at 5.61 ppm.19  
It was decided to remove the benzyl protecting groups by hydrogenation first as this left the 
lipophilic benzoyl protecting groups in situ to aid recovery of the compound from the 
palladium on activated charcoal (Pd/C) catalyst.  After hydrogenation, the benzoyl protecting 
groups were removed using a mixture of MeOH/H2O/Et3N (5:2:1).  1H NMR spectra recorded 
after global deprotection showed the presence of aromatic signals, despite the fact mass 
spectrometry indicated that the global deprotection had gone to completion. Due to the 
water present in the methoxide catalysed debenozylation step, it was possible for both base 
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catalysed hydrolysis and trans-esterification of the benzyl ether protecting groups to occur, 
leading to both methyl benzoate and benzoic acid.  While the former is volatile, the latter 
may have remained in the mixture.  As (1) contains no acidic groups, the crude mixture was 
dissolved in methanol and passed through Dowex® 1X2-400 resin (OH- form) which bound 
any benzoic acid but allow 1,3-dihydroxypropan-2-yl-β-ᴅ-galactofuranoside (1) to pass 
through.  The 1H NMR was run again and the aromatic signals were no longer present in the 
spectrum.  The stereochemistry at the anomeric position was confirmed by the H-1’ signal as 
at 4.99 ppm, with a small J1’,2’ coupling value of 1.7 Hz. Due to overlapping peaks in the 1H 
NMR, a COSY and HSQCed spectrum were used to assign the 13C NMR peaks, as well as give 
a better indication as to where the varying proton signals are on the 1H NMR spectrum.  The 
HSQCed spectrum is shown in Appendices, Figure 6.1. 
 
4.2.2.2 1,3-Dihydroxypropan-2-yl α-ʟ-arabinopyranoside (2) 
The synthesis of 1,3-dihydroxypropan-2-yl α-ʟ-arabinopyranoside (2) has previously been 
described by Perlin et al.11 in 1957.  Here the authors accessed (2) via a Koenigs–Knorr 
condensation using acetobromo ʟ-arabinopyranose (19) as the donor, 1,3-di-O-benzylidene 
glycerol (13) as the acceptor and silver carbonate as a promotor.12  The final deprotected 
compound was, however, only characterised by optical rotations.  
Initial attempts to acetylate ʟ-arabinose with acetic anhydride in pyridine led to significant 
quantities of per-O-acetyl ʟ-arabinofuranose which were inseparable from per-O-acetyl ʟ-
arabinopyranose.  Therefore ʟ-arabinose was per-O-benzoylated with benzoyl chloride in 
pyridine to give (18) (Scheme 4.5).20  To minimise the formation of per-O-benzoyl ʟ-
arabinofuranose, it was found necessary to carry out this benzoylation in the presence of 
DMAP, with the addition of benzoyl chloride being performed dropwise at 0 °C.  After 
benzoylation and workup the 1H NMR spectrum showed a H-1 signal at 6.87 ppm as a broad 
singlet which confirmed 1,2,3,4-tetra-O-benzoyl-β-ʟ-arabinopyranose (18) was the major 
species (99% by integration of 1H NMR anomeric signals).20  Treatment of (18) with 33% HBr 
in acetic acid gave the glycosyl bromide donor (19) which was immediately used in the silver 
carbonate promoted glycosylation of 1,3-di-O-benzylglycerol (13).  Neighbouring group 
participation ensured that only the 1,2-trans α-anomer (20) was formed, and this was 
confirmed by the presence of a single H-1’ signal at 5.06 ppm as a doublet, albeit with a 
slightly low J1’,2’ coupling value of 5.9 Hz.  This lower coupling value was attributed to twisting 
of the sugar ring by the bulky benozyl protecting groups.  The glycerol benzyl ether protecting 
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groups were removed by hydrogenation over a Pd/C catalyst and sodium-methoxide 
catalysed transesterification was employed to remove the benzoyl protecting groups, and to 
give 1,3-dihydroxypropan-2-yl α-ʟ-arabinopyranoside (2) as a white powder.  After global 
deprotection, 1H NMR of the (2) showed the presence of aromatic signals at 7.4-7.2 ppm, 
despite mass spectrometry showing that both reaction steps had gone to completion.  
Despite using a fresh sodium methoxide solution, it is evident that there was some moisture 
present during the debenzoylation step, which led to the formation of some benzoic acid.  
This was removed as previously described by passing the crude mixture containing (2) 
through Dowex® 1X2-400 resin (OH- form). 
 
 
Scheme 4.5 – The chemical synthesis of 1,3-dihydroxypropan-2-yl α-ʟ-arabinopyranoside. i) BzOH, 
DMAP, Pyr, 0 °C. ii) 33% v/v HBr/AcOH, DCM. iii) Ag2CO3, Drierite™, toluene. iv) H2, 10% Pd/C, EtOAc, 
Et3N. v) Na, MeOH. 
 
With the protecting groups removed, the 1H NMR of (2) showed a single H-1’ signal at 4.35 
ppm as a doublet with a larger J1’,2’ coupling value of 7.5 Hz, which confirmed the presence 
of the 1,2-trans α-anomer. Apart from the H-1’ signal, most of the proton peaks for (2) 
overlapped in the 1H NMR spectrum.  Much more information was gained from the HSQC 
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spectrum, and by combining this with data from the COSY 2D spectrum and comparison with 
other sugar glycerol fragments it was possible to assign all peaks in the HSQC spectrum and 
therefore the 13C NMR spectrum (Appendices, Figure 6.2). 
 
4.2.2.3 1,3-Dihydroxypropan-2-yl α-ᴅ-arabinopyranoside (6) 
1,3-Dihydroxypropan-2-yl α-ᴅ-arabinopyranoside (6) was synthesised following informal 
discussions with delegates at the 2015 European Conference on Marine Natural Products 
(Strathclyde, Scotland).  These had suggested that there was a new prymnesin toxin 
decorated with ᴅ-arabinose.  However, since synthesising this compounds the delegates 
have published their work, where prymnesin-2 is drawn as being glycosylated with ᴅ-
arabinofuranose at C77,2 rather than ʟ-xylofuranose as had been previously reported.1,3   
 
Scheme 4.6 – The chemical synthesis of 1,3-dihydroxypropan-2-yl α-ᴅ-arabinopyranoside (6).  i) I2, 
Ac2O. ii) 33% v/v HBr/AcOH, DCM. iii) AgOTf, DCE. iv) H2, 10% Pd/C, MeOH. v) Na, MeOH. * Based on 
total mass recovered. 
 
ᴅ-Arabinose was acetylated using acetic anhydride and iodine as a Lewis acid catalyst.21  The 
acetylation resulted in mainly the desired pyranose ring configuration (22), with about 10% 
acetylated furanose seen by NMR.  This was found to give much better control of the ring 
size than using acetic anhydride in pyridine, as was described earlier with with ʟ-arabinose.  
Because of the problems experienced earlier with the removal of benzoyl protecting groups 
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which led to the formation of benzoic acid, it was decided to try and continue with a mixture 
of per-O-acetyl ᴅ-arabinoses (22).  The sugar bromide (23) was synthesised from (22) using 
33% HBr/AcOH, and was subsequently used as the glycosyl donor for the silver triflate 
promoted glycosylation of 1,3-di-O-benzyl glycerol (13).  The glycosylation was very low 
yielding, possibly due to orthoester formation due to the 1,2-trans configuration of the 
anomeric bromide and neighbouring acetate group, as well as additional furanose products 
in the crude mixture.  However enough compound was isolated for use in the next steps, 
with the stereochemistry of the isolated compound being confirmed as 1,2-trans (α-anomer) 
(25) by 1H NMR; the H-1’ signal at 4.69 ppm was a doublet with a J1’,2’ coupling value of 6.9 
Hz.  Removal of the benzyl ether protecting groups by hydrogenation over a Pd/C catalyst 
was deliberately performed before deacetylation.  This was because the hydrogenation step 
of other glyceryl glycoside compounds in this series had given very low yields.  Informal 
discussions with a delegate at the 'Carbohydrate Active Enzymes in Industrial 
Biotechnological Applications’ conference in St Andrews (August 2015), had revealed she too 
was having problems with the recovery of similar sugar glycerol compounds from the 
palladium catalyst after hydrogenation.  By leaving the acetate groups in situ on the sugar, it 
was hoped the increased lipophilicity of the compound would make it easier to wash (desorb) 
(25) from the surface of the Pd/C catalyst.  This gave (25) with 75% yield, which was the joint 
highest yield for any hydrogenation in this series.  The acetate groups were removed by 
methoxide-catalysed transesterification to give 1,3-dihydroxypropan-2-yl α-ᴅ-
arabinopyranoside (6).  The 1,2-trans orientation of the anomeric linkage in (6) was 
confirmed by 1H NMR, with the H-1’ signal at 4.35 ppm present as a doublet with a J1’,2’ 
coupling value of 7.5 Hz.  Whilst there was not as much overlap of signals in the 1H NMR 
spectrum as with some of the other glyceryl glycoside fragments, a combination of COSY and 
multiplicity information from the HSQCed spectrum allowed the full assignment of the 13C 
NMR peaks, as well as more precise information about in which regions of the 1H NMR 
spectrum mutliplets the individual proton signals were located (Appendices, Figure 6.3). 
 
4.2.3 Synthesis of 1,2-cis furanosyl glyceryl glycoside fragments 
Synthesis of 1,2-cis furanoses can prove challenging as it can be difficult to control the 
stereochemistry at the anomeric centre.  It was important to use non-participating 
protecting groups for the glycosylation steps to minimise the formation of 1,2-trans 
glycosylation products.22,23 The same general methodology was used for the glycosylation 
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step to synthesise α-ᴅ-ribofuranoside (3), α-ʟ-xylofuranoside (4) and β-ᴅ-arabinofuranoside 
(5) fragments.  The first two sugars are reported as decorating the backbone of prymnesin-1 
and prymnesin-2, respectively.1  A recent paper by Rasmussen et al.2 draws the structure of 
prymnesin-2 as being decorated with the third sugar, α-ᴅ-arabinofuranose instead of β-ʟ-
xylofuranose. 
 
4.2.3.1 Synthesis of fluoro furanoside sugar donors 
Work by Shoda et al.22  showed that the SnCl2-promoted glycosylation of a range of alcohols 
with 1,2-trans glycosyl fluorides gave good stereoselectiveity for 1,2-cis glycosides.22 
Furthermore, it was found that with ribofuranosides, both yield and stereoselectivity could 
be improved with the addition of trityl perchlorate.22  Before exploring this methodology it 
was first necessary to synthesise the corresponding glycosyl fluoride donors. 
All three 2,3,5-tri-O-benzyl glycosylfuranoside hemi-acetals (ᴅ-ribofuranose (26), ʟ-
xylofuranose (29) and ᴅ-arabinofuranose (32)) necessary for the library of prymnesin toxin 
fragments are commercially available from Carbosynth (UK).  Both Lartey et al.24 and Haines 
at al.25 simultaneously published methodology showing that anomeric hydroxyl groups could 
be conveniently replaced with fluorine using the mild fluorinating reagent 
diethylaminosulfur trifluoride (DAST) (Scheme 4.7).  
Haines et al.25 in particular explored solvent effects on DAST fluorination of anomeric 
hydroxyl groups.  They found that a polar solvent such as THF gave the best stereoselectivity 
for β-fluorides with ᴅ-sugars.  As it is reported to be desirable to have the 1,2-trans fluoride 
for glycosylation, this meant that in each case the β-fluoride would be the target 
compound.22   
 
  P a g e  | 115 
 
Scheme 4.7 - Fluorination of the 2,3,5-tri-O-benzyl glycosyl fluorides using DAST.24,25  A) DAST, THF, 0 
°C to r.t, 20 minutes. B) DAST, DCM, r.t, 20 minutes.  Note: yield refer to the total α/β mixture 
recovered. 
 
The synthesis of 2,3,5-tri-O-β-ᴅ-ribofuranosyl fluoride (27) was performed following the 
literature protocol.24,25  Comparison of the 1H NMR with literature values showed the 1,2-
trans β-fluoride (27) was the major anomer, with 1H NMR showing the H-1 signal as a doublet 
at 5.67 ppm with J1,F coupling value of 63.3 Hz and no observed J1,2 coupling.  By comparison 
the 1H NMR H-1 signal for the 1,2-cis α-fluoride (28) showed an H-1 signal as a doublet of 
doublet with a similar J1,F coupling value of 65.8 Hz and also a J1,2 coupling value of 3.4 Hz.  
19F NMR was also found to be very useful in identifying and characterising the two anomers, 
with the α-ribosyl fluoride having a F-1 signal as a doublet of doublet at -131.7 ppm with J1,F 
and J2,F splitting; the β-ribosyl fluoride having a F-1 signal as a doublet of multiplet at -115.3 
ppm. 
2,3,5-Tri-O-β-ʟ-xylofuranosyl fluoride (30) was synthesised using the same DAST fluorination 
methodology as for the ribosyl fluoride (27).  The anomers were inseparable by normal phase 
chromatography.  It was however still possible to characterise the two anomers in the 
mixture by 1H, 13C and 19F NMR.  The anomers were readily distinguished by the coupling 
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constants of the H-1 signals.  The 1,2-cis α-fluoride (31) H-1 signal appeared as a doublet of 
doublets with both J1,F coupling and also a J1,2 coupling value of 3.5 Hz. The 1,2-trans β-
fluoride (30) H-1 signal however appeared as doublet, with only J1,F coupling be observed.  
19F NMR (Figure 4.7) showed the β anomer (30) had large J2,F coupling value of 18.9 Hz, whilst 
the α anomer (31) had a much smaller J2,F coupling value of 6.8 Hz, but also exhibited J4,F 
coupling of 6.8 Hz.   
 
 
Figure 4.7 - 19F NMR spectrum of 2,3,5-tri-O-benzyl-β/α-ʟ-xylofuranosyl fluorides (30,31) 
Interestingly, 13C NMR also showed C4α,F coupling whilst there was no coupling between 
fluorine and the C4 carbon for the β-fluoride (30) (Figure 4.8). 
 
 
Figure 4.8 – 13C NMR spectrum for the mixture of 2,3,5-tri-O-benzyl-β/α-ʟ-xylofuranosyl fluoride 
(30,31) highlighting the difference in carbon-fluorine coupling at the C4 position between the two 
anomers. 
β-fluoride 
(1,2-trans) 
α-fluoride 
(1,2-cis) 
C4β 
C4α C2α 
C3β 
C3α 
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Finally, 2,3,5-tri-O-β-ᴅ-arabinofuranosyl fluoride (33) was considered.  DAST fluorination 
worked well, and the ratio of α/β fluoride was judged to be 5.3:1 by integration of the H-1 
NMR signals.  The 1,2-trans α-fluoride (33) gave an H-1 signal at 5.78 ppm as a doublet with 
a J1,F coupling value of 61.6 Hz and no observed J1,2 coupling; the 1,2-cis β-fluoride (34) was 
identified by an H-1 signal at 5.62 ppm as a doublet of doublets with a J1,2 coupling value of 
3.5 Hz.  Although the anomers separated on a TLC plate they were not separated for the 
following glycosylation step.   
 
4.2.3.2 1,3-Dihydroxypropan-2-yl α-ᴅ-ribofuranoside (3) 
 
1,2-cis Selective glycosylation of 1,3-di-O-benzyl glycerol (13) was performed using 2,3,5-tri-
O-benzyl-β-ᴅ-ribofuranosyl fluoride (27) as the donor (Scheme 4.8).  SnCl2 was used as a 
promotor due to the high affinity of the tin-fluorine bond, and trityl perchlorate was also 
used as a Lewis acid additive to try to increase 1,2-cis selectivity.22  It was found however 
that for this glycosylation trityl perchlorate made a negligible difference to the 
stereochemical outcome of glycosylation, with an α/β ratio of 1.3:1 as judged by integration 
of the 1H NMR H-1’ signals.   
 
Scheme 4.8 – The chemical synthesis of 1,3-dihydroxypropan-2-yl α-ᴅ-ribofuranoside. (3)  i) SnCl2, 
Ph3C+ClO4-, Et2O. ii) H2, 10% Pd/C, MeOH/EtOH (5:1) 
 
The stereochemistry of the glycosidic linkages was determined by comparison with literature 
NMR values of ribofuranosides, with α-ribosides having J1,2 couplings of 3-5 Hz and C-1’ 
values of 96-102 ppm; β-ribosides having J1,2 couplings of 0-2.8 Hz and C-1’ values of 100-107 
ppm.22  In the case of a mixture of ribofuranoside anomers, HSQC NMR along with 1H NMR J 
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couplings can be an expedient way to quickly determine which isomer is which, as shown in 
Figure 4.9.   
  
Figure 4.9 - HSQCed NMR spectrum of a crude mixture containing 1,3-bis(benzyloxy)propan-2-yl 2,3,5-
tri-O-benzyl-α/β-ᴅ-ribofuranosides (3,36)  
 
1,3-Bis(benzyloxy)propan-2-yl 2,3,5-tri-O-benzyl-α-ᴅ-ribofuranoside (35) was isolated by 
normal phase chromatography and the 1,2-cis stereochemistry at the α-anomeric position 
confirmed by the H-1’ signal at 5.38 ppm as a doublet with a J1,2 coupling value of 4.3 Hz.  
Further confirmation of the anomeric stereochemistry was obtained by running a NOESY 
NMR which showed long range interactions between the H-1’α, H-2’α and H-3’α protons, but 
no long-range nOe interactions for the H-1’β proton.  By contrast the 1,2-trans β-anomer 
showed a H-1’ signal in the 1H NMR at 5.30 ppm as a singlet; the 13C NMR showed a C1’ signal 
at 104.9 ppm. 
The benzyl ether protecting groups were removed by hydrogenation of (35) over a Pd/C 
catalyst in AcOH.  The H-1’ signal after hydrogenation appeared as a singlet at 5.07 ppm and 
the C-1’ signal at 106.5 ppm.  These signals were characteristic of a 1,2-trans furanose (36), 
which suggested that anomerisation had occurred during the hydrogenation.22  Acetic acid 
had been used as the solvent as it is able to dissolve both the protected and deprotected 
products.  However this may have caused acid catalysed anomerisation via the pathway 
shown in Scheme 4.9.4  Kennedy et al.4 have shown that protonation of the ring oxygen leads 
to structural changes in the furanose ring, one of which is a significant change in the length 
of the C1-O5 bond which breaks during ring opening.  The energy barriers between 
conformers of furanose rings are much smaller than those for pyranoses.  Therefore 
1’α 
1’β 
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protonation of the ring oxygen in furanoses is able to bring about larger conformational 
changes than might be the case with pyranoses.  The authors explained that protonation of 
the ring oxygen “enhances ring-opening by inducing structural changes in the furanose ring 
that move the reactant closer to the transition states” than the original reactants.4  As the 
mechanism of inversion at the anomeric position is at equilibrium it would make sense that 
the equilibrium lies in favour of the thermodynamic product.  Dubois et al.26 have suggested 
that this may be due to the flexibility in furanose rings allows the best overlap of the endo 
oxygen lone pair and the C1-O1 σ* orbital when the anomeric substituent is in the axial 
position. 
 
Scheme 4.9 – A proposed mechanism for the inversion of stereochemistry at the anomeric position 
under acidic conditions; protonation of the ring oxygen lengthens the C1-O5 bond and brings about a 
conformation change in the furanose ring that brings the reactant state closer to the transition states.4 
 
The hydrogenation was repeated in a mixture of MeOH/EtOH (5:1) to give 1,3-
dihydroxypropan-2-yl α-ᴅ-ribofuranoside (3).  Following reports by Filippov et al.27  we were 
keen to check that hydrogenation had not caused an intramolecular side reaction forming 
anhydro ribfuranose and glycerol. Fortunately, there was no NMR or mass spectrometry 
evidence for this happening. 
The 1H NMR signals of 3 were not particularly well resolved after deprotection, but the 
HSQCed NMR (Appendices, Figure 6.4) gave much more information, and coupled with COSY 
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NMR it was possible to fully assign the 13C NMR spectrum as well as gain more insight about 
which regions of the 1H NMR correlated with which protons on the compound. 
 
4.2.3.3 1,3-Dihydroxypropan-2-yl α-ʟ-xylofuranoside (4) 
1,3-Bis(benzyloxy)propan-2-yl 2,3,5-tri-O-benzyl-α-ʟ-xylofuranoside (37) was synthesised by 
using 2,3,5-tri-O-α,β ᴅ-xylofuranosyl fluoride (30/31) to glycosylate 1,3-di-O-benzyl glycerol 
(13) (Scheme 4.10).  Glycosylation was promoted using SnCl2 and gave a mixture of α/β 1.0 : 
0.8.  The mixture of anomers proved to be challenging to separate but after several rounds 
of FCC there was enough of each anomer isolated for full characterisation.  The anomers 
were identified by 13C and 1H NMR, with the 1,2-cis α-anomer (37) giving an H-1’ signal at 
5.35 ppm as a characteristic doublet showing a J1’,2’ coupling value of 4.3 ppm; by contrast 
the 1,2-trans β-anomer gave an H-1’ signal at 5.31 ppm with a lower J1’,2’ coupling value of 
1.9 Hz.  As expected the 1,2-cis anomer (37) gave a lower C-1’ shift at 99.9 ppm compared 
with the higher 1,2-trans C-1’ shift at 107.1 ppm.22    
 
 
Scheme 4.10 – The chemical synthesis of 1,3-dihydroxypropan-2-yl α-ʟ-xylofuranoside (4).  i) SnCl2, 
Et2O. ii) H2, Pd(OH)2/C, MeOH/EtOAc (9:1). 
 
The desired 1,2-cis α-anomer (37) was debenzylated by hydrogenation but this time over a 
20% Pd(OH)2/C catalyst to try and avoid isomerisation at the anomeric position as seen with 
ribose, to give 1,3-dihydroxypropan-2-yl-α-ʟ-xylofuranoside (4).  The 1,2-cis stereochemistry 
of the deprotected compound gave an anomeric H-1’ signal at 5.09 ppm as a characteristic 
doublet with a J1’,2’ coupling value of 4.4 Hz and a C1’ signal at 101.3 ppm.  There was an 
overlap of the H-2a,2b and H-5’ signals in the 1H NMR, but by using HSQCed (Appendices, 
Figure 6.5) and COSY spectra it was possible to assign all peaks in the 13C NMR.  As further 
confirmation of the stereochemistry at the anomeric position a NOSEY NMR spectrum was 
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recorded which showed long range coupling between H-1’ and H-2’ & H-5’ but not between 
H-3’ & H-4’ (Figure 4.10). 
 
Figure 4.10 – NOESY 2D NMR spectrum of 1,3-dihydroxypropan-2-yl α-ʟ-xylofuranoside (5).  The cross-
peaks (1’,2’) and (1’,5’), reinforced by the lack of a cross-peak (1’,3’) or (1’,4’) confirm the 1,2-cis 
stereochemistry at the anomeric position. 
 
4.2.3.4 1,3-Dihydroxypropan-2-yl β-ᴅ-arabinofuranoside (5) 
2,3,5-Tri-O-benzyl-α,β ᴅ-arabinofuranosyl fluoride (33/34) was used as a glycosyl fluoride 
donor to glycosylate 1,3-di-O-benzyl glycerol (13), using SnCl2 was used as a promotor.  Shoda 
et al.22 included an example in their paper ‘Stereoselective synthesis of 1,2-cis-
glycofuranosides using glycofuranosyl fluorides’ using 2,3,5-tri-O-benzyl-ʟ-arabinofuranosyl 
fluoride as an example, and showed that they obtained very good 1,2-cis selectivity without 
the addition of trityl perchlorate.  It was therefore decided to try the glycosylation without 
trityl perchlorate, which gave a α/β ratio of 1:2.2 as judged by integration of the H-1’ NMR 
signals.  The 1,2-cis β-anomer (38) was identified by the C-1’ signal at 100.8 ppm and the H-
1’ signal at 5.32 ppm as a characteristic doublet with a J1’,2’ coupling value of 4.4 Hz.  By 
contrast the 1,2-trans α-anomer gave a higher C-1’ signal at 106.1 ppm and the H-1’ signal at 
4.08 ppm as a broad singlet.  The anomers had very similar Rf values and so several rounds 
of FCC were required to separate enough of each for characterisation from the crude 
glycosylation mixture.  The desired 1,2-cis β-anomer was subject to debenylation by 
hydrogenation over Pd/C catalyst to give 1,3-dihydroxypropan-2-yl β-ᴅ-arabinofuranoside 
(5).   
1’        CD3OD       3’,4’    2’ 2,1,3,5’  
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Scheme 4.11 – The chemical synthesis of 1,3-dihydroxypropan-2-yl β-ᴅ-arabinofuranoside (5).  i) SnCl2, 
Et2O. ii) H2, 10% Pd/C, MeOH:EtOAc (9:1).  * Note due to the difficulty in separating the anomers, once 
a useable amount of (38) had been isolated (560 mg, 37%) no further rounds of FCC purification were 
performed.  Therefore, not all material was recovered and so a yield is not given. 
 
As expected, there was a lot of overlap of proton signals in the 1H NMR, and as such the 
HSQCed NMR spectrum (Appendices, Figure 6.6) is much more informative, and by 
combining the HSQCed with COSY NMR it was possible to completely assign the 13C NMR 
spectrum. 
A NOESY NMR spectrum was also run (Figure 4.11) which showed long range coupling 
between H-1’ and H-2’ & H-4’ but not between H-1’ and H-3’, which confirmed the presence 
of the 1,2-cis isomer. 
 
Figure 4.11 - NOESY 2D NMR spectrum of 1,3-dihydroxypropan-2-yl β-ᴅ-arabinofuranoside (5).  The 
cross-peaks (1’,2’) and (1’,4’), reinforced by the lack of a cross-peak (1’,3’) confirm the stereochemistry 
as 1,2-cis (β-ᴅ-arabinofuranoside) 
 
1’    CD3OD              3’        2’        1,4’,2,5,3  
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4.2.4 Synthesis of 1,2-cis glyceryl pyranoside fragments 
Ethereal solvents have been shown to promote 1,2-cis axial glycosylation, with diethyl ether 
giving predominantly (but not exclusively) the equatorial intermediate as shown in Scheme 
4.12.28.  By contrast, acetonitrile forms an nitrilium intermediate species which due to 
stabilisation by the anomeric effect sits in exclusively the axial position; this leads to 
exclusively top side attack of the sugar.28 
 
 
Scheme 4.12 – Solvent effect on glycosylation using pyranoses with non-participating protecting 
groups.  Ethereal solvents sit equatorial to the intermediate directing attack from the bottom face of 
the sugar, whilst acetonitrile forms a 1,2-cis nitrilium species which directs attack from the top face.28  
 
1,3-Dihydroxypropan-2-yl α-ᴅ-galactopyranoside (7) 
The newly reported toxin prymnesin-B1 has been shown to be glycosylated with α-ᴅ-
galactopyranose.2  Although published recently, it was decided prudent to synthesise a 
glycerol inspired toxin fragment to add to the library of glyceryl glycoside compounds.  The 
synthesis of 1,3-dihydroxypropan-2-yl α-ᴅ-galactopyranoside (7) has been reported in two 
previous papers, and is better known as fluoridoside.7,9   
The key literature glycosylation steps are shown in Scheme 4.13, where Linhardt et al.9 
choose to use a thioglycoside donor (39) which afforded them good stereochemical control 
at the anomeric position, especially when employing a mixture of dioxane and toluene as 
solvents.  By contrast Boisset et al.8 used a glycosyl imidate (41) as the sugar donor and cis-
1,3-benzylidenglycerol (9) as the acceptor (Scheme 4.13).  However, we have experienced 
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problems using (9) in other glycosylations (see 4.2.1), which were attributed to the low 
reactivity of the axial OH group.  We therefore decided to try using an amalgamation of both 
glycosylations, using 1,3-di-O-benzyl glycerol (13) as the acceptor and 41 as the donor to try 
and improve on the stereocontrol at the anomeric position. 
 
 
Scheme 4.13 – A comparison of the published literature glycosylation steps in the synthesis of 
floridoside.  Linhardt et al.9 relied on a thiol donor with NIS/TMSOTf promoted glycosylation which 
gave much better stereocontrol then Boisset et al.8 who employed an imidate glycosyl donor with 
TMSOTf promoted glycosylation of cis-1,3-O-benzylidene glycerol (13). 
 
In keeping with previous methodology in this work, 1,3-dibenzyl glycerol (13) was used as 
the acceptor.  This would allow access to the target compound in a single deprotection step 
(Scheme 4.14).  Tetra-O-benzyl-α-ᴅ-galactopyranosyl trichloroacetimidate (41) was selected 
as the glycosyl donor, and the glycosylation promoted with TMSOTf.29  A mixture of toluene 
and diethyl ether was selected as the solvent system.  The yield was low, probably due to 
moisture in the solvents but the stereocontrol was excellent and the 1,2-cis α anomer (40) 
was easily separated from the crude reaction mixture, with the H-1’ anomeric signal at 4.11 
ppm having a slightly high J1’,2’ coupling value of 5.2 Hz, which might be attributed to some 
distortion of the sugar ring by the large benzyl ether protecting groups on the molecule.  
Debenzylation was carried out in a single step by hydrogenation over a Pd/C catalyst to give 
1,3-dihydroxypropan-2-yl α-ᴅ-galactopyranoside (7), which without the benzyl protecting 
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groups gave an H-1’ signal at 5.02 ppm with a J1’,2’ coupling value of 3.8 Hz which is reasonable 
for a 1,2-cis orientated glyosidic bond.  Both the 1H and 13C NMR were in agreement with the 
published literature values.8,9 
 
Scheme 4.14 – The chemical synthesis of 1,3-dihydroxypropan-2-yl α-ᴅ-galactopyranoside (7).  i) 
CCl3CN, DBU, DCM, 0 °C to r.t. ii) TMSOTf, toluene/Et2O (4:1), 0 °C to r.t. iii) H2, 10% Pd/C, MeOH. 
 
4.3 Comparison of synthetic glyceryl glycoside fragments with 
literature toxin NMR values 
The 1H and 13C NMR values for the 2° position on glycerol (H-2 and C2) for the glycosylated 
fragments were compared with literature values for the corresponding signals from the 
prymnesins (Chart 4.1, Table 2 Supporting Information).  For the synthetic glyceryl glycoside 
fragments, in many cases the H-2 signal was part of a larger multiplet of peaks in the 1D 1H 
NMR spectrum, and so a more accurate H-2 shift was extracted from the HSQCed spectrum 
instead.  For PRM-1 and PRM-2, the literature NMR values were obtained using a mixture of 
CD3OD/C5D5N 1:1, with the machine locked onto d4-methanol as the reference solvent.1  It is 
immediately obvious that there are large differences in the literature and the synthetic 
glyceryl glycoside fragment 13C NMR values for α-ʟ-Xylf (4) and α-ᴅ-Ribf (3).  Interestingly 
these are both 1,2-cis anomeric linkages to the backbone.  By comparison the difference 
between the 13C NMR values of the toxin backbone and analogous 2° position on the glyceryl 
glycoside fragments for α-ʟ-Arap (2) and β-ᴅ-Galf (1) is much smaller.  These two species 
have a 1,2-trans configuration with regards to the anomeric position.  Regarding the new 
carbohydrate assignment of β-ᴅ-Araf on PRM-2 by Rasmussen et al.2 the 1H and 13C NMR 
shifts for our synthetic β-ᴅ-Araf (6) and α-ʟ-Xylf (4) glycerol fragment (6) were compared with 
the literature NMR shifts for the carbohydrate on PRM-2.  It was noted that the NMR shifts 
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for our synthetic β-ᴅ-Araf glycerol fragment (6) were closer to the literature NMR shifts for 
the carbohydrate in PRM-2 than for the α-ʟ-Xylf glycerol fragment (4).  However, there is still 
a large difference between the 2° position on glycerol (H-2 and C2) and H-77/C77 values for 
PRM-2 when compared to either fragment (6) or fragment (4). 
 
Chart 4.1 - Comparing the literature NMR values 2° position on the glyceryl glycosides with 
the analogous glycosylated parts of prymnesin toxins.  Raw data and solvent conditions are 
shown in Appendices, Table 6.2. 
 
 
4.4 Summary 
A library of glyceryl glycoside fragments inspired by the published prymnesin toxins has been 
synthesised.  The 1,2-trans glyceryl pyranoside fragments (α-ʟ-Arap (2), α-ᴅ-Arap (6)) were 
synthesised using Koenigs-Knorr methodology, with excellent stereocontrol at the anomeric 
position.12  The 1,2-trans glyceryl furanoside fragment (β-ᴅ-Galf (1)) was synthesised using 
SnCl4 promoted glycosylation, again with excellent stereocontrol.  1,2-cis Glyceryl furanoside 
fragments (α-ᴅ-Ribf (3), α-ʟ-Xylf (4), β-ᴅ-Araf (5)) were synthesised from the corresponding 
glycofuranosyl fluoride donor, with moderate stereoselectivity.  By contrast the 1,2-cis 
glyceryl pyranoside fragment (α-ᴅ-Galp (7)) was synthesised from the corresponding glycosyl 
imidate with excellent stereocontrol, which may be attributed to the anomeric effect leading 
to formation of the thermodynamic product.  Removal of ester protecting groups was 
relatively straight forward, and in the case of benozyl protecting groups any benzoic acid by-
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product from hydrolysis was easily removed using Dowex® 1X2-400 hydroxide form anion 
exchange resin.  Removal of benzyl groups by hydrogenation was problematical; in the case 
of 1,3-bis(benzyloxy)propan-2-yl 2,3,5-tri-O-benzyl-α-ᴅ-ribofuranoside (3) a change of 
solvent was required to prevent isomerisation at the anomeric position.  Some 
hydrogenation yields were also low, albeit with no by-products seen by NMR of mass-
spectrometry, which suggested particularly strong adsorption of the deprotected 
compounds onto the hydrogenation catalyst. 
Comparison of the 13C and 1H NMR shifts between the synthetic glyceryl glycoside fragments 
and the carbohydrate NMR shifts reported by Igarashi et al.1,3 showed that the synthetic 
fragments with a 1,2-trans configuration with respect to the anomeric position had NMR 
shifts that were much closer to those reported for carbohydrates on the prymnesin toxins.  
By contrast, fragments with a 1,2-cis orientation with respect to the anomeric position 
deviated in their NMR chemical shifts at the anomeric position when compared with the 
values published by Igarashi et al.1  It was also noted that some ambiguity about the 
carbohydrate present on PRM-2 had been caused by Rasmussen et al.2 who had drawn the 
toxin as being glycosylated with β-ᴅ-Araf, rather than α-ʟ-Xylf as reported by Igarashi et al.3  
Comparison of the anomeric chemical shifts for the anomeric positions of the glyceryl 
glycoside fragments β-ᴅ-Araf (6) and α-ʟ-Xylf (4) were compared with the published shifts for 
the carbohydrate on PRM-2 by Igarashi et al.1 and it was found that the literature chemical 
shifts were closer to those of the β-ᴅ-Araf glyceryl glycoside fragment (6). 
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4.5 Experimental 
2-Phenyl-1,3-dioxan-5-one (10)15 
 
cis-1,3-O-Benzylideneglycerol (600 mg, 3.3 mmol) and Dess-Martin periodinane (2.1 g, 5.0 
mmol) were dissolved into DCM (50 mL) and stirred overnight at room temperature.  TLC 
(hexane/EtOAc 1:1) showed complete consumption of the alcohol and the reaction mixture 
was quenched with a mixture of aqueous Na2S2O5/NaHCO3 solution (1:1, 40 mL).  The organic 
layer was separated and the aqueous layer was washed with Et2O (3 × 20 mL).  The organic 
layers were combined and dried over MgSO4, before being filtered and dried in vacuo to give 
2-phenyl-1,3-dioxan-5-one (10) (580 mg, 98%) as a yellow oil; Rf 0.40 (hexane/EtOAc 1:1); 
δH(400 MHz; CDCl3) 7.54-7.52 (m ,2H, Ar), 7.43-7.38 (m, 3H, Ar), 5.89 (s, 1H, H-2), 4.53 (d, 
J1a,1b =  J3a,3b = 18.0 Hz, 2H, H-1a,3a), 4.46 (d, J1a,1b =  J3a,3b = 18.0 Hz, 2H, H-1b,3b); δC(100 MHz; 
CDCl3) 204.2 (C=O), 136.8, 129.4, 128.5, 126.1 (6 × Ar), 99.0 (C2), 72.4 (C1,C3).  1H and 13C 
NMR values were in agreement with literature values.15 
 
Trans-1,3-O-benzylidene glycerol (11)15 
 
2-Phenyl-1,3-dioxan-5-one (10) (580 mg, 3.3 mmol) was dissolved into a mixture of THF/H2O 
(3:1, 40 mL) and cooled in an ice bath.  Sodium borohydride (250 mg, 6.6 mmol) was added 
in a single portion and the reaction mixture was stirred for 30 minutes.  The reaction mixture 
was then allowed to warm to room temperature before being washed with Et2O (5 × 10 mL).  
The organic layers were combined and dried over MgSO4, before being filtered and dried in 
vacuo to give trans-1,3-O-benzylidene glycerol (11) (560 mg, 96%) as a colourless oil; Rf 0.59 
(hexane/EtOAc 1:1); δH(400 MHz; CDCl3) 7.48-7.45 (m, 2H, Ar), 7.39-7.34 (m, 3H, Ar), 5.41 (s, 
1H, H-4), 4.28 (dd, J1a,1b = 11.2 Hz, J1a,5 = 5.0 Hz, 1H, H-1a), 4.28 (dd, J3a,3b = 11.2 Hz, J3a,5 = 5.0 
Hz, 1H, H-3a), 3.99-3.90 (m, 1H, H-2), 3.76-3.73 (m, 1H, OH), 3.58 (dd, J1a,1b = 11.2 Hz, J1a,5 = 
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9.8 Hz, 1H, H-1b), 3.55 (dd, J1a,1b = 11.2 Hz, J1a,5 = 9.8 Hz, 1H, H-1b); δC(100 MHz; CDCl3) 137.5 
(C5), 129.1 (C8), 128.4 (C6), 126.1 (C7), 101.0 (C4), 71.7 (C1, C3), 61.3 (C2).  The 1H and 13C 
NMR values were in agreement with literature values.15 
 
1,3-Bis(benzyloxy)propan-2-yl 2’,3’,5’,6’-tetra-O-acetyl-β-ᴅ-glucopyranoside (14)6 
 
2,3,4,6-Tetra-O-acetyl-α-ᴅ-glucopyranosyl bromide (12) (200 mg, 0.5 mmol) and 1,3-O-di-
benzyl-glycerol (13) (250µL, 1.0 mmol) were dissolved into dry DCM (5 mL).  Silver carbonate 
(200 mg, 0.75 mmol) was added in a single portion and the reaction mixture was stirred 
overnight.  TLC showed consumption of the glyosyl bromide donor (Rf 0.42 (hexane/EtOAc 
8:2)).  The reaction mixture was filtered and the solvent removed under reduced pressure.  
Purification by FCC gave the title compound (14) (210 mg, 70%) as a white powder; Rf 0.22 
(hexane/EtOAc 8:2); [α]D -4.7 (c 1.0, CHCl3) (lit.6 -5.0 (c 1.0, CHCl3); δH(400 MHz; CDCl3) 7.37-
7.26 (m, 10H, Ar), 5.20 (dd, J2’,3’ = 10.0 Hz, J3’,4’ = 10.0 Hz, 1H, H-3’), 5.07 (dd, J3’,4’ = 10.0 Hz, 
J4’,5’ = 10.0 Hz, 1H, H-4’), 5.00 (dd, J1’,2’ = 8.1 Hz, J2’,3’ = 10.0 Hz, 1H, H-2’), 4.80 (d, J1’,2’ = 8.1 Hz, 
1H, H-1’), 4.52 (s, 2H, PhCH2), 4.51 (s, 2H, PhCH2), 4.21 (dd, J5’,6’a = 4.8 Hz, J6’a,6’b = 12.2 Hz, 1H, 
H-6’a), 4.08 (dd, J5’,6’b = 2.4 Hz, J6’a,6’b = 12.2 Hz, 1H, H-6’b), 4.05-4.03 (m, 1H, H-2), 3.69-3.61 
(m, 3H, H-1,5’), 3.52-3.50 (m, 2H, H-3), 2.04 (s, 3H, Ac),  2.01 (s, 3H, Ac),  2.00 (s, 3H, Ac),  1.93 
(s, 3H, Ac); δC(100 MHz; CDCl3) 170.6, 170.3, 169.4, 169.4 (4 × C=O), 138.2, 138.0, 128.4, 
128.4, 127.7, 127.6, 127.6, 127.6 (Ar), 100.8 (C1’), 78.4 (C2), 73.5 (CH2Ph), 73.4 (CH2Ph), 72.9 
(C3’), 71.7 (C1), 71.5 (C3), 71.0 (C5’), 70.1 (C2’), 68.5 (C4’), 62.0 (C6’), 20.7, 20.6, 20.6, 20.6 
(4 × Me).  NMR were in agreement with literature values.6 
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1,3-Bis(benzyloxy)propan-2-yl 2’,3’,5’,6’-tetra-O-benzoyl-β-ᴅ-galactofuranoside (14) 
 
A solution of per-O-benzoyl-β-ᴅ-galactofuranose (15) (250 mg, 0.36 mmol) dissolved in DCM 
(4 mL) was cooled in an ice bath.  SnCl4 solution (1M in DCM, 400 µL, 0.4 mmol) was slowly 
added by syringe.  After 15 minutes at 0 °C 1,3-O-di-benzyl-glycerol (13) (80 µL, 0.32 mmol) 
was added by syringe and the mixture was allowed to warm and was stirred for 18 hours at 
room temperature after which TLC analysis (hexane/EtOAc 7:3) showed consumption of 15.  
The mixture was diluted with DCM (30 mL) and washed with sat. aqueous NaHCO3 (2 × 10 
mL).  The organic layers were combined, dried over MgSO4, filtered and dried in vacuo to 
give a crude residue which was purified by FCC to give the title compound (14) (120 mg, 39%) 
as a colourless oil; Rf 0.61 (hexane/EtOAc 7:3); [α]D -1.2 (c 1.0, CHCl3); δH(400 MHz; CDCl3) 
8.07-8.04 (m, 2H, Bz), 7.97-7.95 (m, 1H, Bz), 7.90-7.88 (m, 1H, Bz), 7.57-7.20 (m, 25H, Ar), 
6.03-5.99 (m, 1H, H-5’), 5.61 (s, 1H, H-1’), 5.59 (d, J3’,4’ = 5.4 Hz, 1H, H-3’), 5.55 (s, 1H, H-2’), 
4.75 (dd, J3’,4’ = 5.4 Hz, J4’,5’ = 3.4 Hz, 1H, H-4’), 4.73 (dd, J5’,6’a = 7.7 Hz, 2J6’a,6’b = 12.0 Hz, 1H, H-
6’a), 4.58-4.52 (m, 3H, H-6’b, PhCH2,), 4.51 (d, 2J = 11.9 Hz, PhCHH), 4.45 (d, 2J = 11.9 Hz, 
PhCHH), 4.25-4.20 (m, 1H, H-2), 3.71-3.67 (m, 2H, H-1), 3,62 (d, J2.3 = 5.3 Hz, 2H, H-3); δC(100 
MHz; CDCl3) 166.1, 165.8, 165.7, 165.4 (4 × C=O), 138.2, 138.1, 133.4, 133.3, 133.2, 133.0, 
130.0, 129.9, 129.8, 129.7, 129.6, 129.2, 129.1, 128.4, 128.4, 128.3, 127.7, 127.6 (Ar), 105.0 
(C1’), 82.1 (C2’), 81.4 (C4’), 77.8 (C3’), 74.6 (C2), 73.5, 73.5 (2 × PhCH2), 70.6 (C1), 70.3 (C5’), 
70.2 (C3), 63.9 (C6’); HRMS (ESI+) m/z calc. for C51H46O12Na+ 873.2887 ([M+Na]+)  found 
873.2875 [M+Na]+. 
 
1,3-Dihydroxypropan-2-yl 2,3,5,6-tetra-O-benzoyl-β-ᴅ-galactofuranoside (17) 
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To a solution of 1,3-bis(benzyloxy)propan-2-yl 2,3,5,6-tetra-O-benzoyl-β-ᴅ-
galactofuranoside (15) (115 mg, 140 µmol) in EtOAc/EtOH (10:1) (20 mL) was added activated 
10% palladium on charcoal (10 mg).  The system was flushed with N2 (×3) followed by H2 (×3) 
and stirred overnight at room temperature.  After the system had been flushed with N2 (×3) 
the catalyst was filtered off and the solvent remove under reduced pressure to give the title 
compound (17) (60 mg, 64%) as a colourless oil; Rf 0.18 (hexane/EtOAc 1:1);  [α]D = -1.1 (c 
1.0, CHCl3); δH(400 MHz; CDCl3) 8.09-8.06 (m, 2H, Ar), 8.02-7.97 (m, 4H, Ar), 7.93-7.90 (m, 
2H, Ar), 7.59-7.51 (m 4H, Ar), 7.49-7.30 (m, 8H, Ar), 6.00-5.96 (m 1H, H-5’), 5.73 (dd, J2’,3’ = 
2.1 Hz, J3’,4’ = 5.7 Hz, 1H, H-3’), 5.52 (s, 1H, H-1’), 5.49 (d, J2’,3’ = 2.1 Hz, 1H, H-2’), 4.85 (dd, J3’,4’ 
= 5.7 Hz, J4’,5’ = 3.8 Hz, 1H, H-4’), 4.79 (dd, J5’,6’a = 4.6 Hz, 2J6’a,6’b = 11.8 Hz, 1H, H-6’a), 4.72 (dd, 
J5’,6’b = 6.6 Hz, 2J6’a,6’b = 11.8 Hz, 1H, H-6’b), 3.94-3.89 (m, 1H, H-2), 3.78-3.72 (m 4H, H-2,3), 
2.56 (bs, 1H, OH), 2.47 (bs, 1H, OH) ; δC(100 MHz; CDCl3) 166.2, 166.2, 165.7, 165.6 (4 × C=O), 
133.7, 133.7, 133.4, 133.2, 130.0, 129.9, 129.8, 129.5, 129.3, 128.8, 128.6, 128.5, 128.5, 
128.4 (Ar), 106.5 (C1’), 83.3 (C2’), 81.1 (C4’), 80.8 (C2), 77.3 (C3’), 70.3 (C5’), 63.1 (C1), 63.1 
(C6’), 62.4 (C3); HRMS (ESI+) m/z calc. for C37H34O12Na+ 693.1948 ([M+Na]+) found 693.1956 
[M+Na]+. 
 
1,3-Dihydroxypropan-2-yl β-ᴅ-galactofuranoside (1) 
 
1,3-Dihydroxypropan-2-yl 2,3,5,6-tetra-O-benzoyl-β-ᴅ-galactofuranoside (17) (55 mg, 82 
µmol) was dissolved into a solution of MeOH/H2O/NEt3 (5:2:1, 8 mL) and stirred vigorously 
for 18h at room temperature.  The solvent was removed in vaccuo and the crude mixture 
was dissolved in MeOH (5 mL) and passed through Dowex® 1X2-400 hydroxide form ion 
exchange resin (1 g).  The eluted compound was dried in vacuo to give the title compound 
(1) (7 mg, 51%) as a colourless oil; Rf 0.06 (tol/MeOH, 8:2); [α]D -144 (c 0.5, MeOH); δH(400 
MHz; MeOH); 4.99 (d, J1’,2’ = 1.7 Hz, 1H, H-1’), 3.93-3.92 (m, 2H, H-3’,4’), 3.90 (dd, J1’,2’ = 1.7 
Hz, J2’,3’ = 4.0 Hz, 1H, H-2’), 3.65-3.58 (m, 2H, H-5’,2), 3.56-3.48 (6H, H-1,3,6’a,6’b); δC(100 
MHz; MeOH) 107.8 (C1’), 83.4 (C3’), 81.6 (C2’), 78.8 (C2), 77.3 (C4’), 71.0 (C5’), 63.0 (C6’), 
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61.9 (C1), 61.1 (C3); HRMS (ESI+) calc. for C9H18O8Na+ 277.0899 ([M+Na]+) found 277.0895 
[M+Na]+. 
 
per-O-benzoyl-β-ʟ-arabinopyranose (18)20 
 
A solution of ʟ-arabinose (1.0 g, 6.7 mmol) and DMAP (1 mol %) in dry pyridine (15 mL) was 
cooled in an ice bath and benzoyl chloride (5.0 mL, 43 mmol) was added dropwise over 30 
minutes. The reaction was allowed to warm and stirred overnight at room temperature.  The 
solvent was removed in vacuo and the crude mixture was dissolved in EtOAc (20 mL) and 
washed with 1M HCl solution (3 × 5 mL) to remove any residual pyridine.  The organic layer 
was dried over MgSO4 and the solvent was removed under reduced pressure before the 
crude mixture was purified by FCC to give the title compound (18) (3.40 g, 90%) as a white 
foam, Rf 0.4 (hexane/EtOAc 3:1); [α]D +301 (c 1.0, CHCl3) (lit.20 +291.2 (c 0.1, CHCl3)); δH(400 
MHz; CDCl3) 8.14-8.12 (m, 4H, Ar), 7.90-7.87 (m, 4H, Ar), 7.65-7.61 (m, 2H, Ar), 7.55-7.45 (m, 
6H, Ar), 7.32-7.28 (m, 4H, Ar), 6.87 (bs, 1H, H-1), 6.07-6.06 (2H, m, H-2,3), 5.91-5.89 (m, 1H, 
H-4), 4.42 (dd, J4,5a = 1.0 Hz, 2J5a,5b = 13.5 Hz, 1H, H-5a), 4.18 (dd, J4,5b = 2.1 Hz, 2J5a,5b = 13.5 
Hz); δC(100 MHz; CDCl3) 165.8, 165.7, 165.6, 164.7 (4 × C=O), 133.8, 133.6, 133.5, 133.4, 
129.9, 129.8, 129.4, 129.1, 128.9, 128.8, 128.8, 128.6, 128.4, 128.4 (Ar), 91.1 (C1), 69.5 (C4), 
68.2 (C3), 67.8 (C2), 63.0 (C5).  1H and 13C NMR values were in agreement with literature 
values20 
 
2,3,4-Tri-O-benzoyl-β-ʟ-arabinopyranosyl bromide30 
 
Per-O-benzoyl-β-ʟ-arabinopyranose (18) (2.4 g, 4.2 mmol) was dissolved into dry DCM (10 
mL) under N2.  A solution of 33% HBr in AcOH (2.5 mL) was added in a single portion and the 
reaction mixture stirred for 3 hours at room temperature after which time TLC showed 
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consumption of the start material.  The solvent was removed under reduced pressure and 
the reaction mixture was re-dissolved into EtOAc (10 mL) before being washed with ice cold 
saturated NaHCO3 (3 × 3 mL).  The organic layer was dried over MgSO4 and the solvent 
removed under reduced pressure to give the title compound (19) (2.1 g, 95%) as an oil which 
was immediately used in the next step, Rf 0.42 (hexane/EtOAc 3:1); δH(400 MHz; CDCl3) 8.11-
8.08 (m, 1H, Ar), 8.03-8.01 (m, 1H, Ar), 7.87-7.85 (m, 1H, Ar), 7.63-7.30 (m, 9H, Ar), 6.94 (d, 
J1,2 = 3.9 Hz, 1H, H-1), 6.00 (dd, J2,3 = 10.5 Hz, J3,4 = 3.9 Hz, 1H, H-3), 5.84-5.83 (m, 1H, H-4), 
5.71 (dd, J1,2 = 3.9 Hz, J2,3 = 10.5 Hz, 1H, H-2), 4.47 (dm, 2J5a,5b = 12.9 Hz, 1H, H-5a), 4.23 (dd, 
J4,5b = 1.9 Hz, 2J5a,5b = 12.9 Hz, 1H, H-5b); δH(100 MHz; CDCl3) 165.6, 165.6, 165.4 (3 × C=O), 
133.8, 133.7, 133.4, 130.0, 129.9, 129.8, 128.7, 128.6, 128.4 (12 × Ar) 89.8 (C1), 68.9 (C4), 
68.7 (C2), 65.0 (C3), 60.4 (C5).  The 1H NMR were in agreement with literature values.30 
 
1,3-Bis(benzyloxy)propan-2-yl 2,3,4-tri-O-benzoyl-α-ʟ-arabinopyranoside (20) 
 
2,3,4-Tri-O-benzoyl-β-ʟ-arabinopyranosyl bromide (19) (2.1 g, 4.0 mmol), was dried 
azeotropically with dry toluene (3 × 20 mL).  The glycosyl bromide (19) was then dissolved 
into dry toluene (10 mL) under N2 and 1,3-O-di-benzyl-glycerol (13) (0.9 mL, 3.8 mmol, 0.9 
eq), and Ag2CO3 (1.8 g, 6.4 mmol, 1.5 eq) were added.  The reaction was stirred at 55 °C under 
N2 for 4 hours after which time TLC (hex:EtOAc 3:1) showed complete consumption of the 
glycosyl bromide.  The reaction mixture was filtered and the solvent removed under reduced 
pressure.  Purification by FCC gave the title compound (20) (1.5 g, 50%) as a colourless oil, Rf 
0.48 (toluene/EtOAc 9:1); [α]D +94.4 (c 1.0, CHCl3); δH(400 MHz; CDCl3) 8.05-7.94 (m, 5H, Ar), 
7.58-7.17 (m, 20H, Ar), 5.71 (dd, J1’,2’ = 5.9 Hz, J2’,3’ = 8.3 Hz, 1H, H-2’), 5.67-5.65 (m, 1H, H-4’), 
5.60 (dd, J2’,3’ = 8.3 Hz, J3’,4’ = 3.5 Hz, 1H, H-3’), 5.06 (d, J1’,2’ = 5.9 Hz, 1H, H-1’), 4.35 (s, 2H, 
PhCH2), 4.37-4.32 (m, 3H, H-5a’, PhCH2), 4.15-4.12 (m, 1H, H-2), 3.82 (dd, J4’,5’ = 2.3 Hz, 2J5a’,5b’ 
= 12.6 Hz, 1H, H-5b’), 3.69 (dd, J1a,2 = 5.3 Hz, 2J1a,1b = 10.3 Hz, 1H, H-1a), 3.63-3.59 (m, 2H, H-
1b,3a), 3.50 (dd, J2,3b = 6.4 Hz, J3a,3b = 10.3 Hz, 1H, H-3b); δC(100 MHz; CDCl3); 165.7, 165.6, 
165.2 (3 × C=O), 138.2, 138.1, 133.4, 133.3, 129.9, 129.8, 129.5, 129.2, 128.5, 128.4, 128.3, 
127.7, 127.6, 127.5, 127.5 (Ar), 100.4 (C1’), 77.6 (C2), 73.4, 73.4 (2 × PhCH2), 70.8 (C1), 70.4 
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(C3’), 70.4 (C3), 70.2 (C2’), 68.3 (C4’), 62.0 (C5’); HRMS (ESI+) m/z calc. for C43H40O10Na+ 
739.2519 [M+Na]+ found 739.2513 [M+Na]+. 
 
1,3-Dihydroxypropan-2-yl 2,3,4-tri-O-benzoyl-α-ʟ-arabinopyranoside (21) 
 
To a solution of 1,3-bis(benzyloxy)propan-2-yl 2,3,4-tri-O-benzoyl-α-ʟ-arabinopyranoside 
(20) (1.50 g, 2.1 mmol) in EtOAc/EtOH 10:1 (50 mL) was added palladium on activated 
charcoal (10% Pd basis) (50 mg).  The system was flushed with N2 (×3) followed by H2 (×3) 
and stirred overnight at room temperature.  After the system had been flushed with N2 (×3) 
the catalyst was filtered off and the solvent removed under reduced pressure to give the title 
compound (21) (182 mg, 22%) as a white powder. Rf 0.21 (EtOAc/hexane 6:4); [α]D +261 (c 
1.0, CHCl3); δH(400 MHz; CDCl3) 8.10-8.08 (m, 2H, Ar), 8.01-7.99 (m, 2H, Ar), 7.89-7.87 (m, 
2H, Ar), 7.62-7.27 (m, 9H, Ar), 5.80 (dd, J1’,2’ = 7.3 Hz, J2’,3’ = 9.7 Hz, 1H, H-2’), 5.73-5.71 (m, 
1H, H-4’), 5.62 (dd, J2’,3’ = 9.7 Hz, J3’,4’ = 3.4 Hz, 1H, H-3’), 4.90 (d, J1’,2’ = 7.3 Hz, 1H, H-1’), 4.36 
(dd, J4’,5’a = 2.8 Hz, 2J5’a,5’b = 13.2 Hz, 1H, H-5’a), 3.96 (dd, J4’,5’b = 1.5 Hz, 2J5’a,5’b = 13.2 Hz, 1H, 
H-5’b), 3.86-3.83 (m, 1H, H-2), 3.69-3.67 (m, 2H, H-1), 3.58-3.55 (m, 2H, H-3), 2.85 (bs, 1H, 
OH),2.05 (bs, 1H, OH); δC(100 MHz; CDCl3) 165.7, 165.6, 165.6 (3 × C=O), 133.7, 133.6, 133.5, 
129.9, 129.8, 129.7, 129.3, 129.0, 128.9, 128.6, 128.6, 128.4, (12 × Ar), 102.0 (C1’), 83.9 (C2), 
71.0 (C3’), 70.4 (C2’), 68.7 (C4’), 64.0 (C5’), 62.7 (C1), 62.4 (C3); HRMS (ESI)+ calc. for 
C29H28O10Na+ 559.1580 [M+Na]+ found 559.1577 [M+Na]+. 
 
1,3-Dihydroxypropan-2-yl α-ʟ-arabinopyranoside (2) 
 
Sodium (20 mg) was added to dry methanol (18 mL) under N2.  After the cessation of 
effervescence 1,3-Dihydroxypropan-2-yl 2,3,4-tri-O-benzoyl-α-ʟ-arabinopyranoside (21) 
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(180 mg, 0.3 mmol) was added in dry MeOH (8 mL) and the mixture was vigorously stirred 
overnight at room temperature.  The reaction mixture was neutralised using Amberlite IR-
120 resin, filtered and the solvent removed under in vacuo.  The crude mixture was dissolved 
in H2O and passed through Dowex® 1X2-400 (OH- form) ion exchange resin (1 g) to give 1,3-
dihydroxypropan-2-yl α-ʟ-arabinopyranoside (2) (62 mg, 76%) as a colourless oil. [α]D + 6.8 (c 
1.0, H2O); δH(400 MHz; D2O) 4.35 (d, J1’,2’ = 7.5 Hz, 1H, H-1’), 3.83-3.78 (m, 2H, H-4’,5’a), 3.77-
3.73 (m, 1H, H-2), 3.65-3.62 (m, 6H, H-1,2,5’b,3’), 3.45 (dd, J1’,2’ = 7.5 Hz, J2’,3’ = 9.4 Hz, 1H, H-
2’); δH(100 MHz; D2O) 103.4 (C1’), 81.1 (C2), 72.9 (C3’), 71.3 (C2’), 68.4 (C4’), 66.2 (C5’), 61.4 
(C1), 61.0 (C3); HRMS (ESI+) m/z calc. for C8H16O7Na+ 247.0794 [M+Na]+ found 247.0798 
[M+Na]+. 
 
Per-O-acetyl-α/β-ᴅ-arabinopyranose (22)31 
 
ᴅ-Arabinose (1.0 g, 6.7 mmol) was suspended in acetic anhydride (20 mL) under a N2 
atmosphere, iodine (100 mg, 0.4 mmol) was added in a single portion and the reaction 
mixture was left to stir over night.  The reaction mixture was diluted with DCM (150 mL) and 
washed with saturated aqueous Na2S2O3 solution (3 × 15 mL) and saturated NaHCO3 solution 
(3 × 15 mL).  The organic layer separated and was dried over MgSO4, filtered and the solvent 
was removed under reduced pressure to give the title compound (22) as a yellow syrup (2.0 
g, 95%); Rf = 0.42 (Hexane/EtOAc 7:3);  δH(400 MHz; CDCl3) 6.88 (1H, d, J1,2 = 6.9 Hz, H-1α), 
6.35 (1H, d, J1,2 = 3.0 Hz, H-1β); δC(100 MHz; CDCl3) 90.2 (C1β), 85.7 (C1α).  1H and 13C NMR 
spectra are in good agreement with data extracted from spectra of an anomeric mixture.31 
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2,3,4-Tri-O-acetyl-β-ᴅ-arabinopyranosyl bromide (23)32 
 
Per-O-acetyl-ᴅ-arabinopyranose (22) (1.0 g, 3.1 mmol) was dissolved in DCM (10 mL) under 
a N2 atmosphere.  33% v/v HBr in AcOH (2 mL) was added in a single portion and the reaction 
mixture stirred at room temperature for 3 hours, after which time TLC showed consumption 
of the start material.  The reaction mixture was diluted with DCM (50 mL) and poured into 
ice cold saturated NaHCO3 solution (10 mL).  The organic layer was separated and further 
washed with saturated NaHCO3 solution (2 × 15 mL) before being dried over MgSO4. 
Following filtration, the solvent was removed under reduced pressure to give the title 
compound (23) as a yellow oil (1.0 g, 95%) which was immediately used in the next step; Rf 
0.50 (hexane/EtOAc 7:3); δH(400 MHz; CDCl3) 6.70 (d, J1,2 = 3.8 Hz, 1H, H-1’), 5.42-5.28 (m, 
2H, H-3,4), 5.11-5.07 (m, 1H, H-2), 4.12 (d, J5a,5b = 13.3 Hz, 1H, H-5a), 3.94 (dd, J4,5b = 1.7 Hz, 
J5a,5b = 13.3 Hz, 1H, H-5b), 2.16, 2.12, 2.03 (3 × OAc); δC(100 MHz; CDCl3) 170.0, 170.0, 169.8 
(3 × C=O), 89.7 (C1), 67.9 (C4), 67.8 (C2), 67.7 (C3), 64.7 (C5), 20.8, 20.7, 20.6 (3 × OAc).  The 
1H and 13C NMR were in agreement with literature values.32 
 
1,3-Bis(benzyloxy)propan-2-yl 2’,3’,4’-tri-O-acetyl-α-ᴅ-arabinopyranoside (24) 
 
Freshly prepared 4Å MS (2 g) were added to a solution of 2,3,4-tri-O-acetyl-α-ᴅ-
arabinopyranosyl bromide (24) (1.0 g, 2.9 mmol) and 1,3-di-O-benzyl glycerol (13) (740 µL, 
3.0 mmol) dissolved in DCE (20 mL) under a N2 atmosphere.  The mixture was stirred at room 
temperature for 30 minutes to ensure anhydrous conditions.  The reaction mixture was then 
cooled to 0 °C and AgOTf (1.1 g, 4.4 mmol) was added in a single portion.  The reaction 
mixture was allowed to warm to room temperature and was stirred overnight in the dark.  
The resulting white precipitate and 4Å MS were removed by filtration through Celite, and 
the solvent was removed under reduced pressure.  The crude reaction mixture was then 
purified by FCC (hexane/EtOAc 9:1 to 6:4) to give the title compound (24) as a colourless oil 
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(200 mg, 13%); Rf 0.22 (hexane/EtOAc 7:3); [α]D -4.4 (c 1.0, CHCl3) ; δH(400 MHz; CDCl3) 7.37-
7.27 (m, 10H, ArH), 5.24 (m, 1H, H-4’), 5.20 (dd, J2’,3’ = 9.5 Hz, J1’,2’ = 6.9 Hz, 1H, H-2’), 5.02 
(dd, J2’,3’ = 9.5 Hz, J3’,4’ = 3.6 Hz, 1H, H-3’), 4.69 (d, J1’,2’ = 6.9 Hz, 1H, H-1’), 4.52 (d, J = 6.1 Hz, 
1H, PhCH2), 4.04 (m, 1H, H-2), 4.01 (dd, 2J5’a,5’b = 13.1 Hz, J4’,5’a = 3.3 Hz, 1H, H-5’a), 3.68-3.65 
(m, 2H, H-1), 3.58 – 3.53 (m, 3H, H-3,5’b); δC(100 MHz; CDCl3) 170.4, 170.2, 169.5 (3 × C=O), 
128.4, 128.4, 127.7, 127.6 (Ar), 100.9 (C1’), 77.75 (C1) 173.5, 173.4 (2 × PhCH2), 70.9 (C2), 
70.9 (C3), 70.2 (C3’), 69.4 (C2’), 67.7 (C4’), 63.1 (C5’), 21.0, 20.7, 20.7 (3 × OAc); HRMS (ESI+) 
m/z calc. for C28H34O10Na 553.2050 ([M+Na]+) found 553.2044 [M+Na]+. 
 
1,3-Dihydroxypropan-2-yl 2’,3’,4’-tri-O-acetyl-α-ᴅ-arabinopyranoside (25) 
 
1,3-Bis(benzyloxy)propan-2-yl 2’,3’,4’-tri-O-acetyl-α-ᴅ-arabinopyranoside (24) (200 mg, 0.4 
mmol) was dissolved in MeOH (10 mL) and palladium on activated charcoal (10% Pd basis) 
(50 mg) was added.  The system was flushed with N2 (×3) followed by H2 (×3) and stirred 
overnight at room temperature.  After the system had been flushed with N2 (×3) the catalyst 
was filtered through Celite and the filter was washed with MeOH (20 mL).  The organic 
washes were combined and the solvent was removed under reduced pressure to give the 
title compound (25) (100 mg, 75%) as a white powder; Rf 0.15 (9:1 EtOAc:Hex) [α]D -9.8 (c 
1.0, MeOH); δH(400 MHz; CDCl3) 5.29 (bs, 1H, H-4’), 5.23 (dd, J2’,3’ = 9.8 Hz, J1’,2’ = 7.8 Hz, 1H, 
H-2’); 5.07 (dd, J2’,3’ = 9.8 Hz, J3’,4’ = 3.4 Hz, 1H, H-3’), 4.57 (d, J1’,2’ = 7.8 Hz, 1H, H-1’), 4.06 (dd, 
2J5’a,5’b = 13.2 Hz, J4’,5’a = 1.8 Hz, 1H, H-5’a), 3.81-3.76 (m, 1H, H-2), 3.71 (d, 2J5’a,5’b = 13.2 Hz, 
1H, H-5’b), 3.69-3.66 (m, 4H, H-1,3), 2.93 (bs, 1H, OH), 2.33 (bs, 1H, OH), 2.17 (s, 3H, OAc), 
2.10 (s, 3H, OAc), 2.03 (s, 3H, OAc); δC(100 MHz; CDCl3) 170.3, 170.1, 170.1 (3 × C=O), 101.9 
(C1’), 83.5 (C2), 70.3 (C3’), 69.6 (C2’), 67.7 (C4’), 64.1 (C5’), 62.7 (C1), 62.4 (C3), 20.9, 20.8, 
20.7 (3 × OAc); HRMS (ESI+) m/z calc. for C14H22O10Na 373.1111 ([M+Na]+) found 373.1107 
[M+Na]+. 
 
1,3-Dihydroxypropan-2-yl α-ᴅ-arabinopyranoside (6) 
  P a g e  | 138 
 
1,3-Dihydroxypropan-2-yl 2’,3’,4’-tri-O-acetyl-α-ᴅ-arabinopyranoside (25) (100 mg, 0.29 
mmol) was dissolved into MeOH (10 mL) under N2.  A solution of sodium metal (5 mg, 0.2 
mmol) in dry MeOH (10 mL) was added by syringe and the reaction mixture was left to stir 
overnight. Low resolution mass spectrometry showed only the desired product, and the 
reaction mixture was neutralised to pH 7.0 with Amberlite® 120 (H+) resin, before being 
filtered and the was solvent removed under reduced pressure to give the title compound (6) 
as an oil (52 mg, 80%); [α]D -4.6 (c 1.0, MeOH); δH(400 MHz; MeOH) 4,25 (d, J1’,2’ = 7.0 Hz, 1H, 
H-1’), 3.78 (dd, 2J5’a,5’b = 12.5 Hz, J5’a,4 = 2.6 Hz, 1H, H-5’a), 3.72-3.69 (m, 1H, H-4’), 3.66-3.62 
(m, 1H, H-2), 3.59-3.53 (m, 4H, H-1,3), 3.50-3.42 (m, 3H, H-2’, H-5’b, H-3’); δC(100 MHz; 
MeOH) 103.5 (C1’), 81.1 (C2), 72.8 (C3’), 71.3 (C2’), 68.4 (C4’), 65.8 (C5’), 61.7 (C1), 61.3 (C3); 
HRMS (ESI+) m/z calc. for C8H16O7Na 247.0794 [M+Na]+ found 247.0794 [M+Na]+ 
 
Trityl perchlorate (Ph3C+.ClO4-)33 
Triphenyl methanol (500 mg, 1.9 mmol) was dissolved into acetic anhydride (8 mL) and in an 
ice bath.  70% w/w Perchloric acid (700 µL, 8.2 mmol) was added dropwise and the reaction 
mixture immediately turned dark yellow.  The reaction mixture was stirred for 1 hour at 0 °C 
before the solvent was carefully filtered off and the remaining yellow powder was rinsed 
with dry Et2O (5 × 2 mL).  The reaction mixture was then dried in the dark on a high vacuum 
line overnight to give the title compound (455 mg, 69%) as a yellow powder; νmax/cm-1 (FTR-
IR) 1579 (s), 1483 (m), 1447 (m), 1353 (s), 1294 (m), 1191 (w), 1166 (w), 1073 (broad, vs),  
δH(400 MHz; CD3CN) 7.37-7.27 (m, 15H, Ar), δC(100 MHz; CD3CN) 148.1 (Ph3C+), 128.4 (6 × 
Ar), 128.3 (6 × Ar), 127.6 (3 × Ar).  The infrared spectrum is in good agreement with literature 
values.33 
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2,3,5-Tri-O-benzyl-ᴅ-ribofuranosyl fluoride (27/28)25 
 
2,3,5-Tri-O-benzyl-ᴅ-ribofuranose (26) (1.0 g, 2.4 mmol) was dissolved into dry THF (10 mL) 
and cooled to -30 °C.  DAST (0.4 mL, 2.9 mmol, 1.2 eq) was added in a single portion and the 
reaction mixture was allowed to warmed to room temperature. After 20 minutes TLC 
indicated all start material had been consumed.  The reaction mixture was cooled back down 
to -30 °C and the residual DAST was quenched with MeOH (0.5 mL).  The solvent was 
removed under reduced pressure and the glycosyl fluorides separated by FCC to give the title 
compound (645 mg, 64%),  
(27) (α-anomer) Rf 0.70 (hexane/EtOAc 9:1); δH(400 MHz; CDCl3) 7.34-7.17 (m, 15H, Ar), 5.69 
(dd, J1,2 = 3.4 Hz, J1,F = 65.8 Hz, 1H, H-1), 4.71-4.57 (m, 4H, 2 × PhCH2), 4.49-4.39 (m, 3H, PhCH2 
& H-4), 3.91 (m, 1H, H-3), 3.89 (ddd, J2,F = 25.9, J1,2 = 3.4 Hz, J2,3 = 6.4 Hz, 1H, H-2), 3.43 (dd, 
J4,5a = 3.9 Hz, 2J5a,5b = 10.5 Hz, 1H, H-5a), 3.38 (dd, J4,5b = 3.5 Hz, 2J5a,5b = 10.5 Hz, 1H, H-5b); 
δC(100 MHz; CDCl3) 137.9, 137.7, 137.4 (3 × Ar), 128.5, 128.5, 128.4, 128.3, 128.1, 128.0, 
127.8, 127.6 (Ar), 108.6 (d, JC1,F = 234 Hz, C1), 85.1 (C4), 78.6 (d, JC2,F = 20.7 Hz, C2), 74.3 (C3), 
73.5, 72.7, 72.5 (3 × CH2Ph), 69.7 (C5); δF(376 MHz; CDCl3) -131.7 (dd, J1,F = 234 Hz, J2,F = 20.7 
Hz). 
(28) (β-anomer) Rf 0.82 (hexane/EtOAc 9:1) [α]D +49.4 (c 1.0, CHCl3); δH(400 MHz; CDCl3) 7.35-
7.29 (m, 15H, Ar), 5.67 (d, J1,F = 63.3 Hz, 1H, H-1), 4.64-4.44 (m, 6H, PhCH2,), 4.46-4.41 (m, 1H, 
H-4), 4.14-4.10 (m, 1H, H-3), 3.99 (dd, J2,3 = 4.2 Hz, J2,F = 4.2 Hz, 1H, H-2), 3.68 (dd, J4,5a = 3.4 
Hz, 2J5a,5b = 11.1 Hz, 1H, H-5a), 3.58 (dd, J4,5b = 5.3 Hz, 2J5a,5b = 11.1 Hz, 1H, H-5b); δC(100 MHz; 
CDCl3) 138.1, 137.5, 137.4 (3 × Ar), 128.6, 128.5, 128.4, 128.1, 128.0, 128.0, 127.7, 127.6 (Ar), 
112.6 (d, JC1,F = 224 Hz, C1), 82.4 (C4), 78.9 (d, JC2,F = 30.1 Hz, C2), 77.1 (C3), 73.4, 72.8, 72.8 
(3 × CH2Ph), 70.2 (C5); δF(376 MHz; CDCl3) -115.3 (dm, J1,F = 63.3 Hz). 
The diagnostic NMR signals for both anomers are in agreement with literature values.22 
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1,3-Bis(benzyloxy)propan-2-yl 2,3,5-tri-O-benzyl-α-ᴅ-ribofuranoside (35) 
 
2,3,5-Tri-O-benzyl-β-ᴅ-ribofuranosyl fluoride (28) (210 mg, 0.5 mmol), SnCl2 (95 mg, 0.5 
mmol) and trityl perchlorate (170 mg, 0.5 mmol) were dissolved into a suspension of 4Å MS 
(1.0 g) in dry Et2O (5 mL) under N2.  The reaction mixture was wrapped with aluminium foil 
to exclude light and cooled to -15 °C.  1,3-Di-O-benzyl glycerol (13) (100 µL, 0.40 mmol, 0.8 
eq) was added in a single portion and the reaction mixture was stirred for 6 hours before 
being placed in the fridge overnight.  When TLC (hexane/EtOAc 7:3) showed consumption of 
the acceptor, the reaction mixture was diluted with Et2O (50 mL), filtered and washed with 
saturated aqueous NH4Cl solution (3 × 10 mL).  The organic layer was separated, dried over 
MgSO4 and filtered before the solvent was removed under reduced pressure.  The anomers 
were separated by FCC to give the title compound (35) (148 mg, 44%) as a colourless oil: Rf 
0.10 (hexane/Et2O 7:3); [α]D +52.5 (c 1.0, CHCl3); δH(400 MHz; CDCl3) 7.32-7.18 (m, 25H, Ar), 
5.38 (d, J1’,2’ = 4.3 Hz, 1H, H-1’), 4.73 -4.38 (m, 10H, 5 × PhCH2), 4.26-4.24 (m, 1H, H-4’), 4.23-
4.17 (m, 1H, H-2), 3.82 (dd, J2’,3’ = 7.1 Hz, J3’,4’ = 3.9 Hz, 1H, H-3’), 3.75 (dd, J1’,2’ = 4.3 Hz, J2’,3’ = 
7.1 Hz, 1H, H-2’), 3.74-3.59 (m, 4H, H-1,3), 3.41 (dd, J4’,5’a = 3.9 Hz, 2J5’a,5’b = 10.6 Hz, 1H, H-
5’a), 3.34 (dd, J4’,5’b = 4.2 Hz, 2J5’a,5’b = 10.6 Hz, 1H, H-5’b); δC(100 MHz; CDCl3) 138.6, 138.6, 
138.4, 138.1, 138.0 (5 × Ar), 128.3, 128.3, 128.2, 128.0, 127.9, 127.6, 127.6, 127.6, 127.5, 
127.5, 127.4 (Ar), 101.5 (C1’), 81.5 (C4’), 77.2 (C2’), 75.6 (C2), 75.5 (C3’), 73.4, 73.4, 73.3 72.2, 
72.0 (5 × CH2Ph), 71.7 (C1), 70.7 (C3), 69.9 (C5’); HRMS (ESI+) m/z calc. for C43H46O7Na+ 
697.3141 [M+Na]+ found 697.3129 [M+Na]+. 
The β-anomer was a colourless oil: Rf 0.20 (hexane/Et2O 7:3); [α]D + 42.4 (c 1.0, CHCl3); δH(400 
MHz; CDCl3) 7.31-7.22 (m, 25H, Ar), 5.30 (s, 1H, H-1’), 4.65-4.39 (m, 10H, PhCH2), 4.36-4.30 
(m, 1H, H-4’), 4.05-4.01 (m, 1H, H-2), 4.03 (dd, J2’,3’ = 4.8 Hz, J3’,4’ = 7.4 Hz, 1H, H-3’), 3.92 (d, 
J2’,3’ = 4.8 Hz, 1H, H-2’), 3.65-3.42 (m, 6H, H-1,3,5’a,5’b); δC(100 MHz; CDCl3) 138.4, 138.3, 
138.3, 138.0, 138.0, 128.4, 128.4, 128.3, 128.0, 127.8, 127.7, 127.6, 127.6, 127.5, 127.5 (Ar), 
104.9 (C1’), 80.4 (C4’), 79.7 (C2’), 78.5 (C2), 74.8 (C3’), 73.4, 73.2, 73.0, 72.4, 72.1 (5 × PhCH2), 
71.5 (C5’), 70.2 (C1), 70.2 (C3). 
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1,3-Dihydroxypropan-2-yl α-ᴅ-ribofuranoside (3) 
 
1,3-Bis(benzyloxy)propan-2-yl 2,3,5-tri-O-benzyl-α-ᴅ-ribofuranoside (35) (80 mg, 120 µmol) 
was dissolved in MeOH/EtOH (5:1, 12 mL) and palladium on activated charcoal (10% Pd basis) 
(50 mg) was added.  The system was flushed with N2 (×3) followed by H2 (×3) and stirred 
overnight at room temperature.  After the system had been flushed with N2 (×3) the catalyst 
was filtered through Celite and the filter was washed with AcOH (50 mL).  The organic washes 
were combined and the solvent was removed under reduced pressure to give the title 
compound (3) (20 mg, 75%); [α]D +68.2 (c 1.0, MeOH); δH(400 MHz; CD3OD) 5.11 (d, J1’,2’ = 4.3 
Hz, 1H, H-1’) 4.01-3.89 (m, 3H, H-4’,2’,3’), 3.72-3.47 (m, 7H, H-2,5’a,5’b,1,3); δC(100 MHz; 
CD3OD) 102.0 (C1’), 85.9 (C4’), 79.0 (C2), 71.9 (C2’), 70.1 (C3’), 61.9 (C5’), 61.5 (C1), 60.8 (C3); 
HRMS (ESI+) m/z calc for C8H16O7Na+ 247.0794 [M+Na]+ found 247.0798 [M+Na]+. 
 
The 1,2-trans β-anomer 1,3-dihydroxypropan-2-yl β-ᴅ-ribofuranoside (36): δH(400 MHz; 
CD3OD) 5.07 (s, 1H, H-1’), 4.22 (dd, J2’,3’ = 4.3 Hz, J3’,4’ = 6.9 Hz, 1H, H-3’), 4.03 (d, J2’,3’ = 4.3 Hz, 
1H, H-2’), 3.96-3.93 (m, 1H, H-4), 3.78-3.49 (m, 7H, H-2,1,3,5’a,5’b); δC(100 MHz; CD3OD) 
106.5 (C1’), 82.5 (C4’), 79.4 (C2), 74.7 (C2’), 70.0 (C3’), 61.7 (C1), 61.3 (C3), 60.6 (C5’). 
 
2,3,5-Tri-O-benzyl-β/α-ʟ-xylofuranose fluoride (30/31) 
 
2,3,5-Tri-O-benzyl-ʟ-xylofuranose (29) (500 mg, 1.2 mmol) was dissolved in dry THF (10 mL), 
the solution was cooled to -30 °C and DAST (0.2 mL, 1.5 mmol) was added in a single portion.  
The reaction mixture was allowed to warm to room temperature and stirred for 20 minutes, 
after which time TLC (hexane/EtOAc indicated 29 had been consumed.  The reaction mixture 
was cooled back to – 30 °C and quenched with MeOH (0.5 mL).  The solvent was removed 
under reduced pressure and the crude mixture of anomers was passed through a short silica 
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plug and the solvent was removed under educed pressure to give the mixture of fluoride 
anomers (31/30) (450 mg, 90%) as a colourless oil.  The ratios of anomers was judged to be 
α/β 1.0:0.3 by integration of the anomeric 1H NMR signals; Rf 0.31 (hexane/EtOAc 8:2); 
δH(400 MHz; CDCl3) 7.38-7.25 (m, 26H, Ar), 5.74 (d, J1β,F = 64.6 Hz, 1H, H-1β), 5.67 (dd, J1α,F = 
64.8 Hz, J1α,2α = 3.5 Hz, 0.3H, H-1α), 4.68-5.90 (m, 11.7H, H-4α,4β,PhCH2), 4.35 (dd, J2α,3α = 6.5 
Hz, J3α,4β = 6.5 Hz, 0.3H, H-3α), 4.15 (d, J2β,F = 6.8 Hz, 1H, H-2β),  4.13 (ddd, J2α,F = 18.9 Hz, J1α,2α 
= 3.5 Hz, J2α,3α = 6.5 Hz, 0.3H, H-2α) 4.07 (d, J3β,4β = 5.7 Hz, 1H, H-3β), 3.84 (dd, J4α,5aα = 5.1 Hz, 
J5aα,5bα = 10.3 Hz, 1H, H-5aα), 3.76 (dd, J4α,5bα = 7.0 Hz, 2J5aα,5bα = 10.3 Hz, 1H, H-5bα), 3.70 (dd, 
J4β,5aβ = 3.9 Hz, J5aβ,5bβ = 10.9 Hz, 1H, H-5aβ), 3.60 (dd, J4β,5bβ = 5.8 Hz, 2J5aβ,5bβ = 10.9 Hz, 1H, H-
5bβ); δC(100 MHz; CDCl3) 138.2 (C=O β), 138.1 (C=O α), 137.8 (C=O α), 137.5 (C=O β), 134.4 
(C=O α), 137.0 (C=O β), 128.6, 128.6, 128.5, 128.5, 128.4, 128.2, 128.1, 128.0, 127.9, 127.8, 
127.8, 127.8, 127.7, 127.7, 127.7, 127.6 (Ar), 113.3 (d, JC1β,F = 225 Hz, C1β), 107.5 (d, JC1α,F = 
230 Hz, C1α), 85.1 (d, J2β,F = 31.0 Hz, C2β), 83.9 (d, J2α,F = 21.0 Hz, C2α), 83.3 (d, J4,F = 2.4 Hz, 
C4β), 80.1 (C3β), 80.0 (C3α), 78.4 (C4α), 73.5 (PhCH2 β), 73.5 (PhCH2 α), 72.9 (PhCH2 α), 72.8 
(PhCH2 α), 72.5 (PhCH2 β), 72.2 (PhCH2 β), 69.3 (C5β), 68.7 (C5α); δF(376 MHz; CDCl3) -177.4 
(ddd, J1,F = 64.6, J2,F = 6.8 Hz, J4,F = 6.8 Hz, Fβ), -133.0 (dd, J1,F = 64.8 Hz, J2,F = 18.9 Hz, Fα); 
HRMS (ESI+) m/z calc. for C26H27FO4Na+ 445.1786 [M+Na]+ found 445.1791 [M+Na]+. 
 
1,3-Bis(benzyloxy)propan-2-yl 2,3,5-tri-O-benzyl-α-ʟ-xylofuranoside (37) 
 
2,3,5-Tri-O-benzyl-β/α-ʟ-xylofuranosyl fluoride (30/31) (200 mg, 0.47 mmol) and 1,3-di-O-
benzyl glycerol (13) (100 µL, 0.4 mmol) were dissolved into a suspension of 4Å MS (1.0 g) in 
Et2O (5 mL).  The suspension was cooled to 0 °C in an ice bath and SnCl2 (90 mg, 0.47 mmol) 
was added in a single portion to initiate the reaction.  The reaction mixture was then kept in 
a refrigerator overnight at 4 °C.  The next morning the reaction mixture was filtered and the 
solvent removed in vacuo to give a crude mixture, which was judged to contain a mixture of 
α/β 1.0:0.8 by 1HNMR.  The crude mixture was purified by FCC to give the two anomers gave 
the title compound (37) (59 mg, 19%) as a colourless oil; Rf 0.48 (hexane/Et2O 7:3); [α]D -39.6 
(c 1.0, DCM); δH(400 MHz; CDCl3) 7.31-7.22 (m, 25H, Ar), 5.35 (d, J1’,2’ = 4.3 Hz, 1H, H-1’), 4.71 
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(d, 2JPhCHH,PhCHH = 11.9 Hz, 1H, PhCHH), 4.63 (d, 2JPhCHH,PhCHH = 11.9 Hz, 1H, PhCHH), 4.57 (d, 
2JPhCHH,PhCHH = 12.1 Hz, 1H, PhCHH), 4.53-4.45 (m, 7H,3.5 × PhCH2), 4.43-4.41 (m, 1H, H-4’), 
4.31 (dd, J2’,3’ = 5.9 Hz, J3’,4’ = 7.0 Hz, 1H, H-3’), 4.20-4.15 (m, 1H, H-2), 3.97 (dd, J1’,2’ = 4.3 Hz, 
J2’,3’ = 5.9 Hz, 1H, H-2’), 3.74-3.54 (m, 6H, H-5’a,1,3,5’b); δC(100 MHz; CDCl3) 138.4, 138.4, 
138.3, 138.3, 137.9, 128.4, 128.4, 128.3, 128.3, 128.0, 127.7, 127.7, 127.6, 127.6, 127.5, 
127.5 (Ar), 99.9 (C1’), 83.8 (C2;), 81.6 (C3’), 76.0 (C4’), 75.4 (C2), 73.4, 73.4, 73.3, 72.4, 71.8 
(4 × PhCH2), 71.5 (C1), 70.4 (C3), 69.4 (C5’); HRMS (ESI+) m/z calc. for C43H46O7Na+ 697.3141 
([M+Na]+) found 697.3129 [M+Na]+. 
The β anomer (32 mg, 12%) was a colourless oil; Rf 0.54 (hexane/Et2O 7:3); [α]D +5.6 (c 1.0, 
DCM); δH(400 MHz; CDCl3) 7.32-7.23 (m, 25H, Ar), 5.31 (d, J1’,2’ = 1.9 Hz, 1H, H-1’), 4.58-4.40 
(m, 11H, 5 × PhCH2, H-4’), 4.11-4.06 (m, 3H, H-2’,3’,2), 3.76 (dd, J4’,5a’ = 4.9 Hz, 2J5’a,5’b = 10.3 
Hz, 1H, H-5’a), 3.71 (dd, J4’,5’b = 3.7 Hz, 2J5’a,5’b = 10.3 Hz, 1H, H-5’b), 3.71-3.55 (m, 4H, H-1,3); 
δC(100 MHz; CDCl3) 138.5, 138.4, 138.3, 138.0, 137.7, 128.4, 128.3, 128.3, 128.3, 127.8, 
127.7, 127.7, 127.6, 127.6, 127.6, 127.5, 127.5, 127.5 (Ar), 107.0 (C1’), 86.8 (C2’), 82.0 (C3’), 
79.9 (C4’), 75.7 (C2), 73.4, 73.3, 73.3, 72.0, 71.8 (5 × PhCH2), 70.7 (C1), 70.4 (C3), 69.8 (C5’); 
 
1,3-Dihydroxypropan-2-yl α-ʟ-xylofuranoside (4) 
 
1,3-Bis(benzyloxy)propan-2-yl 2,3,5-tri-O-benzyl-α-ʟ-xylofuranoside (37) (100 mg, 145 µmol) 
was dissolved in a mixture of MeOH/n-PrOH (9:1) (20 mL) and palladium on activated 
charcoal (10% Pd basis) (50 mg) was added.  The system was flushed with N2 (×3) followed 
by H2 (×3) and stirred overnight at room temperature.  After the system had been flushed 
with N2 (×3) the catalyst was filtered through Celite and the filter was washed with MeOH 
(20 mL).  The organic washes were combined and the solvent was removed under reduced 
pressure to give the title compound (4) (16 mg, 45%) as a colourless oil; Rf 0.28 (DCM/MeOH 
85:15); [α]D -139 (c 1.0 MeOH) 5.09 (d, J1’2’ = 4.4 Hz, 1H, H-1’), 4.16-4.08 (m, 2H, H-3’,4’), 3.92 
(dd, J1’,2’ = 4.4 Hz, J2’,3’ = 4.4 Hz, 1H, H-2’), 3.65-3.51 (m, 7H, H-2,1,3,5’); δH(400 MHz; MeOH) 
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101.3 (C1’), 80.0 (C2), 78.7 (C4’), 78.1 (C2’), 75.7 (C3’), 61.7 (C5’), 61.2 (C1), 61.0 (C3); (HRMS 
ESI+) m/z calc for C8H16NaO7+ 247.0794 ([M+Na]+) found 247.0785 [M+Na]+. 
The β-anomer (5.6 mg, 29%) was a colourless oil; Rf 0.65 (DCM/MeOH 8:2); [α]D + 4.6 (c 0.2, 
MeOH); δH(400 MHz; CD3OD) 5.10 (s, 1H, H-1’), 4.38 (m, 1H, H-4’), 4.12-4.10 (m 2H, H-2’,3’), 
3.84-3.83 (m, 2H, H-5’a,5’b), 3.77-3.75 (m, 1H, H-2), 3.72-3.59 (m, 4H, H-1,3); δC(100 MHz; 
CD3OD) 108.0 (C1’), 82.6 (C4’), 81.0 (C2’), 79.4 (C2), 72.3 (C3’), 61.8 (C1), 61.0 (C5’,C3); (HRMS 
ESI+) m/z calc for C8H16NaO7+ 247.0794 ([M+Na]+) found 247.0785 [M+Na]+. 
 
 
 
2,3,5-Tri-O-benzyl-α/β-ᴅ-arabinofuranosyl fluoride (33/34)24 
 
2,3,5-Tri-O-benzyl-α-ᴅ-arabinofuranose (32) (1.0 g, 2.4 mmol) was dissolved into dry DCM 
(10 mL) and the solution cooled in an ice bath.  Diethylaminosulfur trifluoride (DAST) (390 
µL, 2.9 mmol) was added in a single portion and the reaction mixture was allowed to warm 
to and was stirred at room temperature for 30 minutes.  The reaction mixture was then 
cooled in an ice bath and MeOH (300 µL) was added to quench any unreacted DAST and the 
reaction mixture was again allowed to warm to and was stirred at room temperature for 30 
minutes. The reaction mixture was then diluted with DCM (20 mL) and washed with 
saturated aqueous NaHCO3 solution (2 × 10 mL).  The aqueous extract was washed with DCM 
(3 × 5 mL) and the organic layers were combined, dried over MgSO4, filtered and dried in 
vacuo to give the title compounds as a 5.3:1 mixture α/β mixture of anomers (33/34) (950 
mg, 94%).  The crude mixture was judged by NMR as clean enough used in the step without 
further purification; Rf 0.73 (α) 0.66 (β) (hexane/ethyl acetate 8:2); δH(400 MHz; CDCl3) 7.37-
7.25 (m, 15H, Ar), 5.78 (d, J1,F = 61.5 Hz, 1H, H-1α), 5.62 (dd, J1,F = 64.9 Hz, J1,2 = 3.5 Hz, H-1β), 
4.56-4.46 (m, 7H, 3 × PhCH2 & H-4α), 4.16 (dd, J2,F = 9.3 Hz, J2,3 = 2.0 Hz, 1H, H-2α), 3.97 (dd, 
J2,3 = 2.0 Hz, J3,4 = 5.2 Hz, 1H, H-3α), 3.64-3.57 (m, 2H, H-5α & H-5α’);  δC(100 MHz; CDCl3) 
137.9, 137.5, 137.0 (3 × Ar), 128.6, 128.5, 128.4, 128.1, 127.9, 127.8, 127.8, 127.8, 127.7, 
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113.6 (d, JC1,F = 224.7 Hz, C1α), 108.4 (d, JC1,F = 232.3 Hz, C1β), 86.9 (d, JC2,F = 33.9 Hz, C2α), 
84.1 (C4α), 82.5 (C3α), 73.5, 72.1, 72.1 (3 × PhCH2), 69.4 (C5α); δF(376 MHz; CDCl3) -120.6 
(dd, J1,F = 61.4 Hz, J2,F = 9.0 Hz, α-fluoride), 126.6 (ddd, J1,F = 64.6 Hz, J2,F = 20.6 Hz, J3,F = 6.1 
Hz, β-fluoride); HRMS (ESI+) m/z calc. for C26H27FO4Na 445.1786 [M+Na]+ found 445.1784 
[M+Na]+.  The 1H, 13C and 19F NMR diagnostic signals were in agreement with literature 
values.24 
 
1,3-Bis(benzyloxy)propan-2-yl 2’,3’,5’-tri-O-benzyl-β-ᴅ-arabinofuranoside (38) 
 
2,3,5-Tri-O-benzyl-α/β-ᴅ-arabinofuranosyl fluoride (33/34) (950 mg, 2.3 mmol) and 1,3-di-O-
benzyl glycerol (13) (540 µL, 2.2 mmol) were dissolved into a suspension of 4Å MS (1.0 g) in 
Et2O (7 mL).  The suspension was cooled in an ice bath and SnCl2 (440 mg, 2.3 mmol) was 
added in a single portion to initiate the reaction.  The reaction mixture was then kept in a 
refrigerator overnight at 4 °C.  The next morning the reaction mixture was filtered and the 
solvent removed in vacuo to give a crude mixture.  The anomers were challenging to 
completely separate by FCC, and as such not all of the crude mixture was purified.  Three 
rounds of chromatography gave the β-anomer (38) (560 mg, 37%) also as a colourless oil; Rf 
0.46 (hexane/Et2O 6:4); [α]D -38.7 (c 1.0, CHCl3); δH(400 MHz; CDCl3) 7.32-7.24 (m, 25H, Ar), 
5.32 (d, J1’,2’ = 4.4 Hz, 1H, H-1’), 4.71-4.36 (m, 10H, 5 × PhCH2), 4.13-4.06 (m, 3H, H-3’,4’,2), 
4.03 (dd, J1’,2’ = 4.4 Hz, J2’,3’ = 7.0 Hz, 1H, H-2’), 3.71 (dd, J4’,5’ = 3.4 Hz, 2J5a’,5b’ = 10.3 Hz, 1H, H-
5a’), 3.64-3.47 (m, 5H, H-5b’,1,3); δC(100 MHz; CDCl3) 138.4, 138.3, 138.3, 138.2, 137.9 (5 × 
Ar), 128.4, 128.4, 128.4, 128.3, 128.0, 127.8, 127.7, 127.7, 127.7, 127.6, 127.6, 127.6, (Ar), 
100.8 (C1’), 83.7 (C2’), 83.1 (C3’), 80.1 (C4’), 75.6 (C2), 73.5, 73.3, 73.1 (3 × PhCH2), 72.6 (C1), 
72.3, 71.8 (2 × PhCH2), 71.3 (C5’), 70.3 (C3); HRMS (ESI+) m/z calc. for C43H46O7 697.3136 
[M+Na]+ found 697.3132 [M+Na]+. 
The 1,2-trans α-anomer (47 mg) was as a colourless oil Rf 0.46 (hexane/Et2O 6:4); [α]D + 26.8 
(c 1.0, CHCl3); δH(400 MHz; CDCl3) 7.35-7.22 (m, 25H, Ar), 5.35 (bs, 1H, H-1’), 4.57-4.41 (m, 
10H, 5 × PhCH2), 4.23 (dm, J3’,4’ = 7.3 Hz, 1H, H-4’), 4.15-4.09 (m, 1H, H-2), 4.08 (d, J2’,3’ = 3.4 
Hz, 1H, H-2’), 3.92 (dd, J2’,3’ = 3.4 Hz, J3’,4’ = 7.3 Hz, 1H, H-3’), 3.70 (dd, J1,2 = 3.8 Hz, 2J1a,1b = 10.2 
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Hz, 1H, H-1a), 3.65-3.54 (m, 5H, H-1b,3,5’); δC(100 MHz; CDCl3) 138.4, 138.3, 138.2, 138.0, 
137.7 (5 × Ar), 128.4, 128.3, 128.0, 127.8, 127.7, 127.7, 127.6, 127.6, 127.5 (Ar), 106.1 (C1’), 
88.5 (C2’), 83.7 (C3’), 80.3 (C4’), 75.0 (C2), 73.4 73.3, 73.3, 72.1, 71.8 (5 × PhCH2), 70.8 (C1), 
70.5 (C3), 69.6 (C5’); HRMS (ESI+) m/z calc. for C43H46O7 697.3136 [M+Na]+ found 697.3132 
[M+Na]+. 
 
1,3-Dihydroxypropan-2-yl β-ᴅ-arabinofuranoside (5) 
 
1,3-Bis(benzyloxy)propan-2-yl 2’,3’,5’-tri-O-benzyl- β-ᴅ-arabinofuranoside (38) (560 mg, 0.8 
mmol) was dissolved in a mixture of MeOH/EtOAc (9:1) (50 mL) and palladium on activated 
charcoal (10% Pd basis) (50 mg) was added.  The system was flushed with N2 (×3) followed 
by H2 (×3) and stirred for 48 hours at room temperature.  After the system had been flushed 
with N2 (×3) the catalyst was filtered through Celite and the filter was washed with MeOH 
(20 mL).  The organic washes were combined and the solvent was removed under reduced 
pressure to give the title compound (5) (80 mg, 45%) as a colourless oil; Rf 0.45 (DCM/MeOH 
85:15); [α]D -78.1 (c 1.0, MeOH); δH(400 MHz; MeOH) 5.05 (d, J1’,2’ = 4.7 Hz, 1H, H-1’), 4.18 
(dd, J2’,3’ = 8.0 Hz, J3’,4’ = 8.0 Hz, 1H, H-3’), 4.00 (dd, J1’,2’ = 4.7 Hz, J2’,3’ = 8.0 Hz, 1H, H-2’), 3.78-
3.73 (m,3H, H-1,4’), 3.72-3.68 (m, 1H, H-2), 3.66-3.61 (m, 4H, H-5’,3); δC(100 MHz; MeOH) 
101.3 (C1’), 82.5 (C2), 80.8 (C4’), 77.6 (C2’), 73.5 (C3’), 61.7 (C5’), 61.4 (C1,C3); HRMS (ESI+) 
m/z calc. for C8H16O7Na+ 247.0794 [M+Na]+ found 247.0788 [M+Na]+. 
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2,3,4,6-Tetra-O-benzyl-α-ᴅ-galactopyranosyl trichloroacetimidate (41)34 
 
2,3,4,6-Tetra-O-benzyl-α-ᴅ-galactopyranose (43) (200 mg, 0.37 mmol) and CCl3CN (370 µL, 
3.7 mmol) were dissolved into DCM (8 mL) under N2 and the reaction mixture cooled to 0 °C.  
DBU (5µL, 33 µmol) was added and the cooling bath was removed to allow the reaction 
mixture to stir at room temperature for 2 hours, after which time TLC (hexane/EtOAc 8:2) 
showed consumption of the starting material. The solvent was evaporated under reduced 
pressure and the crude reaction mixture was filtered through a silica plug (hexane/EtOAc 
8:2) to give the title compound (41) (170 mg, 65%) as a yellow oil. δH(400 MHz; CDCl3) 8.51 
(s, 1H, C=NH), 7.36-7.15 (m, 20H, ArH), 6.52 (d, J1,2 = 3.4 Hz, 1H, H-1), 4.97 (d, 2J = 11.3 Hz, 
1H, C4OBn), 4.82 (d, 2J = 11.8 Hz, 1H, C3OBn), 4.75 (d, 2J = 11.8 Hz, 1H, C3OBn), 4.74 (s, 2H, 
C2OBn), 4.59 (d, 2J = 11.3 Hz, 1H, C4OBn), 4.46 (d, 2J = 11.7 Hz, 1H, C6OBn), 4.40 (d, 2J = 11.7, 
1H, C6OBn), 4.24 (dd, J2,3 = 10.0 Hz, J1,2 = 3.4 Hz, 1H, H-2), 4.17-4.14 (m, 1H, H-5), 4.06-4.05 
(m, 1H, H-4), 4.02 (dd, J2,3 = 10.0 Hz, J3.4 = 2.8 Hz, 1H, H-3), 3.64-3.53 (m, 2H, H-6a & H-6b); 
δC(100 MHz; CDCl3) 161.3 (C=NH), 138.6, 138.5, 138.4, 137.7 (4 × Ph), 129.1 – 127.5 (Ph), 
125.3 (CCl3), 95.2 (C1), 77.8 (C3), 75.6 (C2), 75.0, (OCH2Ph), 74.7 (C4), 73.5 (OCH2Ph), 73.0 
(OCH2Ph), 72.9 (OCH2Ph), 72.2 (C5), 68.3 (C6). 1H and 13C NMR spectra are in good agreement 
with data extracted from spectra of an anomeric mixture.34 
 
1,3-bis(benzyloxy)propan-2-yl 2’,3’,4’,6’-tetra-O-benzyl-α-ᴅ-galactopyranoside (40)9 
 
Tetra-O-benzyl-α-ᴅ-galactopyranosyl trichloroimidate (41) (165 mg, 0.24 mmol) and 1,3-di-
O-benzyl glycerol (13) (140 µL, 0.56 mmol) were dissolved in a mixture of toluene/Et2O (4:1, 
5 mL) and cooled in an ice bath under N2.  TMSOTf (35 µL, 15 mol%) was added in a single 
portion and the reaction mixture was allowed to warm to room temperature and stirred 
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overnight.  The solvent mixture was evaporated under reduced pressure and the crude 
mixture was purified by FCC (hexane/EtOAc 9:1 to 7:3) to give the title compound (40) as a 
colourless oil (70 mg, 37%); Rf 0.51 (hexane/EtOAc 8:2); [α]D = +26 (c 1.0, CHCl3) ; δH(400 MHz; 
CDCl3) 5.23 (d, J1’,2’ = 3.7 Hz, 1H, H-1’), 4.93 (d, 2J = 11.4 Hz, 1H, OCH2Ph), 4.8 (d, 2J = 11.7 Hz, 
1H, OCH2Ph), 4.72 (d, 2J = 11.7 Hz, 1H, OCH2Ph), 4.68 (s, 2H, OCH2Ph), 4.55 (d, 2J = 11.4 Hz, 
1H, OCH2Ph), 4.51 (s, 1H, OCH2Ph), 4.43–4.31 (m, 3H, OCH2Ph), 4.19-4.16 (m, 1H, H-4’), 4.12-
4.10 (m, 1H, H-2), 4.03 (dd, J2’,3’  = 9.7 Hz, J1’,2’ = 3.7 Hz, 1H, H-2’), 3.99-3.96, (m, 1H, H-5’), 3.94 
(dd, J2’,3’ = 9.7 Hz, J3’,4’ =  2.8 Hz, 1H, H-3’), 3.64-3.47 (m, 6H, H-6’a,6’b,1,2);  δC(100 MHz; CDCl3) 
139.0 – 138.2 (6 × Ar-C), 129.1 (Ar-H), 128.4 – 127.4 (16 × Ar-H), 125.32 (Ar-H), 97.0 (C1’), 
79.0 (C3’), 77.2 (OCH2Ph) 76.3 (C2’), 75.2 (C5’), 74.08 (OCH2Ph), 74.8 (C2), 73.4 (OCH2Ph), 
73.4 (OCH2Ph), 73.1 (OCH2Ph), 72.7 (OCH2Ph), 70.6 (C1), 70.4 (C3), 69.2 (C4’), 69.0 (C6’); 
HRMS (ESI+) m/z calc. for C51H54O8Na 817.3716 [M+Na]+ found 817.3711 [M+Na]+.  The 1H 
and 13C NMR were in agreement with literature values.9 
 
1,3-Dihydroxypropan-2-yl α-ᴅ-galactopyranoside (7) 
 
1,3-Bis(benzyloxy)propan-2-yl 2’,3’,4’,6’-tetra-O-benzyl-α-ᴅ-galactopyranoside (40) (70 mg, 
90 µmol) was dissolved in MeOH (10 mL) and palladium on activated charcoal (10% Pd basis) 
(50 mg) was added.  The system was flushed with N2 (×3) followed by H2 (×3) and stirred for 
48 hours at room temperature.  After the system had been flushed with N2 (×3) the catalyst 
was filtered through Celite and the filter was washed with MeOH (20 mL).  The organic 
washes were combined and the solvent was removed under reduced pressure to give 1,3-
dihydroxypropan-2-yl α-ᴅ-galactopyranoside (7) (16 mg, 72%) as a white powder; [α]D = +86° 
(c 1.0, MeOH); δH(400 MHz; D2O) 5.02 (d, J1’,2’ = 3.8 Hz, 1H, H-1’), 3.99-3.96 (m, 1H, H-5’), 3.86 
(d, J3’,4’ = 2.8 Hz, 1H, H-4’), 3.78 (dd, J2’,3’ = 10.2 Hz, J3’,4’ = 2.8 Hz, 1H, H-3’), 3.70 (dd, J2’,3’ = 10.2 
Hz, J1’,2’ = 3.8 Hz, 1H, H-2’), 3.68-3.67 (m, 2H, H-6’a, 6’b), 3.64-3.60 (m, 5H, H-1,2,3); δC(100 
MHz; D2O) 98.0 (C1’), 78.7 (C2), 71.0 (C5’), 69.3 (C3’), 69.2 (C4’), 68.4 (C2’), 61.3 (C1), 61.1 
(C3), 60.3 (C6’); HRMS (ESI+) m/z calc. for C9H18O8 277.0899 [M+Na]+ found 277.0898 
[M+Na]+.   
  P a g e  | 149 
4.6 References: 
1. T. Igarashi, M. Satake, and T. Yasumoto, J. Am. Chem. Soc., 1999, 121, 8499–8511. 
2. S. A. Rasmussen, S. Meier, N. G. Andersen, H. E. Blossom, J. Ø. Duus, K. F. Nielsen, P. 
J. Hansen, and T. O. Larsen, J. Nat. Prod., 2016, 79, 2250–2256. 
3. T. Igarashi, M. Satake, and T. Yasumoto, J. Am. Chem. Soc., 1996, 118, 479–480. 
4. J. Kennedy, J. Wu, K. Drew, I. Carmichael, and A. S. Serianni, J. Am. Chem. Soc., 1997, 
119, 8933–8945. 
5. D. K. Hincha and M. Hagemann, Biochem. J., 2004, 383, 277–283. 
6. R. Suhr, O. Scheel, and J. Thiem, J. Carbohydr. Chem., 1998, 17, 937–968. 
7. A. Courtois, Mar. Drugs, 2008, 6, 407–417. 
8. B. Thollas and C. Boisset, Synlett, 2007, 2007, 1736–1738. 
9. M. Weïwer, T. Sherwood, and R. J. Linhardt, J. Carbohydr. Chem., 2008, 27, 420–427. 
10. M. Horisberger, B. A. Lewis, and F. Smith, Carbohydr. Res., 1972, 23, 175–182. 
11. A. J. Charlson, P. A. J. Gorin, and A. S. Perlin, Can. J. Chem., 1957, 35, 365–373. 
12. W. Koenigs and E. Knorr, Berichte der Dtsch. Chem. Gesellschaft, 1901, 34, 957–981. 
13. D. Crich, A. L. J. Beckwith, C. Chen, Q. Yao, I. G. E. Davison, R. W. Longmore, C. Anaya 
de Parrodi, L. Quintero-Cortes, and J. Sandoval-Ramirez, J. Am. Chem. Soc., 1995, 
117, 8757–8768. 
14. Y. D. Wu and K. N. Houk, J. Am. Chem. Soc., 1987, 109, 908–910. 
15. N. Bartlett, L. Gross, F. Péron, D. J. Asby, M. D. Selby, A. Tavassoli, and B. Linclau, 
Chem. Eur. J., 2014, 20, 3306–3310. 
16. R. Das and B. Mukhopadhyay, ChemistryOpen, 2016, 5, 401–433. 
17. C. Marino, O. Varela, and R. M. de Lederkremer, Carbohydr. Res., 1989, 190, 65–76. 
18. Q. Zhang and H. Liu, J. Am. Chem. Soc., 2000, 122, 9065–9070. 
19. V. M. Mendoza, G. A. Kashiwagi, R. M. de Lederkremer, and C. Gallo-Rodriguez, 
Carbohydr. Res., 2010, 345, 385–396. 
20. C. Gauthier, J. Legault, S. Lavoie, S. Rondeau, S. Tremblay, and A. Pichette, 
Tetrahedron, 2008, 64, 7386–7399. 
21. B. Mukhopadhyay, K. P. R. Kartha, D. A. Russell, and R. A. Field, J. Org. Chem., 2004, 
69, 7758–7760. 
22. T. Mukaiyama, Y. Hashimoto, and S. Shoda, Chem. Lett., 1983, 935–938. 
23. H. Uchiro and T. Mukaiyama, Chem. Lett., 1996, 271–272. 
24. W. Rosenbrook, D. A. Riley, and P. A. Lartey, Tetrahedron Lett., 1985, 26, 3–4. 
  P a g e  | 150 
25. G. H. Posner and S. R. Haines, Tetrahedron Lett., 1985, 26, 5–8. 
26. A. Cossé-Barbi, D. . Watson, and J. . Dubois, Tetrahedron Lett., 1989, 30, 163–166. 
27. H. A. V Kistemaker, H. S. Overkleeft, G. A. Van Der Marel, and D. V. Filippov, Org. 
Lett., 2015, 17, 4328–4331. 
28. S. S. Nigudkar and A. V Demchenko, Chem. Sci., 2015, 6, 2687–2704. 
29. B. Yu and H. Tao, Tetrahedron Lett., 2001, 42, 2405–2407. 
30. H.-S. Dang, B. P. Roberts, J. Sekhon, and T. M. Smits, Org. Biomol. Chem., 2003, 1, 
1330–1341. 
31. I. Konstantinova, K. Antonov, I. Fateev, A. Miroshnikov, V. Stepchenko, A. 
Baranovsky, and I. Mikhailopulo, Synthesis (Stuttg)., 2011, 2011, 1555–1560. 
32. E. C. Garnier and L. S. Liebeskind, J. Am. Chem. Soc., 2008, 130, 7449–7458. 
33. W. R. Longworth and C. P. Mason, J. Chem. Soc. A Inorganic, Phys. Theor., 1966, 
1164–1167. 
34. N. Santschi and R. Gilmour, European J. Org. Chem., 2015, 2015, 6983–6987. 
 
  
  P a g e  | 151 
 
 
 
 
 
 
 
 
 
 
 
5 Synthesis of a glycosylated 
prymnesin-1 inspired fragment with a 
view to developing an antibody based 
prymnesin toxin detection device 
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5.1 Introduction 
5.1.1 Detection of Prymnesium parvum 
One of the simplest methods of detecting Prymnesium parvum is by optical light microscopy.1  
More recently, solid phase cytometry (SPC) methods have been employed using monoclonal 
antibodies to quantify the levels of some strains of P. parvum in natural samples.1,2  For 
example, Moreau et al.2 raised monoclonal antibodies against five strains of P. parvum in 
mice; these antibodies were then used in an indirect immunofluorescence assay, and the 
levels of algae quantified by SPC.  This method was shown to work with natural P. parvum 
samples, although the antibodies exhibited very narrow specificity for only a few P. parvum 
strains.2 Real-time polymerase chain reaction (PCR) detection and quantification has also 
been developed for several strains of P. parvum.3  Galluzzi et al.3 have developed a 
quantitative polymerase chain reaction (qPCR) assay designed on the internal transcribed 
spacer 2 rDNA region of P. parvum.  They found this assay to be both sensitive and specific 
to P. parvum, with a limit of detection of 2500 cells per mL.  Project collaborators at the 
University of East Anglia (UEA) have recently developed a qPCR assay specific to the strain of 
P. parvum found in the Norfolk Broads.   
It is worth noting, however, that none of these methods can help with quantifying toxin 
levels in water samples.  It has been noticed that in some cases blooms of P. parvum do not 
necessarily lead to fish kills, which would suggest that there is not an active mode of toxin 
release into water systems.4  Work in our group by Wagstaff et al.5 has reported a new double 
stranded DNA megavirus, PpDNAV, which infects the local strain of P. parvum in the Norfolk 
Broads.  In their paper Wagstaff et al.5 suggest that viral infection of Prymnesium blooms 
leads to rapid cell lysis of a P. parvum population, and as such there is a passive mass toxin 
release into the water system.  It would therefore seem prudent not to rely too heavily on P. 
parvum cell counts alone when assessing the likelihood of a prymnesin toxin induced fish-
kill.   
 
5.1.2 Detection of polyketide algal toxins 
Antibody based detection and quantification systems have been developed for polyketide 
algal toxins such as okadaic acid and brevetoxins.6,7  For example Elliot et al.8 developed a 
competitive immunoassay lateral flow device for the polyketide toxin okadaic acid which is 
the basis for the schematic shown in Figure 5.1.  A sample is loaded onto the sample pad 
where it is wicked through the reagent pad containing colloidal gold nanoparticles 
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conjugated with antitoxin antibodies.  If the sample contains toxin then this binds with the 
antitoxin antibodies on the gold nanoparticles (AuNP).  The resulting complex is then wicked 
through a nitrocellulose membrane containing a test zone with protein bound toxin and a 
control zone with surface bound anti-species antibody.  The test zone captures any antitoxin 
antibody-AuNP conjugate which is not already bound with toxin in the sample.  Therefore, 
the more toxin present in the sample, the lower the intensity of the signal at the test zone.  
The control zone anti-species antibody will always bind with antitoxin antibodies, regardless 
of whether or not they have bound with toxin.8 
 
Figure 5.1 - Diagram of a competitive immunoassay lateral flow device, showing the composition of a 
typical test strip.8  The key interactions for a positive and negative result due to the presence or lack 
thereof of toxin in a sample are also shown. 
 
Because the intensity of the test response is inversely proportional to the amount of toxin 
present in a sample, Elliot et al.8 were able to use a commercially available 
immunofluorescence assay reader to quantify the level of okadaic acid in a sample, with a 
limit of detection was 25 µg/kg of shellfish.  
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A lateral flow immunodipstick device has been developed by Zhang et al.9 for the detection 
and quantification of the algal cyclic polyether neurotoxin, brevetoxin B, which was shown 
to work with spiked seafood samples as well as lab based controls.  By using hollow gold-
nanospheres rather than gold colloids they could obtain a limit of detection for brevetoxin B 
of between 0.1 – 1.5 ng/mL.  The increase in sensitivity may be attributed to the 
comparatively large surface area of hollow nanoparticles, which allows for a higher loading 
of antibodies when compared with non-hollow nanoparticles.10 
To date, however, no such system has been developed for prymnesin toxins.  This is most 
probably because of the difficulties involved in obtaining sufficient quantities of suitably 
purified toxins for animal immunisation;  Igarashi et al (1996).11 obtained 10 mg of 
prymnesin-1 and 15 mg of prymnesin-2 from 400 L of P. parvum culture, whilst Rasmussen 
et al.12 obtained just 1.8 mg of prymnesin-B1 and 1.0 mg of prymnesin-2 from 100 L of P. 
parvum culture.  As well as the toxin required for antibody production, toxin is also required 
for a competitive immunoassay device, and as such it is not feasible to access suitable 
quantities of prymnesin toxins from lab extracts.  An alternative strategy would be to try and 
use a synthetic fragment of a prymnesin toxin (Figure 5.2). 
 
Figure 5.2 – The chemical structure of prymnesin-1, with the synthetic target region (glycosylated with 
α-ʟ-arabinopyranose and α-ᴅ-ribofuranose) highlighted in red. 
 
5.1.3 Exploring antibody based prymnesin detection 
The glycosylated region of prymnesin-1 (Figure 5.2) offers an interesting target for producing 
antibodies.  Antibodies to carbohydrates can give ‘exquisite specificity and sensitivity’,13 
which make them potentially very powerful tools for the detection of prymnesin toxins.  
However, carbohydrates are themselves poor antigens which only elicit a B-cell response; 
this results in the production of low affinity IgM antibodies with no long term memory.13,14  
Furthermore, repeated doses of a carbohydrate antigen may lead to a reduction in antibody 
production (hypo-responsiveness).14  By conjugating the carbohydrate antigen with a carrier 
protein, it is possible to elicit a T-cell response which leads to antibody production and 
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immune memory.14,15  This leads to the production of higher concentrations of antibodies, 
and an elevated immune response towards booster immunisations.  The choice of carrier 
protein is partly dictated by the species being immunised against the glycoprotein.  For 
human immunisation, diphtheria or tetanus toxoid are often used as the host is often already 
vaccinated against these antigens, and so a better immune response is seen.13  However, this 
is unlikely the case for animals, and as such the much cheaper alternative, bovine serum 
albumin (BSA) has proved an effective and convenient carrier protein.13  For joining the 
carbohydrate based prymnesin fragment with a carrier protein there are a plethora of 
available methods,16 and some of these are discussed in more detail later in this chapter.  
A general overview of the process envisaged is shown in Figure 5.3, whereby a glycosylated 
fragment inspired by prymnesin-1 is conjugated to a carrier protein decorated with a suitable 
linker.  The blue star on the fragment and the red stars on the protein linkers represent 
complimentary functional groups for ‘click’ or cross coupling reactions.  Once coupled, this 
toxin fragment-protein conjugate would then be used to inoculate an animal, the immune 
system of which produces antibodies against the antigen presented by the carrier protein.15  
These antibodies would be harvested from the animal and if found to be specific for the 
prymnesin-1 toxin then they would be incorporated into a lateral flow device (Figure 5.1).17,18  
Such a device would be of use to stakeholders in the project as it would allow a very simple, 
cost effective way of detecting prymnesin-1 toxins in waterways. 
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Figure 5.3 – An abstract overview of how a synthetic fragment might be utilised to develop a lateral 
flow device based toxin detection system.  Cross coupling groups on the fragment and linkers on the 
carrier protein are shown as blue and red stars respectively.  Cross coupling gives a fragment-protein 
conjugate which is then used to immunise a suitable animal with a view to producing antibodies 
against the antigen.13  If the antibodies prove specific and sufficiently sensitive towards PRM-1, these 
antibodies would be used to produce a lateral flow device for detecting and quantifying PRM-1 in 
waterways.18 
 
Building on the experience gained in synthesising the glyceryl glycoside fragments inspired 
by the various prymnesin toxins, we decided to try and synthesise a slightly larger fragment 
containing two sugar moieties with a view to using it to raise antibodies for prymnesin toxin 
detection.  There are a few benefits to using a synthetic fragment.  First it is possible to 
ensure the fragment being used is homologous; secondly if the antibodies raised from the 
fragment do show a response to the whole toxin, it is easier to determine which part of the 
toxin is being detected.  Finally, the stereochemistry of the prymnesin backbones in the 
glycosylated regions of the toxin are currently undefined.  If antibodies raised against one 
fragment isomer show an immune response when challenged with the whole prymnesin 
toxin but those from the other fragment isomer do not, it may help to elucidate the 
stereochemistry at the analogous backbone region of the natural toxin. 
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5.2 Chemistry  
5.2.1 Retrosynthetic analysis of toxin fragment 
 
The retrosynthetic pathway shown in Scheme 5.1 was used to plan the synthetic pathway 
towards the glycosylated toxin fragment inspired by prymnesin-1.  Step i) in the pathway 
considered the final molecule which would be present before global deprotection (2).  The 
1,2-cis α-ribose linkage would require non-participating protecting groups, and so benzyl 
ether groups were selected as 2,3,5-tri-O-benzyl ribose is commercially available.  The 1,2-
trans α-ʟ-arabinose linkage would be obtained efficiently using ester protecting groups 
which would control the stereochemistry of the glycosidic bond by neighbouring group 
participation.19  Because per-O-benzoyl β-ʟ-arabinopyranose (1) was already available from 
the previous synthesis described in this project (Chapter 4), benzoyl protecting groups were 
selected. 
Step ii) in the retrosynthetic pathway breaks the ribose glycosidic linkage.  The synthons are 
an oxygen anion a ribosidic cation, which gives a 2° alcohol (3) and an appropriate riboside 
donor (4). For the forward glycosylation step there was some literature precedence to show 
that 1,2-cis glycosylation at this 2° OH group might best be performed using a 
trifluoroimidate donor and TMSOTf promotor.20–22  This lead to 2,3,5-tri-O-benzyl-1-O-
[(2,2,2-trifluoro-N-phenylethanimidoyl]-β-ᴅ-ribofuranose (4) as the ribose donor, the 
synthesis for which has already been reported in the literature.22 
Step iii) breaks the bond between the fragment and the linker.  At this point an open mind 
was being kept on which linker would be most appropriate for conjugating the fragment onto 
a carrier protein (see Figure 5.5).  The synthons would be a terminal cation on the main 
fragment and an oxygen anion on the linker.  The real reagent for the linker would therefore 
be an alcohol (6).  For the main fragment one can imagine the alkyl cation as either an alkyl 
bromide (7), or imagine an intramolecular quenching of the synthon cation by the 2° hydroxyl 
group to form an epoxide (5). Of the two possible fragments, an epoxide seems the most 
appropriate choice as the alkyl bromide would probably be synthesised from the epoxide 
anyway.23  The forward ring opening step has been explored in the literature and attack of 
the epoxide by an alcohol in the presence of a Lewis acid in a non-polar solvent showed 
promise of working well.24 
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Step iv) and v) explore two different ways of installing the epoxide.  Step iv) breaks the 
glycosidic bond to give an appropriate glycosidic donor (8) and glycidol as the acceptor.  This 
has the advantage that both enantiomers of glycidol are commercially available as optically 
pure compounds, leading to an epoxide with known stereochemistry.  A similar forward 
reaction which uses a thiogalactoside to glycosylate glycidol has been reported in the 
literature. 25,26  However we had problems replicating this methodology in the lab.  By 
contrast step v) considers the reduction of the epoxide to a corresponding alkene (9).  The 
forward reaction for this could correspond to a mCPBA mediated epoxidation of the alkene.  
The disadvantage to this is that a mixture of anti and syn epoxide isomers will be formed.24,27  
Of the two methods it was decided that oxidation of the alkene would be the preferred 
forward step as both the syn and anti epoxides were required, and preliminary attempts to 
glycosylate glycidol had proved unsuccessful. 
Step vi) breaks the 1,2-trans glyosidic linkage between allyl alcohol and per-O-benzoyl α-ʟ-
arabinopyranose (11).  The forward glycosylation step could be performed under Koenigs–
Knorr conditions using the corresponding glycosyl bromide (10).28  Per-O-benozyl ʟ-
arabinopyranose (11) had already been synthesised for previous use in this project and allyl 
alcohol is commercially available. 
This retrosynthetic analysis was used to propose a sensible forward synthetic pathway 
towards a two glycosylated prymnesin-1 fragment (1) with a (R-) and (S-) stereochemistry at 
the glycerol backbone and a linker for later conjugation onto a carrier protein with a view to 
antibody production. 
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Scheme 5.1 – The retrosynthetic analysis used to plan the synthesis of the PRM-1 fragment.  i) Ester 
protecting groups direct 1,2-trans glycosylation by neighbouring group participation, whilst benzyl 
ether protecting groups are suitable for 1,2-cis glycosylations.19 ii) Breaking of ribosidic linkage to give 
the known ribose donor (4) shown in blue.29 iii)  Breaking the linker bond gives a terminal carbocation.  
This could exist as either the alkyl bromide (7) or epoxide (5) shown. iv)  The epoxide is cleaved to give 
the glycosyl donor (8) and glycidol26 or v) the epoxide ring oxygen is cleaved to give an adjacent alkyl 
anion and cation which could best equates to an alkene (9).  vi)  Breaking the glycosidic linkage to give 
a glycosyl bromide (10) and allyl alcohol. 
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5.2.2 Synthesis of (2-R/S-Oxiranyl)methyl 2’,3’,5’-tri-O-benzoyl-α-ʟ-
arabinopyranoside (5) 
ʟ-arabinose was per-O-benzoylated using benzoyl chloride and DMAP to give per-O-benzoyl 
β-ʟ-arabinopyranose (11) (Scheme 5.2).30  Attempts to use per-O-benzoyl β-ʟ-
arabinopyranose  (11) for the BF3.OEt2 promoted glycosylation of allyl alcohol gave a 3.2:1.0 
mixture of α and β anomers as judged by integration of the 1H NMR H-1’ signals (Figure 5.4). 
 
Figure 5.4 – 1H NMR showing the integration of the H-1’’ signals for a mixture of prop-2-en-1-yl 2,3,5-
tri-O-benzoyl-α/β-ʟ-arabinopyranoside. 
 
To ensure only the desired 1,2-trans α-anomer was synthesised, the glycosylation was 
repeated under Koenigs-Knorr conditions (Scheme 5.2).19,31   
 
 
Scheme 5.2 – The chemical synthesis of (oxiran-2-yl) methyl 2,3,5-tri-O-benzoyl-α-ʟ-
arabinopyranoside (5).  i) BzCl, DMAP, Pyr. ii) allyl alcohol, BF3.OEt2, DCM; iii) 33% v/v HBr/AcOH, DCM. 
iv) Ag2CO3, DCE, 4ÅMS. v) mCPBA, DCE, reflux. 
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2,3,5-Tri-O-benzoyl bromo-β-ʟ-arabinopyranoside (10) was produced by treating per-O-
benzoyl β-ʟ-arabinopyranose (11) with 33% v/v HBr in AcOH.  The glycosyl bromide donor 
(10) was used to glycosylate allyl alcohol using silver carbonate as the promotor.28  The 1,2-
trans configuration of prop-2-en-1-yl 2,3,5-tri-O-benzoyl-α-ʟ-arabinopyranoside (9) was 
confirmed by 1H NMR spectrum which showed the H-1’ signal at 4.82 ppm as a doublet with 
a J1’,2’ coupling value of 6.1 Hz.  The next step was the oxidation of the alkene to an epoxide 
which could subsequently be ring opened to form the glycosyl glycerol; this was achieved 
using mCPBA.32  The epoxidation gave a 1:1 mixture of (R)- and (S)- epoxides (5) as judged by 
integration of the H-1’ signals of the sugars, but the epoxide diastereoisomers were 
inseparable by TLC.  As the stereochemistry at the glycosylated backbone of prymnesin toxins 
is not defined in the literature, it was necessary to make both possible isomers of the 
fragment.12,33  Therefore whilst it was unfortunate the two isomers were inseparable, it was 
not a barrier to further progress as we would need use both isomers in the synthesis anyway.  
It was still possible to characterise the two isomers of (oxiran-2-yl)methyl 2,3,5-tri-O-
benzoyl-α-ʟ-arabinopyranoside) (5) using a combination of HSQCed and COSY 2D NMR to 
assign the 1H and 13C NMR signals. 
 
5.2.3 Epoxide ring opening to synthesise 3-(3-azidopropoxy)-2-
hydroxypropyl 2,3,4-tri-O-benzoyl-α-ʟ-arabinopyranoside (12) 
Next it was necessary to consider ring opening the epoxide to install a functional group which 
could be used to couple the fragment with a protein bound linker (Figure 5.5).  Two coupling 
reactions were explored, the first was a copper(I)-catalyzed alkyne-azide cycloaddition 
(CuAAC) to give a 1,2,3-triazole linkage.34,35  The second was a carbodiimide crosslinking 
reaction to give an amide linkage.36   
For the CuAAc coupling, an alkyne or azide was required on the prymnesin fragment, and 
commercially available reagents were considered.  It quickly became obvious that having an 
alkyne on the prymnesin fragment was a problem because the benzyl ether protecting 
groups on ribose (4) which was going to be installed at the 2° glycerol OH would need to be 
removed by hydrogenation.  Although there is some literature precedence for protecting 
alkyne groups from reduction by hydrogenation, this is by no means perfect and there is still 
a significant degree of alkyne reduction.37  An alternative strategy involved placing the azide 
on the prymnesin fragment, but again azides are prone to reduction to amines by 
hydrogenation.  
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Figure 5.5 – Exploring reactions which could be used to couple the PRM-1 fragments to a protein 
bound linker.  R = PRM-1 fragment, R2 = protein bound linker 
 
Carbodiimide crosslinking of the PRM-1 fragment to a protein bound linker would provide a 
way of utilising functional groups (amines and esters) which are not affected by 
hydrogenation during global deprotection.  The first attempted epoxide ring opening of (2-
R/S-oxiranyl)methyl 2’,3’,5’-tri-O-benzoyl-α-ʟ-arabinopyranoside (5) employed methyl 3-
hydroxypropionate and Sc(OTf)2 as the catalyst.24  This was unsuccessful with 3-
hydroxypropionate apparently polymerising to form a single rubber like ball (Scheme 5.3).  
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Scheme 5.3 - Attempted Lewis-acid catalysed epoxide opening using methyl-3-hydroxypropionate. 
It was therefore decided to try and switch the functional groups around and attach the amine 
group to the toxin fragment.  3-Azido propanol was used as a protected amine linker to ring 
open the epoxide (Scheme 5.4).  The azide acted as a protected amine group to ensure only 
the alcohol could nucleophilically attack the epoxides (5).  The azide would be readily 
reduced to the amine by hydrogenation during the global deprotection steps.   
 
Scheme 5.4 – Epoxide ring opening to give 3-(3-Azidopropoxy)-2-hydroxypropyl 2,3,4-tri-O-benzoyl-
α-ʟ-arabinopyranoside.  i) 3-azidopropanol, Sc(OTf)3, toluene. 
 
The ring opening (5) reaction using 3-azidopropanol and Sc(OTf)2 was successful, forming 3-
(3-azidopropoxy)-2-hydroxypropyl 2,3,4-tri-O-benzoyl-α-ʟ-arabinopyranoside (12) which 
was judged to be a 1:1 mixture of (R)- and (S)- isomers with respect to the 2° glycerol 
hydroxide group by integration of the H-1’ and H-1’* 1H NMR signals at 4.92 and 4.82 ppm 
respectively.  The isomers were inseparable but it was possible to fully assign the 1H and 13C 
NMR signals in the mixture using a combination of HSQCed and COSY 2D NMR. 
 
5.2.4 Synthesis of 3-(3-aminopropoxy)-2-(α-ᴅ-ribofuranosyloxy)propyl)-
α-ʟ-arabinopyranoside (13) 
With the epoxides successfully ring opened, the new 2° alcohols (12) were ready to be used 
as acceptors in the final glycosylation step which would install an α-ribose 1,2-cis linkage 
(Scheme 5.5).  First a suitable ribose donor needed to be synthesised.  As a 1,2-cis linkage was 
required, it was necessary to use a ribose donor with non-participating protecting groups.  
Commercially available 2,3,5-tri-O-benzyl α/β-ᴅ-ribose was treated with 2,2,2-trifluoro-N-
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phenylacetimidoyl chloride and caesium carbonate to make 2,3,5-tri-O-benzyl-1-O-[(2,2,2-
trifluoro-N-phenylethanimidoyl]-β-ᴅ-ribofuranose (4).22  This donor has been used several 
times to good effect by Filippov et al.20–22 for stereoselective ribosylations using TMSOTf as 
a promotor and either DCM or DCE as a solvent.  
 
Scheme 5.5 – Continued synthesis: the epoxide ring opening and 1,2-cis glycosylation step to give 3-
(3-azidopropoxy)-2-[(2’,3’,5’-tri-O-benzyl-α-ᴅ-ribofuranosyl)oxy]propyl-2’’,3’’,4’’-tri-O-benzoyl-α/β-ʟ-
arabinopyranoside.  i) TMSOTf, DCE, 4ÅMS, -30 °C. ii) TMSOTf, DCM, 4ÅMS, -78 °C. 
 
The initial glycosylation of 3-(3-azidopropoxy)-2-hydroxypropyl 2,3,4-tri-O-benzoyl-α-ʟ-
arabinopyranoside (12) with 2,3,5-tri-O-benzyl-1-O-[(2,2,2-trifluoro-N-phenylethanimidoyl]-
β-ᴅ-ribofuranose (4) was attempted in DCE at -30 °C.  HSQCed and 1H NMR of the crude 
reaction mixture allowed for rapid identification of the ribose anomeric signals (as described 
in Chapter 4, Figure 4.9).  A 1,2-cis α-ribose linkages give H-1’’ signals as doublets and C-1’’ 
shifts of ~100 ppm; by contrast 1,2-trans β-ribose linkages showed H-1’’ signals as singlets 
and C-1’’ shifts of ~105 ppm.38  Unfortuantely it was quickly obvious that the glycosylation at 
-30 °C had produced predominately the thermodynamic 1,2-trans β-riboside, with an α/β 
ratio of 1.0:5.8 as judged by integration of the H-1’’ NMR signals of the crude glycosylation 
mixture (13) (Figure 5.6). 
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Figure 5.6 – 1H NMR of the crude glycosylation mixture showing the H-1’ signals for the 1,2-cis and 
1,2-trans glycosidic linkages.  Glycosylation at -30 °C gave predominately the undesired 1,2-trans β-ᴅ-
riboside. 
  
The glycosylation was attempted again in DCM which allowed the reaction mixture to be 
cooled to -78 °C in a dry ice-acetone bath without freezing.  This time 1H NMR of the crude 
reaction mixture (13) showed an excess of the desired kinetic 1,2-cis α riboside, with an α/β 
ratio of 1.4:1 as judged by integration of the H-1’’ NMR signals.  Because an inseparable 1:1 
mixture of acceptors had been used, the glycosylation had resulted in 4 products (2 x α-
ribosides and 2 × β-ribosides).  Because antibody response relies on fit of the antigen, the 
differing shapes of the two isomers has the potential to lead to very different immune 
responses.13  Fortunately the two α-ribosides were separable from both the crude reaction 
mixture and also from one another by semi-preperative TLC, and both were purified from 
the reaction mixture to give the (2R-) and (2S-) isomers of 3-(3-azidopropoxy)-2-[(2,3,5-tri-
O-benzyl-α-ᴅ-ribofuranosyl)oxy]propyl-2,3,4-tri-O-benzoyl-α- ʟ arabinopyranoside, (2R-14) 
and (2S-14) respectively.  Once separated the stereochemistry of the 1,2-cis α-ribose linkages 
were confirmed by 1H NMR with the H-1’’ signals appearing as doublets with J1’’,2’’ coupling 
values of 4.2-4.4 Hz and C-1’’ shifts of 101.4-101.5 ppm.  The 1,2-trans α-ʟ-arabinopyranose 
linkages were confirmed by the H-1’ signals appearing as doublets with J1’,2’ coupling values 
of 6.0-7.0 Hz (Figure 5.7). 
 
 
 
 
  α-ᴅ-Ribf  
  β-ᴅ-Ribf  
Both 
overlapping  
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Figure 5.7 – Zoomed 1H NMR spectra of the separated (2R-) and (2S-) isomers of 3-(3-Azidopropoxy)-
2-[(2,3,5-tri-O-benzyl-α-ᴅ-ribofuranosyl)oxy]propyl-2,3,4-tri-O-benzoyl-α- ʟ arabinopyranoside (14).  
When these spectra were recorded, I did not know which isomer was which.  Therefore the original 
compound names from the time (ESH-2-173-3 and ESH-2-173-4) are shown in red and blue which will 
help to clarify the next section (5.2.5). 
 
5.2.5 Distinguishing between the (R)- and (S)- isomers of (14) 
Although the (R-) and (S-) isomers of 3-(3-azidopropoxy)-2-[(2’,3’,5’-tri-O-benzyl-α-ᴅ-
ribofuranosyl)oxy]propyl-2’’,3’’,4’’-tri-O-benzoyl-α-ʟ-arabinopyranoside (14) had been 
separated, the next challenge was identifying which was which.  The lowest energy 
conformation for both isomers was calculated using MarvinSketch 15.1.19.0 Caluclator 
Plugins (Figure 5.8).  There was a noticeable difference in the lowest energy conformations, 
with the (2S-14) isomer having a benzyl protecting group from ribose lying over the 3-azido 
propanol linker.  By contrast the (2R-14) isomer showed the aromatic sugar protecting 
groups all grouped together, with nothing in close proximity to the 3-azido propanol linker. 
  α-ᴅ-Ribf        α-ʟ-Arap 
ESH-2-173-3 
ESH-2-173-4 
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715 kJ/mol 
 
 
 
664 kJ/mol  
Figure 5.8 - lowest energy calculations and 3D model representations for the (2R-) and (2S-) isomers 
of 13.  There is a clear difference in the conformations, with the (2S)- isomer having aromatic protons 
in close proximity with a the CH2 group on the azido-linker. 
 
As a result of these lowest energy conformation models it was proposed that it should be 
possible to see long range nOe interactions between the 3-azido propanol linker and a benzyl 
protecting group on ribose for one of the compounds (the S- isomer) but not for the other 
(the R- isomer).  NOESEY 2D NMR spectra were recorded for both compounds, with ‘ESH-2-
173-3’ showing clear long range coupling between 3-azido propanol and the benzyl 
protecting groups, whilst ‘ESH-2-173-4’ shows no long-range coupling between 3-azido 
propanol and the benzyl protecting groups (Figure 5.9).  On this basis compound ‘ESH-2-173-
3’ was assigned as the (S)- isomer (2S-14) and compound ‘ESH-2-173-4’ was assigned as the 
(R)- isomer (2R-14). 
No long range nOe 
expected in lowest 
energy conformation 
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Figure 5.9 - NOESEY 2D NMR for compound ESH-2-173-3 shows nOe long range coupling between the 
benzyl groups and 3-azido propanol linker, and as such was assigned as the (2S)- isomer (2S-14); 
NOESEY 2D NMR for compound ESH-2-173-4 does not show any nOe long range coupling between the 
benzyl groups and 3-azido propanol linker, and as such which was assigned as the (2R)- isomer (2R-
14). 
 
Global deprotection was performed by first simultaneously removing the benzyl ether 
groups from ribose and reducing the azide to an amine by hydrogenation over a Pd/C catalyst 
(Scheme 5.6).  The benozyl protecting groups on ʟ-arabinose were removed by 
transesterification using a mixture of MeOH/H2O/Et3N (5:2:1).  This method of removing 
ester protecting groups was chosen over a sodium methoxide solution because the base, 
Et3N, is volatile.  By contrast sodium methoxide which is commonly used for carbohydrate 
de-esterification is removed using a proton resin, which would have also bound with the free 
amine group on the final products.  The inclusion of water in the debenzoylation did lead to 
some hydrolysis as well which meant that there was some benzoic acid contamination.  This 
was readily removed by passing the final compounds through Dowex® 1X2-400 resin (OH- 
form) in water. 
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Scheme 5.6 - global deprotection strategy for the final fragments. i) H2, 10% Pd/C, EtOAc/MeOH 1:1. 
ii) MeOH/H2O/Et3N (5:2:1) 
 
At the end of the deprotection steps we were left with (2R)- and (2S)- isomers of 3-(3-
aminopropoxy)-2-(α-ᴅ-ribofuranosyloxy)propyl α-ʟ-arabinopyranoside, (2R-15) and (2S-15) 
respectively,  as separate and homologous compounds in 59% and 41% yields (2 steps).  The 
yields might be attributed to some adsorption onto the Pd/C catalyst and also the anion 
exchange purification step. 
 
5.3 Summary 
Due to the reported difficulties in producing larger quantities of purified prymnesin toxins, a 
two small fragment inspired by PRM-1, the (2R-) and (2S-) isomers of 3-(3-aminopropoxy)-2-
(α-ᴅ-ribofuranosyloxy)propyl α-ʟ-arabinopyranoside, (2R-15) and (2S-15) respectively, were 
chemically synthesised.  Because there is no literature guidance for the stereochemistry of 
the backbone of this region of prymnesin toxins, both the (2R-15) and (2S-15)- isomers were 
synthesised.  A retrosynthetic analysis of the target compounds was performed which 
considered the use of participating and non-participating protecting groups on the 
carbohydrate donors (2).  The introduction of the glycerol backbone was also considered, 
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and retrosynthetic analysis showed that the ring opening of an epoxide (5) derived from the 
epoxidation of an alkene (9) was found to be the most useful way forward.  A selection of 
functional groups suitable for cross coupling reactions for protein conjugation were also 
considered (Scheme 5.1), and their installation onto the glycerol backbone, as well as the 
compatibility with the global deprotection steps were also discussed.  For the forward 
synthesis, 2,3,4-tri-O-benzoyl-β-ʟ-arabinopyranosyl bromide (10) was used for the Ag2CO3 
promoted glycosylation of allyl alcohol, which gave exclusively the 1,2-trans α-anomer.  The 
alkene (9) was then oxidised to an epoxide (5) with mCPBA.  The epoxide was ring opened 
with 3-azido propanol in toluene using Sc(OTf)3 as a Lewis acid catalyst to give 3-(3-
azidopropoxy)-2-hydroxypropyl 2,3,4-tri-O-benzoyl-α-ʟ-arabinopyranoside (12) as an 
inseparable 1:1 mixture of (2R)- and (2S)- isomers.  This mixture was then glycosylated with 
2’,3’,5’-tri-O-benzyl-β-ᴅ-ribofuranosyl (N-phenyl)-2,2,2-trifluoroacetimidate (4) in DCM at -
78 °C using TMSOTf as a promotor.  Glycosylation gave a mixture of α/β- ribosides in a ratio 
of 1.4:1 (13).  The α-ribosides were separable both from the β-ribosides and also from each 
other to yield both the (2R)- and (2S)- isomers of 3-(3-azidopropoxy)-2-[(2’,3’,5’-tri-O-benzyl-
α-ᴅ-ribofuranosyl)oxy]propyl-2’’,3’’,4’’-tri-O-benzoyl-α- ʟ -arabinopyranoside ((2R-14) and 
(2S-14) respectively) as separate and homologous compounds.  The assignment of the 
stereochemistry at the 2° position of the glycerol backbone was achieved by comparing nOe 
NMR spectra with computational models of the lowest energy conformations of both 
isomers.  It was noted that for (2S-14) one of the benzyl protecting groups on ribose was in 
close proximity to the azido propanol linker.  nOe NMR of the two compounds showed a 
long-range interaction between the aromatic protecting group and the azido propanol linker 
for only one of the two isomers, and this was assigned as the (2S)- isomer (2S-14).  Global 
deprotection was achieved by hydrogenation over Pd/C followed by transesterification to 
give (2R)- and (2S)- 3-(3-aminopropoxy)-2-(α-ᴅ-ribofuranosyloxy)propyl α-ʟ-
arabinopyranoside ((2R-15) and (2S-15) respectively).  Due to time constraints, and also a 
very late discovery in our lab that prymnesin-B1 (which is glycosylated with β-ᴅ-
galactopyranose)12 would seem to be the toxin produced by the P. parvum strain in the 
Norfolk Broads, the fragment was not used for further conjugation or immunisation.  
However now that the fragment is in hand, future attempts could be made to use it as an 
antigen for antiPRM-1 production. 
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5.4 Experimental 
5.4.1 Chemistry 
2’,3’,5’-Tri-O-benzyl-β-ᴅ-ribofuranosyl  (N-phenyl)-2,2,2-trifluoroacetimidate (4) 22 
 
2,3,5-Tri-O-benzyl-β-ᴅ-ribofuranose (840 mg, 2.0 mmol), 2,2,2-trifluoro-N-
phenylacetimidoyl chloride (600 µL, 4.0 mmol), caesium carbonate (720 mg, 2.2 mmol) and 
water (100 µL) were dissolved into acetone and stirred for 3 hours at room temperature.  
The reaction mixture was then filtered through Celite and the solvent was removed in vacuo 
to give a crude syrup.  The crude mixture was purified by FCC to give the title compound (4) 
(800 mg, 59%) as an off white powder;  Rf  0.61 (hexane/EtOAc 8:2); δH(400 MHz; CDCl3) 7.54-
7.52 (m, 3H, Ar), 7.32-7.08 (m, 17H, Ar), 6.79 (d, J = 7.8, 1H), 6.32 (bs, 1H, H-1), 4.66-4.43 (m, 
7H, 3 × CH2Ph & H-4), 4.17-4.06 (m, 1H, H-3), 3.70 (dd, J4,5 = 2.8 Hz, 2J5a,5b = 10.9 Hz, 1H, H-5), 
3.59 (dd, J4,5’ = 5.2 Hz, 2J5a,5b = 10.9 Hz, 1H, H-5’); δC(100 MHz; CDCl3) 143.8 (C=N), 138.1, 
137.5, 137.4, 135.4, 129.5, 128.8, 128.5, 128.5, 128.4, 128.2, 128.1, 128.0, 128.0, 127.7, 
126.3, 124.4 (Ar), 119.7 (CF3), 102.5 (C1), 82.3 (C4), 78.7 (C2), 77.4 (C3) , 73.4, 72.8, 72.4 (3 × 
CH2Ph), 70.2 (C5);  δF (376 MHz; CDCl3) -75.6 (CF3); LRMS (ESI+) m/z calc. for C34H32F3NO5Na+ 
614.2 [M+Na]+ found 613.6 [M+Na]+.  The NMR data were in accordance with the literature.22 
 
Per-O-benzoyl-β-ʟ-arabinopyranose (11)30 
 
A solution of ʟ-arabinose (1.0 g, 6.7 mmol) and DMAP (1 mol %) in dry pyridine (15 mL) was 
cooled in an ice bath and benzoyl chloride (5.0 mL, 43 mmol) was added dropwise over 30 
minutes. The reaction mixture allowed to warm and stirred overnight at room temperature.  
The solvent was removed in vacuo and the crude mixture was dissolved in EtOAc (20 mL) and 
washed with 1M HCl solution (3 × 5 mL) to remove any residual pyridine.  The organic layer 
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was dried over MgSO4 and the solvent was removed under reduced pressure before the 
crude mixture was purified by FCC to give the title compound (11) (3.40 g, 90%) as a white 
foam, Rf 0.4 (hexane/EtOAc 3:1); [α]D +301 (c 1.0, CHCl3) (lit.30 +291.2 (c 0.1, CHCl3)); δH(400 
MHz; CDCl3) 8.14-8.12 (m, 4H, Ar), 7.90-7.87 (m, 4H, Ar), 7.65-7.61 (m, 2H, Ar), 7.55-7.45 (m, 
6H, Ar), 7.32-7.28 (m, 4H, Ar), 6.87 (bs, 1H, H-1), 6.07-6.06 (2H, m, H-2,3), 5.91-5.89 (m, 1H, 
H-4), 4.42 (dd, J4,5a = 1.0 Hz, 2J5a,5b = 13.5 Hz, 1H, H-5a), 4.18 (dd, J4,5b = 2.1 Hz, 2J5a,5b = 13.5 
Hz); δC(100 MHz; CDCl3) 165.8, 165.7, 165.6, 164.7 (4 × C=O), 133.8, 133.6, 133.5, 133.4, 
129.9, 129.8, 129.4, 129.1, 128.9, 128.8, 128.8, 128.6, 128.4, 128.4 (Ar), 91.1 (C1), 69.5 (C4), 
68.2 (C3), 67.8 (C2), 63.0 (C5).  1H and 13C NMR values were in agreement with literature 
values30 
 
2,3,4-Tri-O-benzoyl-β-ʟ-arabinopyranosyl bromide (10)39 
 
Per-O-benzoyl-β-ʟ-arabinopyranose (11) (2.4 g, 4.2 mmol) was dissolved into dry DCM (10 
mL) under N2.  A solution of 33% HBr in AcOH (2.5 mL) was added in a single portion and the 
reaction mixture stirred for 3 hours at room temperature after which time TLC (hex/EtOAc 
3:1) showed consumption of the start material.  The solvent was removed under reduced 
mixture pressure and the reaction re-dissolved into EtOAc (10 mL) before being washed with 
ice cold saturated NaHCO3 (3 × 3 mL).  The organic layer was dried over MgSO4 and the 
solvent removed under reduced pressure to give the title compound (10) (2.1 g, 95%) as an 
oil which was immediately used in the next step, Rf 0.42 (hexane/EtOAc 3:1); δH(400 MHz; 
CDCl3) 8.11-8.08 (m, 1H, Ar), 8.03-8.01 (m, 1H, Ar), 7.87-7.85 (m, 1H, Ar), 7.63-7.30 (m, 9H, 
Ar), 6.94 (d, J1,2 = 3.9 Hz, 1H, H-1), 6.00 (dd, J2,3 = 10.5 Hz, J3,4 = 3.9 Hz, 1H, H-3), 5.84-5.83 (m, 
1H, H-4), 5.71 (dd, J1,2 = 3.9 Hz, J2,3 = 10.5 Hz, 1H, H-2), 4.47 (dm, 2J5a,5b = 12.9 Hz, 1H, H-5a), 
4.23 (dd, J4,5b = 1.9 Hz, 2J5a,5b = 12.9 Hz, 1H, H-5b); δH(100 MHz; CDCl3) 165.6, 165.6, 165.4 (3 
× C=O), 133.8, 133.7, 133.4, 130.0, 129.9, 129.8, 128.7, 128.6, 128.4 (12 × Ar) 89.8 (C1), 68.9 
(C4), 68.7 (C2), 65.0 (C3), 60.4 (C5).  The 1H NMR were in agreement with literature values.39 
 
Prop-2-en-1-yl 2,3,5-tri-O-benzoyl-α-ʟ-arabinopyranoside (9) 
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2,3,4-Tri-O-benzoyl-β-ʟ-arabinopyranosyl bromide (10) (1.8 g,3.5 mmol) and allyl alcohol 
(290 µL, 4.2 mmol) were dissolved in DCE (30 mL).  4Å MS (2.0 g) were added and the solution 
was stirred at room temperature for 30 minutes to remove any moisture.  Silver carbonate 
(1.2 g, 4.2 mmol) was added and the reaction mixture was stirred in the dark at room 
temperature overnight.  The reaction mixture was then filtered through Celite and the 
volatile components were evaporated in vacuo to give a crude syrup which was purified by 
FCC to give the title compound (9) (1.1 g, 62%) as a colourless oil. Rf 0.64 (hexane/EtOAc 7:3); 
[α]D +106° (c = 1.0, CHCl3); δH(400 MHz; CDCl3) 8.05 – 8.01 (m, 4H, Ar), 7.94 (dd, 4JB,B’ = 1.4 Hz, 
JB,C = 8.5 Hz, 2H, Ar), 7.59-7.31 (m, 9H, Ar), 5.86 (m, 1H, H-2), 5.74 (dd, J1’,2’ = 6.1 Hz, J2’,3’ = 8.7 
Hz, 1H, H-2’), 5.71-5.68 (m, 1H, H-4’), 5.62 (dd, J2’,3’ = 8.7 Hz, J3’,4’ = 3.4 Hz, 1H, H-3’), 5.29 (dq, 
J2,3a = 17.3 Hz, 2J3a,3b = 1.7 Hz, 1H, H-3a), 5.17 (dq, J2,3b = 10.5 Hz, 2J3a,3b = 1.7 Hz, 1H, H-3b), 
4.82 (d, J1’,2’ = 6.1 Hz, 1H, H-1’), 4.38 (ddt, J1a,1b = 13.1 Hz, J1a,2 = 5.0 Hz, 4J1a,3 = 1.6 Hz, 1H, H-
1a), 4.33 (dd, J4,5a’ = 4.4 Hz, 2J5a’,5b’ = 12.7 Hz, 1H, H-5a’), 4.16 (ddt, J1a,1b = 13.1 Hz, J1b,2 = 6.2 
Hz, 4J1b,3 = 1.3 Hz, 1H, H-1b), 3.90 (dd, J4,5b’ = 2.3 Hz, 2J5a’,5b’ = 12.7 Hz, 1H, H-5b’); δC(100 MHz; 
CDCl3) 165.7, 165.6, 165.3 (3 × C=O), 133.5 (C2), 133.4, 133.3, 133.3, 129.9, 129.9, 129.8, 
129.8, 129.4, 129.4, 129.1, 128.5, 128.5, 128.4, 117.8 (C3), 99.4 (C1’), 70.5 (C3’), 70.0 (C2’), 
69.7 (C1), 68.3 (C4’), 62.3 (C5’); HRMS (ESI+) m/z calc. for C29H26O8Na+ 525.1525 [M+Na]+ 
found 525.1522 [M+Na]+. 
 
(2-R/S-Oxiranyl)methyl 2’,3’,5’-tri-O-benzoyl-α-ʟ-arabinopyranoside (5) 
 
Prop-2-en-1-yl 2,3,5-tri-O-benzoyl-α-ʟ-arabinopyranoside (9) (1.1 g, 2.2 mmol) and mCPBA 
(450 mg, 2.6 mmol) were dissolved into DCE (20 mL) and heated to 80 °C overnight.  The 
solvent was removed in vacuo, the crude product was re-dissolved into EtOAc (10 mL) and 
washed with sat. sodium bicarbonate solution (3 × 3 mL).  The organic layer was then 
separated and dried over MgSO4, filtered and the solvent evapourated in vacuo to give the 
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title compounds (5) (640 mg, 45%) as a white powder (1:1 mixture of diastereoisomers, as 
judged by the integration of the H-1’ signals at 4.92 and 4.82 ppm). Rf 0.5 (hexane/EtOAc 
7:3); δH(400 MHz; CDCl3) 8.08-7.94 (m, 12H, Ar), 7.60-7.32 (m, 18H, Ar), 5.73 (dd, J1’,2’ = 6.0 
Hz, J2’,3’ = 8.4 Hz, 2H, H-2’,2’*), 5.70-5.69 (m, 2H, H-4’,4’*), 5.62 (dd, J2’3’ = 8.4 Hz, J3’,4’ = 3.4 
Hz, 2H, H-3’,3’*), 4.92 (d, J1’a,2’ = 6.0 Hz, 1H, H-1’), 4.82 (d, J1’b,2’ = 6.0 Hz, 1H, H-1’*), 4.34 (m, 
2H, H-5a’,5a’*), 4.09 (dd, J1a,1b = 12.0 Hz, J1a,2 = 3.0 Hz, 1H, H-1a), 3.91 (dd, 2J5a’,5b’ = 12.1Hz, 
J4,5’’ = 3.0 Hz, 2H, H-5b’,5b’*), 3.85 (dd, J1a*,1b* = 12.0 Hz, J1a*,2* = 5.1 Hz, 2H, H-1a*, H-1b*), 
3.19-3.12 (m, 2H, H-2, 2*), 2.76-2.73 (m, 2H, H-3a,3a*), 2.62 (dd, 2J3b*,3a* = 5.1 Hz, J3b*,2* = 2.6 
Hz, 1H, H-3b*), 2.58 (dd, 2J3b*,3a* = 5.1 Hz, J3b*,2* = 2.6 Hz, 1H, H-3a*); δC(100 MHz; CDCl3) 
165.7, 165.6, 165.3, (3 × C=O), 133.4, 133.4, 133.3, 130.2, 129.9, 129.8, 129.4, 129.3, 129.1, 
128.5, 128.4, 128.3, 100.5 (C1’), 100.2 (C1’*), 70.4 (C3’), 70.2 (C3’*), 69.9, (C2’), 69.9 (C2’*), 
69.9 (C1), 68.9 (C1*), 68.2 (C4), 68.1 (C4*), 50.7 (C2), 50.4 (C2*), 44.3 (C3), 44.1 (C3*); HRMS 
(ESI+) m/z calc. for C29H26O9Na+ 541.1469 [M+Na]+ found 541.1467 [M+Na]+. 
 
3-(3-Azidopropoxy)-2-hydroxypropyl 2,3,4-tri-O-benzoyl-α-ʟ-arabinopyranoside (12) 
 
(2-R/S-Oxiranyl)methyl 2’,3’,5’-tri-O-benzoyl-α-ʟ-arabinopyranoside (5) (1.0 g, 1.9 mmol), 3-
azido propanol (230 µL, 2.5 mmol) and Sc(OTf)3 (140 mg, 15 mol%) were dissolved into 
toluene (100 mL) and stirred vigorously at room temperature overnight.  The reaction 
mixture was then washed with sat. sodium bicarbonate solution (3 × 30 mL) and the organic 
layer dried over MgSO4, filtered and the solvent evaporated in vacuo.  The crude product was 
then purified by FCC to give the title compounds (12) (480 mg, 40%) as a colourless oil (1:1 
mixture of diastereoisomers as judged by the integration of the 1H signals at 4.81 and 4.79 
ppm). Rf 0.27 (hexane/EtOAc 7:3); δH(400 MHz; CDCl3) 8.08-8.00 (m, 8H, Ar), 7.93-7.90 (m, 
4H, Ar), 7.61-7.30 (m, 18H, Ar), 5.74 (dd, J1’,2’ = 6.5 Hz, J2’,3’ = 8.9 Hz, 2H, H-2’, H-2’*), 5.71-
5.67 (m, 2H, H-4’, H-4’*), 5.61 (dd, J2’,3’ =  8.9 Hz, J3’,4’ = 3.5 Hz, 2H, H-3’,3’*), 4.81 (d, J1’,2’ = 6.5 
Hz, 1H, H-1’), 4.79 (d, J1’*,2’* = 6.5 Hz, 1H, H-1’*), 4.34 (dd, J5,5’ = 12.9 Hz, J4,5 = 3.7 Hz, 2H, H-
5’,5’*), 3.98-3.86 (m, 6H, H-5’’,5’’*,2,2*,3a,3a*), 3.75 (dd, 2J3a,3b = 10.2 Hz, J2,3a = 4.4 Hz, 1H, 
H-3b), 3.67 (dd, 2J3a*,3b* = 9.8 Hz, J2,3a* = 3.5 Hz, 1H, H-3b*), 3.45-3.28 (m, 10H, H-
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4,1a,1a*,1b,1b*,6,6*), 2.35 (s, 1H, OH), 2.17 (s, 1H, OH*), 1.78-1.73 (m, 2H, H-5,5*); δC(100 
MHz; CDCl3) 165.7, 165.6, 165.3 (3 × C=O), 133.5, 133.4, 129.9, 129.9, 129.8, 129.4, 129.3, 
129.2, 129.0, 128.5, 128.5, 128.4, 128.2, 101.5 (C1), 101.4 (C1*), 71.6 (C4), 71.6 (C4*), 71.3 
(C3), 71.1 (C3*), 70.6 (C3’3’*), 69.3 (C2), 69.3 (C2*), 68.4 (C4’,4’*), 68.0 (C1,1*), 63.0 (C5’,5’*), 
48.4 (C6,6*), 29.0 (C5), 28.9 (C5*); HRMS (ESI+) m/z calc. for C32H33N3O10Na+ 642.2058 
[M+Na]+ found 642.2051 [M+Na]+. 
 
3-(3-Azidopropoxy)-2-[(2’,3’,5’-tri-O-benzyl-α-ᴅ-ribofuranosyl)oxy]propyl-2’’,3’’,4’’-tri-O-
benzoyl-α- ʟ -arabinopyranoside (14) 
  
3-(3-Azidopropoxy)-2-hydroxypropyl 2,3,4-tri-O-benzoyl-α-ʟ-arabinopyranoside (12) (200 
mg, 0.3 mmol) and 2’,3’,5’-tri-O-benzyl-β-ᴅ-ribofuranosyl (N-phenyl)-2,2,2-
trifluoroacetimidate (4) (270 mg, 0.45 mmol) were co-evaporated with dichloroethane (3 × 
10 mL) before being dissolved into dry dichloromethane (10 mL).   Freshly prepared 4Å MS 
(1.0 g) were added and the suspension was stirred under a nitrogen atmosphere for 30 
minutes.  The reaction mixture was then cooled to -78 °C and TMSOTf (11 µL, 60 µmmol) was 
added by syringe.  After 2 hours of stirring at -78 °C, the reaction was quenched with NEt3 
(20 µL) and the solvents were removed in vacuo.  Excess acceptor was removed by FCC and 
the diastereomeric products were then separated by preparative TLC (hexane/EtOAc 6:4) to 
give (2S-14) (30 mg, 10%) as a colourless oil.  Rf 0.53 (hexane/EtOAc 6:4); [α]D +120 (c 1.0, 
CHCl3); δH(400 MHz; CDCl3) 8.04-8.00 (m, 4H, Bz), 7.93 (dd, J = 8.2 Hz, J = 1.1 Hz, 2H, Bz), 7.57-
7.19 (m, 24H, Ar), 5.67 (dd, J1’,2’ = 6.0 Hz, J2’,3’ = 7.9 Hz, 1H, H-2’), 5.56 (m, 2H, H-4’,3’), 5.23 
(d, J1’’,2’’ = 4.4 Hz, 1H, H-1’’), 4.91 (d, J1’,2’ = 6.0 Hz, 1H, H-1’), 4.69 (d, 2JCHHPh, CHHPh, = 10.0 Hz, 1H, 
CHHPh), 4.66 (d, 2JCHHPh, CHHPh, = 10.0 Hz, 1H, CHHPh), 4.56 (d, 2JCHHPh, CHHPh, = 15.2 Hz, 1H, 
CHHPh), 4.53 (d, 2JCHHPh, CHHPh, = 15.2 Hz, 1H, CHHPh), 4.46 (d, 2JCHHPh, CHHPh, = 12.2 Hz, 1H, 
CHHPh), 4.40 (d, 2JCHHPh, CHHPh, = 12.2 Hz, 1H, CHHPh), 4.27 (dd, J3’’,4’’ = 7.4 Hz, J4’’,5’’ = 3.7 Hz, 1H, 
H-4’’), 4.20 (dd, J4’,5a’ = 3.8 Hz, 2J5a’,5b’ = 12.8 Hz, 1H, H-5a’), 4.03-4.00 (m, 1H, H-2), 3.92 (dd, 
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J2,3a = 6.3, J3a,3b = 10.9, 1H, H-3a), 3.86-3.81 (m, 2H, H-3’’,3b), 3.77 (dd, J1’’,2’’ = 4.4 Hz, J2’’,3’’ = 
6.5 Hz, 1H, H-2’’), 3.72 (dd, J4’,5b’ = 1.8 Hz, 2J5a’,5b’ = 12.8 Hz, 1H, H-5b’), 3.51 (d, J1,2 = 5.4 Hz, 
2H, H-1), 3.36 (dd, J4’’,5’’ = 3.7 Hz, 2J5a’’,5b’’ = 3.7 Hz, 2H, H-5a’’,5b’’), 3.34-3.26 (m, 2H, H-4), 3.27 
(t, J5,6 = 6.8 Hz, 2H, H-6), 1.69-1.62 (m, 2H, H-5); δC(100 MHz; CDCl3) 165.7, 165.6, 165.3 (3 × 
C=O), 138.4, 138.1, 138.0, 133.3, 133.3, 129.9, 129.9, 129.5, 129.2, 128.5, 128.4, 128.4, 
128.4, 128.4, 128.3, 128.1, 127.8, 127.7, 127.7, 127.6, 127.6, 127.6, 101.4 (C1’’), 100.5 (C1’), 
81.8 (C4’’), 75.7 (C2), 75.6 (C3’’), 74.4 (CH2Ph), 72.4 (CH2Ph), 72.2 (CH2Ph), 71.5 (C1), 70.5 
(C3’), 70.1 (C2’), 70.0 (C5’’), 67.0 (C3), 68.5 (C4’), 67.9 (C4), 62.2 (C5’), 48.4 (C6), 29.1 (C5); 
HRMS (ESI+) m/z calc. for C58H59N3O14Na+ 1044.3889 [M+Na]+ found 1044.3890 [M+Na]+ and 
(2R-14) (45 mg, 15%) as a colourless oil.  Rf 0.45 (hexane/EtOAc 6:4); [α]D + 95.9 (c 1.0, CHCl3); 
δH(400 MHz; CDCl3) 8.01-8.00 (m, 4H, Bz), 7.87 (dd, J = 8.2 Hz, J = 1.0 Hz, 2H, Bz), 7.56-7.22 
(m, 24H, Ar), 5.74 (dd, J1’,2’ = 7.0 Hz, J2’,3’ = 9.4 Hz, 1H, H-2’), 5.60-5.58 (m, 1H, H-4’), 5.52 (dd, 
J2’,3’ = 9.4 Hz, J3’,4’ = 3.6 Hz, 1H, H-3’), 5.21 (d, J1’’,2’’ = 4.2 Hz, 1H, H-1’’), 4.88 (d, J1’,2’ = 7.0 Hz, 
1H, H-1’), 4.71 (d, 2JCHHPh, CHHPh, = 12.1 Hz, 1H, CHHPh), 4.69 (d, 2JCHHPh, CHHPh, = 12.1 Hz, 1H, 
CHHPh), 4.56 (d, 2JCHHPh, CHHPh, = 11.7 Hz, 1H, CHHPh), 4.53 (d, 2JCHHPh, CHHPh, = 11.7 Hz, 1H, 
CHHPh), 4.50 (d, 2JCHHPh, CHHPh, = 11.9 Hz, 1H, CHHPh), 4.44 (d, 2JCHHPh, CHHPh, = 11.9 Hz, 1H, 
CHHPh), 4.24 (dd, J3’’,4’’ = 8.3 Hz, J4’’,5’’ = 4.0 Hz, 1H, H-4’’), 4.18 (dd, J4’,5a’ = 3.3 Hz, 2J5a’,5b’ = 13.1 
Hz, 1H, H-5a’), 4.02-3.95 (m, 2H, H-3a,2), 3.85-3.79 (m, 2H, H-3b,3’’), 3.72-3.69 (m, 2H, H-
5b’,2’’), 3.50 (dd, J4’’,5’’a = 5.0 Hz, 2J5a’’,5b’’ = 10.3 Hz, 1H, H-5a’’), 3.45-3.39 (m, 2H, H-5b’’,1), 
3.34-3.27 (m, 2H, H-4), 3.22 (t, J5,6 = 7.0 Hz, 2H, H-6), 1.67-1.61 (m, 2H, H-5); δC(100 MHz; 
CDCl3) 165.7, 165.6, 165.3 (3 × C=O), 133.3, 133.3, 129.9, 129.8, 129.4,129.4, 129.1, 128.5, 
128.4, 128.4, 128.3, 128.1, 128.0, 127.7, 127.7, 127.6, 101.5 (C1’’), 101.1 (C1’), 81.6 (C4’’), 
77.7 (C2’’), 75.7 (C2), 75.5 (C3’’), 73.5 (CH2Ph), 72.3 (CH2Ph), 72.3 (CH2Ph), 71.0 (C3’), 70.6 
(C5’’), 70.2 (C2’), 70.0 (C1), 69.2 (C3), 68.9 (C4’), 67.9 (C4), 63.3 (C5’), 48.4 (C6), 29.0 (C5); 
HRMS (ESI+) m/z calc. for C58H59N3O14Na+1044.3889 [M+Na]+ found 1044.3885 [M+Na]+. 
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(2S)-3-(3-aminopropoxy)-2-(α-ᴅ-ribofuranosyloxy)propyl) α-ʟ-arabinopyranoside (2S-15) 
 
(2S)-3-(3-Azidopropoxy)-2-[(2’,3’,5’-tri-O-benzyl-α-ᴅ-ribofuranosyl)oxy]propyl-2’’,3’’,4’’-tri-
O-benzoyl-α- ʟ -arabinopyranoside (2S-14) (30 mg, 29 µmol) was dissolved in a mixture of 
MeOH (10 mL) and EtOAc (5 mL) and hydrogenated palladium on activated charcoal (10% Pd 
basis) (5 mg)  under a hydrogen pressure of ~15 PSI at 50 °C for 24 hours.  The resulting 
mixture was filtered through Celite and the filter was washed with additional MeOH (25 mL).  
The solvent was removed in vacuo and the resulting crude mixture was dissolved in a mixture 
of MeOH/H2O/NEt3 (5:2:1 mL) and stirred at room temperature overnight.  The solvent 
mixture was evaporated in vacuo and the crude mixture was passed through a short column 
of Dowex® 1X2-400 resin (OH- form) in water.  The water was removed by lyophilisation to 
give (2S-15) (7.4 mg, 41 %) as a white powder. [α]D +35.5 (c  1.0, H2O); δH(400 MHz; D2O) 5.24 
(t, J1’’,2’’ = 3.9 Hz, 1H, H-1’’), 4.29 (d, J1’,2’ = 7.6 Hz, 1H, H-1’), 4.11 (dd, J3’’,4’’ = 7.6 Hz, J4’’,5’’ = 3.7 
Hz, 1H, H-4’’), 4.05-3.92 (m, 4H, H-4’,2’’,3’’,3a), 3.87-3.82 (m, 2H, H-5’,2), 3.74 (dd, J2,3a = 4.9 
Hz, J3a,3b = 10.5 Hz, 1H, H-3b), 3.70-3.47 (m, 8H, H-1,5a’’,5’’b,3’,5b’,4,2’), 2.83 (t, J5,6 = 7.2 Hz, 
1H, H-6), 1.80-1.73 (m, 1H, H-5); δC(100 MHz; CDCl3) 103.5 (C1’), 102.0 (C1’’), 84.7 (C4’’), 75.7 
(C4’), 72.3 (C3’), 71.4 (C2’’), 70.7 (C2’), 69.7 (C1), 69.6 (C3’’), 69.6 (C3), 69.1 (C4), 68.2 (C2), 
66.3 (C5’), 61.4 (C5’’), 37.7 (C6), 29.0 (C5);  HRMS (ESI+) m/z calc. for C16H31NO11Na+ 414.1970 
[M+Na]+ found 414.1969 [M+Na]+ 
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(2R)-3-(3-aminopropoxy)-2-(α-ᴅ-ribofuranosyloxy)propyl α-ʟ-arabinopyranoside (2R-15) 
 
(2R)-3-(3-Azidopropoxy)-2-[(2’,3’,5’-tri-O-benzyl-α-ᴅ-ribofuranosyl)oxy]propyl-2’’,3’’,4’’-tri-
O-benzoyl-α- ʟ -arabinopyranoside (2R-15) (45 mg, 44 µmol) was dissolved in a mixture of 
MeOH (10 mL) and EtOAc (5 mL) and hydrogenated with palladium on activated charcoal 
(10% Pd basis) (5 mg) under a hydrogen pressure of ~15 PSI at 50 °C for 24 hours.  The 
resulting mixture was filtered through Celite and the filter was washed with additional MeOH 
(25 mL).  The solvent was removed in vaccuo and the resulting crude mixture was dissolved 
in a mixture of MeOH/H2O/NEt3 (5:2:1 mL) and stirred at room temperature overnight.  The 
solvent mixture was evapourated in vaccuo and the crude mixture was passed through a 
short column of Dowex 1X2-400 resin (OH- form) in water.  The water was removed by 
lyophilisation to give (2R-15) (10.7 mg, 59%) as a white powder. [α]D +40.4 (c = 1.0, H2O); 
δH(400 MHz; D2O) 5.24 (d, J1’’,2’’ = 4.4 Hz, 1H, H-1’’), 4.29 (d, J1’,2’ = 7.7 Hz, 1H, H-1’); 4.07 (dd, 
J3’’,4’’ = 6.6 Hz, J4’’,5a’’ = 3.7 Hz, 1H, H-4’’), 4.04-4.00 (m, 2H, H-4’,2’’), 3.95 (dd, J2’’,3’’ = 3.5 Hz , 
J3’’,4’’ = 6.6 Hz, 1H, H-3’’), 3.90-3.83 (m, 4H, H-3a, 2, 5a’), 3.75 (dd, J2,3b = 4.4 Hz, J3a,3b = 11.4 
Hz, 1H, H-3b), 3.68 (dd, J4’’,5a’’ = 3.7 Hz, J5a’’,5b’’ = 12.4 Hz), 1H, H-5a’’), 3.63-3.46 (m, 8H, H-
1,5b’’,3’,5’,4,2’), 2.60 (t, J5,6 = 6.9 Hz, 1H, H-6), 1.70-1.61 (m, 1H, H-5); δC(100 MHz; CDCl3) 
103.4 (C1’), 101.9 (C1’’), 84.7 (C4’’) 75.7 (C4’), 72.3 (C3’), 71.3 (C2’’), 70.7 (C2’), 70.2 (C1), 
69.6 (C3’’), 69.3 (C4), 69.1 (C3), 68.2 (C2), 66.2 (C5’), 61.5 (C5’’), 37.7 (C6), 31.4 (C5);  HRMS 
(ESI+) m/z calc. for C16H31NO11Na+  414.1970 [M+Na]+ found 414.1968 [M+Na]+. 
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Table 6.1 – Database of relative retention times and MRM transitions of selected sugar nucleotides.1  
Sugar nucleotides synthesised by me (Chapter 2) are shown in bold.  
Sugar Nucleotide Relative 
Retention time 
MRM 
transitions 
Fragment 
UDP-Glc 1.00 565 → 323 
565 → 79 
[NMP-H]- 
[H3PO4-H3O]- 
UDP-Galp 0.92 565 → 323 
565 → 159 
[NMP-H]- 
[H4P2O7-H3O]- 
UDP-α-D-galactofuranose (UDP-
Galf) 
1.10 565 → 323 
565 → 159 
[NMP-H]- 
[H4P2O7-H3O]- 
UDP-GlcNAc 
 
0.98 606 → 385 
606 → 159 
[NDP-H-H2O]- 
[H4P2O7-H3O]- 
UDP-GlcNAcA 0.89 620 → 403 
620 → 159 
[NDP-H]- 
[H4P2O7-H3O]- 
UDP-2-amino-2-deoxy-α-D-
glucose (UDP-GlcN) 
0.90 564 → 385 
564 → 273 
[NDP-H-H2O]- 
? 
UDP-2-amino-2-deoxy-α-D-
galactose (UDP-GalN) 
0.86 564 → 385 
564 → 273 
[NDP-H-H2O]- 
? 
UDP-2,3-diacetamido-2,3-
dideoxy-α-D-glucuronic acid 
(UDP-GlcdiNAcA) 
0.95 661 → 403 
661 → 159 
[NDP-H]- 
[H4P2O7-H3O]- 
UDP-GlcA 0.74 579 → 403 
579 → 323 
[NDP-H]- 
[NMP-H]- 
UDP-2-deoxy-2-fluoro-α-D-
galactose (UDP-2F-Gal) 
0.94 567 → 385 
567 → 159 
[NDP-H-H2O]- 
[H4P2O7-H3O]- 
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UDP-β-L-rhamnose  
(UDP-L-Rha) 
0.84 549 → 323 
549 → 159 
[NMP-H]- 
[H4P2O7-H3O]- 
UDP-L-Araf 
 
1.05 535 → 323 
535 → 159 
[NMP-H]- 
[H4P2O7-H3O]- 
UDP-L-Arap 
 
0.81 535 → 323 
535 → 159 
[NMP-H]- 
[H4P2O7-H3O]- 
UDP-Xylp 0.99 535 → 323 
535 → 159 
[NMP-H]- 
[H4P2O7-H3O]- 
UDP-α-D-mannose 0.81 565 → 403 
565 → 159 
[NDP-H]- 
[H4P2O7-H3O]- 
dTDP-α-D-glucose 
(dTDP-Glc) 
1.39 563 → 321 
563 → 241 
[NMP-H]- 
[Glc-1-P-H-H2O]- 
dTDP-β-L-rhamnose  
(dTDP-L-Rha) 
1.35 547 → 321 
547 → 225 
[NMP-H]- 
c[Rha-1-P-H-H2O]- 
GDP-Glc 1.56 604 → 362 
604 → 241 
[NMP-H]- 
c[Glc-1-P-H-H2O]- 
GDP-β-L-galactose  
(GDP-L-Gal) 
1.51 604 → 442 
604 → 423 
[NDP-H]- 
[NDP-H-H2O]- 
GDP-Man 1.43 604 → 442 
604 → 424 
[NDP-H]- 
[NDP-H-H2O]- 
GDP-L-Fuc 1.60 588 → 442 
588 → 344 
[NDP-H]- 
[NMP-H-H2O]- 
GDP-α-D-arabinopyranose (GDP-
Arap) 
1.53 574 → 442 
574 → 362 
[NDP-H]- 
[NMP-H]- 
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GDP-β-L-xylopyranose (GDP-L-
Xylp) 
1.52 574 → 442 
574 → 424 
[NDP-H]- 
[NDP-H-H2O]- 
ADP-Glc 1.65 588 → 346 
588 → 241 
[NMP-H]- 
[Glc-1-P-H-H2O]- 
5’’-(adenosine 5'-
pyrophosphoryl)-D-ribose (ADP-
Rib) 
1.64 558 → 346 
558 → 159 
[NMP-H]- 
[H4P2O7-H3O]- 
 
Table 6.1 - adapted from M. Rejzek, L. Hill, E. S. Hems, S. Kuhaudomlarp, B. A. Wagstaff, R. 
A. Field, Methods in Enzymology, Elsevier, 2017 (Article in Press). 
https://doi.org/10.1016/bs.mie.2017.06.005  
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Table 6.2 - values for 2° position on the glyceryl glycosides, compared with literature value for 
analogous glycosylated part of prymnesin backbone 
 PRM-1 
α-ᴅ-Ribf 
PRM-1 
α-ʟ-Arap 
PRM-1 
β-ᴅ-Galf 
PRM-2 
α-ʟ-Xylf 
PRM-2† 
β-ᴅ-Araf 
PRM-B1 
α-ᴅ-Galp 
 1H 13C 1H 13C 1H 13C 1H 13C 1H 13C 1H 13C 
Lit. 3.84a 87.8a 4.53a 78.3a 4.48a 78.6a 3.76a 88.0a 3.76a* 88.0a* 3.59b 90.3b 
Synth. 3.68c 79.0c 3.75c 81.1c 3.63c 78.8c 3.64c 80.0c 3.70c 82.5c 3.62d 78.7d 
† Rasmussen et al.2 have drawn PRM-2 as glycosylated with β-ᴅ-Araf but there is no data or discussion 
to support this in the paper; * The α-ʟ-Xylf published values are used as a substitute.  a Values for N-
acetylated PRM-1/2 using CD3OD/C5D5N 1:1 as solvent; b Values for PRM-B1 using CD3OD as solvent; c 
CD3OD as solvent; d D2O as solvent. 
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Translated tri-functional protein sequence from Prymnesium parvum (Texoma 1) was 
acquired from the publicly available MMETSP database.2  We believe this protein may be 
responsible from the biogenesis of GDP-β-ʟ-Xylf. 
 
 
Ara-4-epimerase, Galp mutase, unknown (lack of homology with NCBI dataset) 
 
>Prymnesium parvum 
MGVPFVRRKLTEQVTNVLVTGGGGFIGSHFALSLIDKKGFNITLVDDLSRGSIETVLRLQALAAQHGQEL
HFEQLDVNEGFKMAALLKRNRVDLVXHFSGNAYVGESMSMPQEYYQNITASTVSLVRAMHSAGVHKL
IFSSSCATFGAPKQFPITEASPQRPTNPYGQAKLQAEQAIVAFLRAQERAGAPFSAALLRYFNVIGADPD
GRLGPHLRHEANAKFPRIVDAAYDVALGVREKMTVMGSSFPTKDGSAQRDYIHVSDLVHAHLKLMYAL
RDNDLLFYNVGNGQPYTVLEIVEQVRQVTGKPIPITLSKERPGDPPILYTDPAKIQYEIGWRPRYPDIHSM
ILHGWNWRVKHYGRPPAPSIDPLAHNGACFNSTTDEAPPLGNNPRIVVIGAGPTGLCAAYRLTELGYTN
WELVEATAKPSGLACTIQDEXKFQWDIGVHCLFSHFEFFDALLDNMLPPKDWLYHQRYSPARMRGTW
VGYPVQSNLWRLPEAEVSGIIADLAQKEVTPQKSGAQIRNFKDWLEAGFGKALTDTFMAPYNAKVWA
HPAEEMNYIWVGERVATIQFKNILSNVINKRDAPAWGPNAQFRYPMNGTGHIWVKVFDALPKERKRL
GARXEKVHTKPGAKAVVLQDGTRIPFDGLLSTMPLPHLLRMTPDHPELAELAEGNNGAADHSKFKHQT
ANIIGVGIDGTAMPAALNGVHWVYFPEKEYIFYRVTVLSNFSPLMVAKPFKQWSLLIEVSESRHRHEVLA
LKGDRAALRARVIEGLHMSGMLPRNATIVSVWDTRLEYGYPVPYVERNMHVHAADKALRQLGVWSR
GRFGSWKYEVGNQDHSCMLGYDAVDSMLFGGNDQGREATFNLPNKVNNMVRPYDRMFDRDELAR
QAGRQHTFGAPYRRLKQLPQWDWVTYHCRGTDEWLDKIREVMIAQPEDTKWLIHGYEVCGFAKVKR
PMHEMLREGLNHHDRIPHPMADSAPTPFPVSGWVRHIIAHYKRLPDILFFAPSDVPASSRLFSSSGRGSI
IAAMKESADFGMWGTRIVDMPAAMHTTFCKVVWPLTARAEKRKLKRSCPERVVTMAEPVILVSKSRIL
NTPLETWKKVLSLLEDATAGKGNDELFSFGWHLLFGQGTVLPPRFMHEHWTAARPRAARGSGNLSEA
ASSKRRGLRAWSSGSKHNSCHESAASNARTWFLFDARMATSGGRVAAMMPTCGLD 
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Figure 6.1 - HSQCed 2D NMR spectrum for 1,3-dihydroxypropan-2-yl-β-ᴅ-galactofuranoside 
 
Figure 6.2 – Assigned HSQC NMR spectrum of 1,3-dihydroxypropan-2-yl α-ʟ-
arabinopyranoside. 
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Figure 6.3 - HSQCed NMR spectrum for 1,3-dihydroxypropan-2-yl β-ᴅ-arabinopyranoside. 
 
Figure 6.4 - HSQCed NMR spectrum of 1,3-dihydroxypropan-2-yl α-ᴅ-ribofuranoside   
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Figure 6.5 - HSQCed NMR spctrum of 1,3-dihydroxypropan-2-yl α-ʟ-xylofuranoside 
 
Figure 6.6 - HSQCed NMR spectrum of 1,3-dihydroxypropan-2-yl β-ᴅ-arabinofuranoside 
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Figure 6.7 – Zoomed HSQCed spectrum of 3-(3-Azidopropoxy)-2R-[(2’,3’,5’-tri-O-benzyl-α-ᴅ-
ribofuranosyl)oxy]propyl-2’’,3’’,4’’-tri-O-benzoyl-α- ʟ -arabinopyranoside  
 
Figure 6.8 – Zoomed HSQCed spectrum of 3-(3-Azidopropoxy)-2S-[(2’,3’,5’-tri-O-benzyl-α-ᴅ-
ribofuranosyl)oxy]propyl-2’’,3’’,4’’-tri-O-benzoyl-α- ʟ -arabinopyranoside 
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Figure 6.9 - Zoomed HSQCed spectrum of 3-(3-aminopropoxy)-2S-(α-ᴅ-ribofuranosyloxy)propyl α-ʟ-
arabinopyranoside 
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Figure 6.10 – Zoomed HSQCed spectrum of 3-(3-aminopropoxy)-2R-(α-ᴅ-ribofuranosyloxy)propyl α-ʟ-
arabinopyranoside   
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